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SUMMARY 
 
Viruses are not more than particles composed of lipids and/or proteins with genetic 
information – the viral RNA or DNA genome – embedded inside. In order to be efficient, once 
they enter the host cell they need to multiply this genetic information, package it into new viral 
particles and spread out from the cell. While in order to produce viral proteins viruses highjack 
cellular machinery, for replicating their genome most viruses use their own, specialized 
polymerases.   
Bunyaviridae is the largest viral family of segmented negative-strand RNA viruses, 
comprising also Arenaviridae and Orthomyxoviridae families. Some bunyaviruses are causative 
agents of severe human diseases including heamorrhagic fevers, encephalitis and meningitis. 
Others infect a variety of plants and animals posing a significant economic threat to the crop 
cultivation and cattle breeding. 
RNA-dependent RNA polymerases of segmented negative-strand RNA viruses are 
multifunctional machines, able to perform both de novo genome replication via positive-strand 
cRNA intermediate, and viral mRNA transcription using cap-snatched host-derived mRNA 
primers. Viral RNA genome of bunyaviruses, arenaviruses, and orthomyxoviruses is divided into 
three, two, and eight segments respectively. Each segment, coated by nucleoproteins and 
attached through its conserved 3ʹ and 5ʹ ends to the polymerase, constitutes an individual 
ribonucleoprotein particle – an autonomous RNA synthesis unit. 
The scope of the PhD project described in this thesis was the structural and functional 
characterization of the La Crosse orthobunyavirus polymerase, also named the L protein. It was 
based on the hypothesis that all polymerases of segmented negative-strand RNA viruses share 
a similar domain organization and mode of action. During the 1st year attempts were made to 
confirm and characterize a putative C-terminal cap-binding domain. During the 2nd year project 
was extended to study 3ʹ and 5ʹ vRNA ends interactions with the full length and C-terminus 
truncated L protein. Facing difficulties to establish replication and transcription assays in vitro, 
vRNA binding studies and co-crystallizastion were continued during the 3rd year. This finally led 
to the main achievement of the thesis – the x-ray structure of La Crosse orthobunyavirus 
polymerase in complex with vRNA. Obtained structure is a breakthrough in the bunyavirus field. 
It reveals – unlike it was initially believed – conserved, sequence specific and separate binding 
sites for 3ʹ and 5ʹ vRNA ends located within the polymerase. The 5ʹ vRNA end binding 
allosterically structures one of the conserved catalytic motifs within the polymerase active site. 
The structure sheds also some new light on bunyaviral replication and transcription 
mechanisms. There exist two distinct product and template exit channels, suggesting that the 
nascent RNA strand is separated from the template and leaves the polymerase as the single-
strand RNA. Close proximity of the template entry and exit channels explains how the 
polymerase can translocate along the genomic template with minimal disruption of the RNP. 
 
 
 
 
 
 
In parallel to the La Crosse polymerase structure, structures of Influenza A and B 
heterotrimeric polymerases in complex with vRNA were also obtained in Stephen Cusack group. 
This gave a great opportunity to compare the domain organization and the nature of vRNA 
binding by viral polymerases belonging to Bunyaviriadae and Orthomyxoviridae families, and 
proved that despite minimal sequence homology the structural similarities are striking. This 
strongly suggests an evolutionary common ancestor, which can possibly be shared with non-
segmented negative-strand RNA viruses as well.  
RÉSUMÉ 
 
Les virus ne sont rien de plus que des particules composées de lipides et/ou de 
protéines qui encapsulent de l’information génétique composée d’ARN ou d’ADN. Au cours du 
cycle viral, les virus entrent dans la cellule hôte où ils dupliquent leur génome, puis forment de 
nouvelles particules virales qui ressortiront de la cellule pour se diffuser. Alors que pour 
produire leurs protéines virales les virus détournent la machinerie cellulaire, ils  utilisent pour la 
plupart leur propre polymérase spécifique pour répliquer leur génome. 
Les Bunyaviridae sont une grande famille des virus à ARN simple brin segmenté de 
polarité négative. Les Arenaviridae et les Orthomyxoviridae sont les deux autres familles de ce 
type. Certains bunyavirus provoquent des maladies humaines graves, comme des fièvres 
hémorragiques, des encéphalites et des méningites. D’autres infectent des plantes et animaux, 
posant une menace économique sérieuse en agronomie. 
Les ARN polymérases ARN-dépendante de virus à ARN négatif segmenté sont des 
machineries multi-fonctionnelles, capables de répliquer le génome viral et de le transcrire en 
ARNs messagers. La réplication est effectuée de novo, en utilisant un intermédiaire d’ARN 
complémentaire de polarité positive, alors que la transcription est initiée par vol de coiffe 
d’ARN cellulaire. Chaque segment du génome viral est recouvert par des nucléoprotéines et fixé 
à la polymérase par ses extrémités 3' et 5' conservées. Le complexe ARN 
viral/nucléoprotéines/polymérase forme une ribonucléoprotéine, qui est l’unité fonctionnelle 
de la réplication/transcription. 
L’objectif de mon projet de thèse était la caractérisation structurale et fonctionnelle de 
la polymérase du virus La Crosse, également nommée protéine L. Ce projet était basé sur 
l'hypothèse que toutes les polymérases de virus à ARN négatif segmenté pourraient partager 
une organisation et un mode d'action similaire. Lors de la première année de ma thèse, j’ai 
tenté de caractériser le domaine C-terminal, que nous supposions être responsable de la 
fixation de coiffe. Au cours de la deuxième année, j’ai étendu mes recherches sur l’étude de 
l’interaction entre les extrémités de l’ARN viral et la protéine L (protéine entière et construction 
tronquée en C-terminal). Confronté à des difficultés pour établir des tests de réplication et de 
transcription in vitro, j’ai poursuivi mes recherches en troisième année avec l’étude 
d’interactions et de co-cristallisation entre polymérase et ARN viral. Cela a finalement conduit 
au résultat principal de ma thèse - la détermination de la structure par cristallographie aux 
rayons X de la polymérase de virus de La Crosse en complexe avec les extrémités 3' et 5' de 
l‘ARN viral. La structure obtenue constitue une percée dans le domaine de bunyavirus. Elle 
révèle – à la différence de ce qui avait été initialement proposé – que les extrémités 3' et 5' de 
l’ARN se lient dans deux sites séparés et conservés. La liaison de l'extrémité 5' de l'ARN viral 
stabilise de façon allostérique l'un des motifs catalytiques du site actif de la polymérase. La 
structure révèle l’existence de deux tunnels séparés pour l’ARN produit et l’ARN matrice de 
 
 
 
 
 
 
sortir, ce qui suggère que le brin d'ARN naissant est séparé de la matrice et quitte la polymérase 
comme ARN simple brin. La proximité des tunnels d'entrée et de sortie de la matrice explique 
comment la polymérase peut se déplacer le long de l’ARN génomique avec une perturbation 
minimale de la ribonucléoprotéine. 
En parallèle de la structure de la polymérase du virus La Crosse, les structures des 
polymérases hétérotrimériques de la grippe A et B en complexe avec l'ARN viral ont également 
été déterminées au sein du groupe du Dr. Stephen Cusack. La comparaison de l'organisation 
des polymérases des deux familles et de la nature de leur liaison avec l’ARN viral montre que, 
malgré une homologie de séquence minimale, des similitudes structurelles sont frappantes. 
Cela suggère fortement la présence d’un ancêtre commun. 
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1.1 Bunyaviruses  
 
Bunyaviridae family was defined in 1973 and at that point comprised a single Bunyavirus 
genus (Porterfield et al., 1975). Its name comes from the Bunyamwera virus (BUNV), isolated in 
1943 during yellow fewer in Uganda (Smithburn et al., 1946). Since then more than 350 isolated 
viruses have been identified which makes Bunyaviridae the largest and the most diverse family 
of segmented negative-strand RNA viruses (sNSV), after Arenaviridae and Orthomyxoviridae. 
Apart from being the causative agents of serious zoonotic human diseases, bunyaviruses infect 
a wide range of crops and cattle, which makes them an important health and economic threat. 
Bunyaviruses are enveloped viruses with the RNA genome (vRNA) divided into three 
segments and coding, depending on the genera, from four to six viral proteins. Depending on 
the size of these genomic segments, the size of viral structural proteins, and the consensus 
sequences of the 3ʹ and 5ʹ vRNA extremities bunyaviruses can be subdivided into five genera: 
Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus and Tospovirus (Fig. 1.1).  
This chapter describes the current understanding of cellular and molecular biology of 
bunyaviruses putting the main emphasis on the genome organization and its transcription and 
replication mechanisms. Several comprehensive and broader reviews on bunyavirus biology are 
available (Elliott, 2014; Plyusnin and Elliott, 2011; Walter and Barr, 2011).  
 
1.1.1 Classification, distribution, and transmission  
 
Bunyaviruses are arthropod-borne viruses (with the exception of rodent-borne 
hantaviruses) and their worldwide distribution is limited to the natural habitat of their insect 
hosts, usually mosquitos. In most cases a particular bunyavirus can be transmitted by only one 
arthropod species. This high dependence on the insect vector greatly limits the ecological niche 
of each bunyavirus, leading on the other hand to the efficient viral emergence and re-
emergence each time the reservoir vector adapts to a new environment.   
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Orthobunyavirus genus is the largest one within Bunyaviridae family, and includes more 
than 170 named viruses, grouped into 48 species, and 18 serogroups. Initally named Bunyavirus 
it was renamed in 2005 in order to avoid confusion while referring to the entire bunyaviral 
family (Nichol et al., 2005). Orthobunyaviruses are mostly transmitted by mosquitos from the 
Aedes genus, with some being transmitted by Haemaphysalis ticks or Culicoides midges. A good 
example of newly emerged orthobunyavirus is the Schmallenberg virus (SBV) which causes a 
significant threat in western european farms since summer 2011, infecting cattle, sheep and 
goat herds (Hoffmann et al., 2012). On the other hand, viruses belonging to the California 
serogroup (e.g. La Crosse virus (LACV)) cause encephalitis and meningitis mainly in children and 
young adults (Haddow and Odoi, 2009).  
 
Figure 1.1 Bunyaviridae genera classification based on RNA segments length, viral protein size, and 
conserved sequence of genomic ends; adapted from (Plyusnin and Elliott, 2011). A) Genomic segments 
length (given in kb). B) Sizes of viral structural proteins (given in kDa). C) Consensus 3ʹ and 5ʹ vRNA 
terminal sequences 
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Hantaviruses, unlike other bunyaviruses, are mainly rodent-borne viruses. The 
Hantavirus genus has been added to the Bunyaviridae family in 1987 (Schmaljohn and 
Dalrymple, 1983). Hantaviruses are distributed worldwide and can generally be divided into Old 
World hantaviruses, causing haemorrhagic fever with renal syndrome (e.g. Hantaan virus 
(HTNV) with 50% mortality rate), and New World hantaviruses, causing hantavirus pulmonary 
syndrome – e.g. Sin Nombre virus (SNV) and Andes virus (ANDV). Hantavirus reservoir hosts 
belong mainly to the families Cricetidae and Muridae, of the order Rodentia, but some viruses 
were also isolated from mammals belonging to the order Soricomorpha. Hantaviruses have the 
ability to adapt their viral cycle to either mammalian reservoir or final host – establishing 
persistence in rodents and causing disease in humans. There are numbers of studies addressing 
virus-host co-evolution of hantaviruses (Nemirov et al., 2004; Plyusnin and Morzunov, 2001).  
Nairoviruses are transmitted principally by ixodid ticks and are restricted to Africa and 
Eurasia. The best studied representative of the genus, the Crimean Congo haemorrhagic fever 
virus (CCHFV), is a highly pathogenic, BSL-4 virus with 50% mortality rate in man. It has initially 
been described in 1944 during an epidemic in Crimea. Since then its geographic distribution 
appeared to range from western China through southern Europe, to south Africa, being 
probably the biggest known viral distribution for a nonavian visrus (Swanepoel et al., 1983). 
Nairobi sheep disease virus (NSDV) – another example of a highly pathogenic agent from 
Nairovirus genus – causes up to 90% mortality rate among domestic animals (Marczinke and 
Nichol, 2002).  
Phleboviruses are emerging human pathogens with Rift Valley fever virus (RVFV) causing 
high mortality haemorrhagic fevers in both Africa and Middle East. In 1991 viruses related to 
the Uukuniemi virus (UUKV) were reclassified and added to the Phlebovirus genus (Francki et 
al., 1991; Palacios et al., 2013). Phleboviruses can be further classified based on the arthropod 
vectors that transmit them. Sandfly fever viruses (SFV), Uukuniemy virus (UUKV), and Rift Valley 
fever virus are transmitted by Phlebotomus sand flies, Haemaphysalis ticks or Aedes 
mosquitoes respectively. The type of the arthropod vector affects the biology of phleboviruses.   
Tospoviruses are the only bunyaviruses infecting plants, threathening global agricultural 
productivity (Pappu et al., 2009; Turina et al., 2012). The Tospovirus genus is the newest one 
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established, and initially contained only the tomato spotted wilt virus (TSWV). Thrips – plant-
feeding arthropods from the family Thripidae – are the major vectors of tospoviruses. Recent 
introduction of one of them in Europe – the Frankliniella occidentalis thrip – allowed the 
tospovirus spread in the Mediterranean, leading to one of the most serious threats to vegetable 
crops in this region. 
 
1.1.2 Viral cycle 
 
Bunyaviruses enter the cell by means of the endocytosis, although detailed entry 
strategies may differ between the genera. Firstly the Gn/Gc glycoproteins have to be 
recognized by various cell surface receptors. Hantaviruses requires receptors from the integrin 
family (Gavrilovskaya et al., 1998), while phleboviruses and orthobunyaviruses entry is 
promoted by DC-SIGN (Lozach et al., 2011). In the next step, as shown for orthobunyaviruses, 
clathrin-mediated endocytosis takes place (Hollidge et al., 2012; Santos et al., 2008). Following 
internalization the endosome undergoes the acid-activated transition from its early to the late 
stage. At pH of around 5.5 the viral membrane fuses with the endosomal one which releases 
the viral genomes to the cytoplasm (Lozach et al., 2010). Each genomic segment is attached to 
the viral polymerase (the L protein), and coated by numerous nucleoproteins (the N proteins). 
Together they form ribonucleoproteins (RNP) – the functional RNA synthesis units. 
Upon entry to the cell and release of the RNPs the primary transcription occurs. During 
this process negative sense viral genomes (vRNA) can be used directly as templates to produce 
the viral mRNA in a single RNA synthesis round. Production of the viral mRNA is initiated via the 
cap-snatching – the sNSV-specific mechanism which involves binding of host capped mRNAs to 
the RNPs, cleavage of these RNAs close to the 5ʹ cap by a viral endonuclease intrinsic to the L 
protein, and use of the short capped fragments as primers for viral mRNA transcription (Morin 
et al., 2010; Plotch et al., 1981; Reguera et al., 2010; Reich et al., 2014). Transcription stops 
before the end of the viral template, resulting in a shorter 3ʹ end which, in case of 
bunyaviruses, is not poly-adenylated (Bouloy et al., 1990; Collett, 1986; Hutchinson et al., 
1996). The viral mRNA is then translated by the cellular machinery producing the viral proteins. 
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In the following phase of infection, accumulation of the viral L and N proteins enables 
replication of the genomic segments to take place. Unlike one-step transcription, replication 
requires the synthesis of a positive sense, complementary RNA (cRNA) which is then used as the 
template to produce vRNA. Moreover, in contrast to transcription, replication initiates de novo 
and results in full copies of genomic segments. During both cRNA and vRNA synthesis the 
emerging nascent RNA strand gets coated by N proteins. A distinctive feature of Bunyaviridae is 
that the polymerase performs both transcription and replication in the cytoplasm, similarly to 
 
Figure 1.2 Model of the bunyavirus infection cycle. After clathrin-mediated endocytosis (1), and pH-
dependent fusion of the viral and endosomal membranes, the vRNPs are realeased to the host-cell 
cytoplasm (2), where they undergo primary transcription enabling translation of the viral proteins by the 
host machinery (3). Accumulation of the viral proteins (the L and N proteins) switches on replication of 
the vRNPs through the intermediate cRNPs (4). Viral replication is thought to occur within the viral 
factories localized in the Golgi complex. Gn/Gc glycoproteins embedded in the Golgi membranes enable 
packaging of the multiplied vRNPs (5). Newly formed virions are transported inside the vesicles to the 
periphery of the cell, and released (6). 
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the Arenaviridae, and differently from the Orthomyxoviridae, whose RNPs are transcribed and 
replicated inside the nucleus. 
Electron microscopy studies using cells infected with Bunyamwera virus (BUNV) 
revealed formation of unique structures within the Golgi complex – the viral factories. It is 
postulated viral replicating machineries are localized within these membrane compartments, 
which results in local accumulation of the newly produced RNPs, without the need of 
transferring them to the assembly and packaging sites (Fontana et al., 2008; Novoa et al., 2005). 
Nature of these factories is different in mammalian and mosquito cells (López-Montero and 
Risco, 2011) 
The final phase of infection is the assembly of newly produced viral RNPs into virions. In 
mammalian cells they are internalized to the lumen of Golgi complex (Fontana et al., 2008). 
Afterwards they bud into secretory vesicles inside which they travel towards the plasma 
membrane to be released. It remains an open question how the RNPs representing three 
genomic segments are properly co-packaged into the same virion. Studies performed on RVFV 
suggest that elements responsible for coordinated packaging of viral segments lies within their 
non-coding ends (Terasaki et al., 2011). Successful generation of an artificial 4-segment RVFV 
proved a certain flexibility in vRNPs packaging (Wichgers Schreur et al., 2014). 
 
1.1.3 Lytic vs. persistent infection  
 
Insects are the natural reservoir vectors for most bunyaviruses (except hantaviruses), 
with mosquitos from the Aedes genus being the most frequent bunyavirus carriers. Humans 
become infected when bitten by the appropriate insect vector. There is almost no evidence for 
horizontal human-to-human transmission, with some exception like the Andes hantavirus 
(ANDV) (Padula et al., 1998), or CCHFV being nosocomially transmitted during surgical 
procedures (Mardani et al., 2009). There is also very few cases of vertical human-to-human 
transmission (Adam and Karsany, 2008). It is thus generally agreed that human infection is a 
dead-end event. Instead, bunyaviruses can be back-transmitted from human to the insect 
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vector during blood-feeding by an arthropod. Within insects bunyaviruses can be spread both 
transovarially (vertical transmission) and venereally (horizontal transmission). The former way 
of inter-arthropod transmission allows bunyaviruses to survive winter seasons. Viral infectious 
cycles are adapted to the host type and vary in the outcome. Unlike lytic infection of the 
vertebrate host cells, in insect reservoir host vector cells bunyaviruses usually cause mild and 
persistent infection. This adaptation for persistence is most likely the effect of the long host-
virus co-evolution. Studies comparing LACV infection in mammalian BHK cells and insect C6/36 
cells revealed that viral replication but not transcription is down-regulated in the insect cells. It 
was suggested that expanding pool of nucleoprotein coats at some point its own mRNA leading 
to the nucleoprotein translation shutdown (Hacker et al., 1989; Rossier et al., 1988).    
 
1.1.4 Organization of the viral genome 
 
Single-stranded negative sense RNA viruses can have their genomic material either as a 
single RNA molecule, as in case of the order Mononegavirales (comprising the rabies virus 
(RSV), the vesicular stomatitis virus (VSV), or the Filoviridae ebolavirus), or divided into several 
segments – two, three, and eight for Arenaviridae, Bunyaviridae, and Orthomyxoviridae 
respectively. The genome segmentation provides several advantages. Since the polymerase 
mutation rate in negative-strand RNA viruses is very high (around 1.0 x 10-4 mutations per base 
(Drake, 1993)), the longer the genome is, the higher number of mutations it accumulates. The 
genome segmentation permits the reassortment of different segments when the cell is co-
infected by several viruses. This greatly boosts genetic diversity and ensures elimination of 
genomic segments with deleterious mutations from the pool (Pressing and Reanney, 1984).   
Having several shorter genomic segments might by beneficial for packing into virions 
from the ergonomic point of view. However it would require a sophisticated packaging system, 
ensuring that each genomic segment is packaged into the same virus.    
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Presence of the three Orthobunyaviridae genomic segments was revealed by electron 
microscopy studies (Obijeski et al., 1976; Pattnaik and Abraham, 1983). In order to highlight the 
difference in their size the genomic segments were called large (L), medium (M), and small (S). 
Their exact length varies and is genus-dependent (Fig 1.1.B, Fig. 1.3).  The S segment codes for 
N protein and in some genera for NSs protein (Akashi and Bishop, 1983; Bouloy et al., 1984; 
Gentsch and Bishop, 1978; Gerbaud et al., 1987), the M segment codes for glycoproteins Gn 
and Gc and for NSm protein in some genera (Eshita and Bishop, 1984; Gentsch and Bishop, 
1979; Grady et al., 1987; Lees et al., 1986; Pardigon et al., 1988), and the L segment codes for L 
protein – the polymerase (Fig. 1.3).  
 
Figure 1.3 Bunyavirus genomic segments. Open reading frames of the proteins (ORF) are marked 
together with the coding strategy (black arrows). Phleboviruses and Tospoviruses exhibit the ambisense 
coding strategy. Size of the segments is reflected by the scale (bottom). Adapted from (Walter and Barr, 
2011). 
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There is high level of similarity throughout the five Bunyaviridae genera concerning 
genetic organization of the segments and coding strategies they exhibit (Bishop et al., 1982; 
Clerx-van Haaster et al., 1982). In most of the cases viral proteins are coded in a negative-sense 
manner. However, some viral mRNAs are transcribed also from the positive-sense templates. 
This ambisense coding strategy is used by phleboviruses and tospoviruses to code for non-
structural proteins NSs and NSm. An artificially generated RVFV phlebovirus, with swapped 
ORFs coding for N and NSs proteins, showed that in consequence the expression level of these 
proteins is altered (Brennan et al., 2014). In orthobunyaviruses the S segment codes both N and 
NSs protein and their ORFs overlap. The NSs protein is translated from the same viral mRNA as 
the N protein, but an alternative AUG start codon is used (Fuller et al., 1983). An exception 
from that rule was noticed in Brazoran virus which contains an enlarged S segment where the 
NSs ORF precedes that of the significantly larger N protein (Lanciotti et al., 2013). Successful 
approach to generate an artificial BUNV orthobunyavirus in which the NSs protein was coded in 
the antisense manner within the S segment proved certain plasticity of the BUNV genome (van 
Knippenberg and Elliott, 2015).  
Sequencing studies revealed that bunyavirus genomic segments are linear and possess 
3ʹ and 5ʹ non-translated ends (NTRs) (Haaster and Bishop, 1980; Obijeski et al., 1980). The NTRs 
length is genus and segment specific but the 5ʹ NTR is usually twice longer than the 3ʹ NTR. In 
case of LACV the 3ʹ NTRs are 60 nucleotides long in both M and L segments, and 80 nucleotide 
long in the S segment. The LACV 5ʹ NTRs are 125, 140, and 195 nucleotides long in L, M, and S 
segments respectively. A characteristic feature of bunyavirus genomic NTRs is their high 
conservation and extended complementarity between first 20-30 nucleotides of 3ʹ and 5ʹ ends. 
In Orthubunyavirus genus the sequence of initial 11 nucleotides is exactly the same for all three 
segments. Following nucleotides are also conserved but segment specific.   
Despite linear nature of the bunyavirus genomic RNA segments, electron microscopy 
analysis of extracted virions revealed that genomic segments are circular (Pettersson and von 
Bonsdorff, 1975). It was shown that the circularity was not due to covalent closure (Dahlberg et 
al., 1977). Instead, the RNAse A protection assays performed on purified genomic RNA 
suggested formation of double-stranded structure (Patterson et al., 1983). The existence of 
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such dsRNA structure was further confirmed in vivo by primer extension upon psoralen 
crosslinking, although it did not exclude that the very NTR ends remain single-stranded and 
primer extension is stopped by the duplex region distal from the ends (Raju and Kolakofsky, 
1989). 
 
1.1.5 L protein – the polymerase 
 
The L segments codes for a single, large L protein which is the viral RNA dependent RNA 
polymerase (RdRp). Its size ranges from 250 kDa in Orthobunyavirus, Hantavirus, and 
Phlebovirus, to 330 in Tospovirus kDa, and 450 kDa in Nairovirus. The L proteins of bunyaviruses 
are multifunctional proteins able to interact with vRNA and cRNA promoters, to transcribe the 
viral mRNA through the cap-snatching mechanism, and to copy the viral genome by de novo 
initiated replication. Multiple sequence alignment of RdRps belonging to several groups of 
negative strand RNA viruses highlighted a region containing strongly conserved polymerase 
catalytic motifs F (preA), A, B, C, D, and E (Müller et al., 1994; Poch et al., 1990). Mutagenesis of 
 
 
Figure 1.4 Comparison of endonuclease domains from polymerases of viruses belonging to three sNSV 
families – LACV (Reguera et al., 2010), LCMV (Morin et al., 2010), and Influenza A (Dias et al., 2009). 
Proteins are rainbow-colored highlighting the N terminus (blue) and the C terminus (red). 
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conserved residues within these motifs abolishes RNA synthesis activity of the BUNV L protein 
(Jin and Elliott, 1992).   
Apart from the central catalytic RdRp domain, the bunyavirus L proteins contain the cap-
snatching endonuclease domains located at the N terminus (Patterson et al., 1984). The 
structure of LACV endonuclease (Reguera et al., 2010) exhibits similar fold to the endonucleases 
from Lymphocytic choriomeningitis (LCMV) or Lassa arenaviruses (Morin et al., 2010; Wallat et 
al., 2014), and the Influenza A PA subunit endonuclease (Dias et al., 2009) (Fig. 1.4). 
Mutagenesis of the conserved catalytic endonuclease residues results in a lack of viral 
transcription in the LACV minireplicon system (Klemm et al., 2013). Multiple sequence 
alignements indicate that all bunyavirus endonucleases are related to the type II endonucleases 
with a common active site motif PD…(D/E)XK. 
The L proteins belonging to the genera Nairovirus and Tospovirus are significantly bigger 
than the ones from remaining bunyaviruses. Apart from catalytic polymerase motifs and 
endonuclease domain sequence alignments reveal additional modules. Studies with CCHFV 
nairovirus resulted in a crystal structure of one of these modules – a cysteine de-ubiquitinating 
motif (DUB) assigned to the ovarian tumour (OTU) superfamily (Capodagli et al., 2011; Frias-
Staheli et al., 2007; James et al., 2011). It is proposed that the role of such domain in CCHFV L 
protein is to remove ubiquitin and ubiquitin-like modifications from host cell proteins, which in 
turn suppress the host-cell antiviral response by inhibiting the RIG I activation by ubiquitination 
(van Kasteren et al., 2012).   
There are several conserved features suggesting that all sNSV polymerases share a 
common overall architecture. The monomeric Bunyaviridae and Arenaviridae polymerases and 
the heterotrimeric Orthomyxoviridae Influenza virus polymerase are similar in size. The 
Influenza virus polymerase PA, PB1, and PB2 subunits interact in the head-to-tail manner. The 
localization of the catalytic RdRp motifs is always central and the endonuclease domain is 
positioned at the N terminus of the polymerase. Altogether these features strongly suggest that 
all sNSV polymerases share common, modular architecture (Fig. 1.5). However it remains an 
open question whether bunyavirus L polymerase possess within its C terminus a cap-binding 
domain, homologous to the Influenza PB2 subunit cap-binding domain (Guilligay et al., 2008).   
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1.1.6 N protein – the nucleoprotein 
 
Bunyavirus nucleoprotein is the most abundantly produced viral protein during 
infection. It is critical for the genomic RNA replication since it coats both negative sense vRNA 
and positive sense cRNA, but not the viral mRNA. As revealed for BUNV the nucleoprotein 
preferentially binds single-stranded RNA and reveals higher affinity for the putative 5ʹ RNA 
encapsidation signal (Osborne and Elliott, 2000). 
 
 
Figure 1.5 Schematic diagram of the polymerase architecture of negative strand segmented viruses The 
polymerase proteins of different genera of negative strand segmented RNA viruses are represented as 
bars (not drawn to scale). The number of genome segments and an example species, the length of 
whose polymerase in amino acids is indicated at the right end, are indicated in brackets. The red bar at 
the left indicates the endonuclease domain with the particular sequence signature. The blue bar 
represents the conserved RdRp motifs in the central region. Three orthomyxovirus polymerase subunits 
PA, PB1 and PB2 are represented co-linearly. The green bar in PB2 represents the cap-binding domain, 
which is possibly located in the C-terminal region of the L-proteins of other sNSV (question mark). Figure 
and the caption to the figure are adapted from (Reguera et al., 2010). 
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Figure 1.6 Bunyavirus nucleoproteins. A) Structures of nucleoproteins belonging to Orthobunyavirus 
LACV (Reguera et al., 2013), SBV (Dong et al., 2013a), LEAV (Niu et al., 2013), and BUNV (Ariza et al., 
2013). Proteins are rainbow-colored highlighting the N terminus (blue) and the C terminus (red). Bottom 
figure represents all four structures superposed – LACV N in blue, SBV N in green, LEAV N in yellow, and 
BUNV N in red. B) Tetrameric LACV N in complex with RNA. Single nucleoprotein sequesters 11 
nucleotides. C) Structures of nucleoproteins belonging to Phlebovirus RVFV (Ferron et al., 2011) and 
Nairovirus CCHFV (Wang et al., 2012) Proteins are rainbow-colored highlighting the N terminus (blue) 
and the C terminus (red). 
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Atomic structures of nucleoproteins belonging to phlebovirus RVFV (Ferron et al., 2011; 
Raymond et al., 2010, 2012), nairovirus CCHFV (Carter et al., 2012; Guo et al., 2012; Wang et al., 
2012), and more recently orthobunyavirus BUNV (Ariza et al., 2013; Li et al., 2013), LACV 
(Reguera et al., 2013), Schmallenberg virus (Ariza et al., 2013; Dong et al., 2013a, 2013b), and 
Leanyer virus (Niu et al., 2013) are available (Fig. 1.6). As reviewed in (Reguera et al., 2014; 
Ruigrok et al., 2011), unlike non-segmented NSV nucleoproteins, whose structures share the 
same fold, comparison of Bunyaviridae nucleoproteins with other available sNSV nucleoprotein 
structures – those from  Orthomyxoviridae Influenza A (Chenavas et al., 2013; Ye et al., 2006), 
Influenza B (Ng et al., 2012), and infectious salmon anemia virus (Zheng et al., 2013), and those 
from Arenaviridae Lassa virus (Brunotte et al., 2011; Qi et al., 2010) and Junin virus (Zhang et 
al., 2013) – clearly shows that there is no common fold of the sNSV nucleoprotein. Instead, 
given different protein sizes, various oligomerization modes through flexible terminal arms, and 
different natures of the RNA-binding, it seems plausible that various sNSV families and even 
various genera belonging to the same family have developed their unique types of 
nucleoprotein-RNA interaction, resulting in different RNP architecture (Reguera et al., 2014; 
Ruigrok et al., 2011).  
The RNA sequence specificity required for the BUNV N protein binding (Osborne and 
Elliott, 2000) contrasts with the unspecific nature of other bunyavirus N protein RNA binding 
revealed by X-ray crystallography. The Orthobunyavirus LACV and the Phlebovirus RVFV N 
proteins sequester 11 or 7 bases respectively in a sequence unspecific manner (Raymond et al., 
2012; Reguera et al., 2010). It is proposed that nucleoproteins form an “armor” covering the 
genomic RNA. The assembly of nucleoproteins is stabilized by head-to-tail interactions 
mediated by the N and C terminal mobile arms which link the nucleoproteins together into long 
and flexible RNPs. 
Although the major role of the sNSV nucleoproteins is the encapsidation of genomic 
RNA and thus formation of the RNPs, there are reports suggesting additional functions of 
nucleoproteins. Structure of the Nairovirus CCHFV N protein revealed a distinct metal-
dependent binding site which turned out to have a DNA-specific endonuclease activity (Guo et 
al., 2012). Another example of the nucleoprotein with a nuclease activity comes from the 
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Arenaviridae family. The C-terminal domain of the Lassa virus N protein contains a 3'-5' RNA 
exoribonuclease activity, which is thought to suppress the interferon induction. Moreover, the 
same N protein has a deep cavity able to accommodate a nucleotide and possibly a m7GpppN 
cap structure, suggesting its role in the cap-snatching mediated transcription. Similar cap-
binding function, although not supported by structural information, was proposed for the 50 
kDa Hantavirus HANV nucleoprotein. It is thought that during translation-dependent 
transcription the HANV N protein replaces entire eIF4F translation initiation complex, and uses 
the pool of the host mRNAs localized in P bodies, thus protecting them from decapping and 
degradation (Mir and Panganiban, 2008; Mir et al., 2008, 2010). 
Bunyavirus nucleoproteins are also targets of the host-cell innate immune response. It 
was shown that the interferon-induced MxA protein can inhibit viruses belonging to various 
Bunyaviridae genera, possibly by affecting the N protein expression level and by direct 
interaction with it, which significantly reduces the pool of free N protein essential for 
replication (Andersson et al., 2004; Bridgen et al., 2004; Frese et al., 1996; Haller et al., 2007). 
Studies on the Orthobunyavirus LACV and BUNV revealed that MxA sequesters the N protein 
and co-localizes with it in cytoplasmic inclusions, thus repressing the viral replication (Kochs et 
al., 2002; Reichelt et al., 2004). Moreover, studies on the Phlebovirus RVFV showed that MxA 
targets as well the primary transcription at the early infection stage (Habjan et al., 2009). 
 
1.1.7 NSs and NSm – the non-structural proteins 
 
The main role of the non-structural protein NSs is to affect the host-cell innate antiviral 
immunity response, and it is achieved at the interferon (IFN) transcription level. In BUNV-
infected mammalian cells NSs prevents the phosphorylation of serine-2 within the host-cell 
RNA Pol II CTD heptapeptide repeats which results in a non-specific down regulation of the 
host-cell mRNA (Thomas et al., 2004). Studies with LACV-infected cells suggest that NSs induces 
degradation of the RNA Pol II subunit RPBI (Verbruggen et al., 2011). Detailed studies using 
RVFV-infected cells revealed that NSs interacts with E3 ubiquitin ligase FBXO3 and recruits it to 
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destroy the general TFIIH-p62 transcription factor by enzymatic removal of p62 (Kainulainen et 
al., 2014). 
An interesting observation is that all nairoviruses and majority of the hantaviruses do 
not possess NSs protein. It is supposed that they evade the host-cell innate immunity using a 
different strategy. Genomes of hantaviruses end with the 5ʹ-monophosphate instead of the 5ʹ-
triphosphate (Garcin et al., 1995). This is a side effect of the prime-and-realign mechanism 
(described in more detail below) and the benefit it gives is that hantavirus genomes avoid 
detection by the RIG-I RNA helicase, an interferon-inducing factor (Habjan et al., 2008). 
Less is known about the NSm protein coded within the M segment. In Tospovirus it is 
coded in the ambisense manner and translated from its own mRNA, whereas in 
Orthobunyavirus and Phlebovirus it is produced together with both Gn and Gc glycoproteins as 
a polyprotein precursor. It is supposed that the BUNV NSm protein is required for virus 
assembly (Shi et al., 2006) and as a membrane protein localizes within the Golgi-related virus-
induced elongated structures (Fontana et al., 2008). 
Apart from already mentioned Nairovirus and Hantavirus there exist examples of viruses 
from other Bunyaviridae genera which lost the capacity to express both NSs and NSm proteins. 
This is the case for several orthobunyaviruses from the California serogroup or the recently 
described Herbert-like orthobunyavirus (Marklewitz et al., 2013).  
 
1.1.8 Gn and Gc – the glycoproteins 
 
Gn and Gc are membrane glycoproteins expressed as a polyprotein precursor, which 
depending on the genera contains as well the NSm protein. The polyprotein precursor co-
transcriptionally inserted into the ER membrane. Upon proteolytic processing Gn and Gc 
proteins form a heterodimer which is later on targeted to the Golgi complex and retained there 
due to the Gn Golgi-retention signal (Andersson and Pettersson, 1998; Gerrard and Nichol, 
2002; Matsuoka et al., 1994; Shi et al., 2004; Snippe et al., 2007).  
Both Gn and Gc proteins bear the N-terminal glycosylation modification and are rich in 
evolutionally conserved cysteine residues, that form intermolecular and intramolecular 
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disulphide bonds. The Gn-Gc heterodimer is essential for the virus assembly, and remaining 
anchored to the viral envelope it allows attachment to the target cells. It was shown that the 
Gn interacts with both L and N protein which would facilitate the packaging (Piper et al., 2011). 
The Gc on the other hand contains an N-terminal ectodomain essential to mediate cell fusion 
(Shi et al., 2009).  
 
1.1.9 Role of genomic non-translated regions in RNA synthesis 
    
The 3ʹ and 5ʹ non-translated regions (NTRs) are functionally important for many aspects 
of viral cycle. They comprise for instance signals for the RNP specific encapsidation (Osborne 
and Elliott, 2000), but also for genomic segments packaging into new virions (Kohl et al., 2006; 
Terasaki et al., 2011). Genomic NTRs are also important for RNA synthesis (Flick et al., 2004; 
Gauliard et al., 2006). Moreover, the 5ʹ end seems to be more critical for RNA synthesis since 
when shortened to 67 nucleotides it cannot rescue the virus, while 22-nucleotide short 3ʹ end 
still can (Lowen and Elliott, 2005). Similarly for the RVFV initial 13 nucleotides of the 3ʹ NTR end 
were sufficient for RNA synthesis (Prehaud et al., 1997). On the other hand artificial BUNV 
genomic segments containing only 25-nucleotide long 3ʹ and 5ʹ NTRs flanking the reference 
gene proved to be efficiently replicated and transcribed (Barr and Wertz, 2005). Detailed 
mutagenesis studies targeting the initial, highly conserved 11 nucleotides of the BUNV genomes 
proved that any modification within this region, even a double mutations maintaining the 
complementarity, greatly reduce RNA synthesis (Kohl et al., 2004). Similar mutagenesis studies 
leading to the same conclusion has been done for the UUKV (Flick et al., 2002). Mutagenesis 
studies on the BUNV NTRs showed as well that while shortening the 3ʹ NTR by a single terminal 
nucleotide does not affect RNA synthesis, it does so in case of the 5ʹ end (Kohl et al., 2004).  
The difference between segments in promoting RNA replication was reported to be M > 
L > S. It was proposed that it is related to the NTR sequences after the initial 11 nucleotides 
(Barr et al., 2003). Shuffling of non-coding and coding regions between BUNV segments 
suggested a certain interplay between 3ʹ and 5ʹ ends (Barr and Wertz, 2004; Barr et al., 2003; 
Kohl et al., 2004; Lowen et al., 2005). Detailed investigation of these two aspects led to the 
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conclusion that a short region of about 5 nucleotides, and following the initial 11 nucleotides, 
can be freely mutated but needs to form dsRNA in order to efficiently promote replication (Barr 
and Wertz, 2004; Kohl et al., 2004). The difference in sequence within this so called distal 
duplex modulated the level of RNA replication, suggesting that this might be a mechanism to 
control RNA synthesis level from different genomic segments.  
Extensive nucleotide complementarity between the orthobunyavirus 3ʹ and 5ʹ NTRs 
ends is broken by a single mismatch resulting in G:U Wobble base pair at position 9. It was 
proposed that the difference between vRNA and cRNA at this position in the 3ʹ but not 5ʹ NTR 
end is the key factor promoting transcription and replication or only replication in case of vRNA 
and cRNA respectively (Barr and Wertz, 2005). Distal NTR regions of both 3ʹ and 5ʹ NTRs, but 
outside the initial 11 nucleotides, are also involved in the transcription-replication switch, but 
their contribution is less evident than it is in case of 3ʹ U9 from the wobble pair (Barr et al., 
2005). 
 
1.1.10 Cap-snatching initiates transcription  
 
After entering the cell bunyaviruses stay in the cytoplasm when they perform the 
primary transcription and in a later infection phase – the replication. As described above 5ʹ end 
of the viral mRNA contains host-derived capped sequence (Bishop et al., 1983; Collett, 1986). At 
its 3ʹ end the viral mRNA is shorter relative to the template and may fold into stem-loop 
structures stabilizing the transcript in absence of the 3ʹpolyadenylation (Abraham and Pattnaik, 
1983; Hacker et al., 1990; Hutchinson et al., 1996). In order to produce such viral mRNA with 
nonviral 5ʹ ends, bunyavirus utilize the cap-snatching mechanism – using L protein 
endonuclease domain and putative cap-binding domain they steal capped RNA oligos from 
cellular mRNA (Patterson et al., 1984; Reguera et al., 2010).  
It remains unclear whether bunyavirus polymerase exhibit any sequence preference for 
the host mRNA used for cap-snatching. There are reports suggesting that snatched primers able 
to form few base pairs with terminal nucleotides of the 3ʹ template end are selected more 
favourably. Studies on HANV mRNA revealed that majority of the host-derived 5ʹ sequences 
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contained a G residue at position -1 (Garcin et al., 1995). Genome-wide RNAi screening in 
Drosophila cells identified Dcp2 as an antiviral factor, and revealed that RVFV performs cap-
snatching on host mRNAs targeted for decapping and degradation. Sequencing of the viral 
mRNA showed no sequence preference for the host mRNA used in cap-snatching by RFVF 
(Hopkins et al., 2013). In contrast, studies of LACV mRNA 5ʹ ends in infected mosquito cell 
cultures (C6/36) and embryos revealed that initial sequence variability decreases during 
infection, leading to several predominant sequences present in the viral mRNAs in the later 
infection stages. Certain host-derived 5ʹ mRNA sequences were found to be preferentially used 
depending on the  developmental stage of the infected insect (Dobie et al., 1997). 
 
1.1.11 Translation-dependent transcription 
 
Another peculiarity about bunyavirus transcription is the need for ongoing translation. 
Translation ensures that the viral transcription will not finish prematurely. Since cellular mRNA 
appears always as RNP in the cytoplasm, it is possible that when performing cap-snatching 
bunyavirus directly hijack the entire translation machinery. 
Initially, during characterization of Akabane virus RNA species, it was noticed that the 
cycloheximidine and puromycin – drugs inhibiting translation – decrease the level of RNA 
synthesis in both early and late phases of infection (Pattnaik and Abraham, 1983). This was 
further confirmed and small genome transcripts, products of premature transcription 
termination, were observed upon treating the cells with the same drugs (Patterson and 
Kolakofsky, 1984). As proposed later, the shutdown in viral transcription results in a decrease of 
available nucleoproteins which cause a subsequent decrease in the viral replication yields (Raju 
and Kolakofsky, 1986). Studies performed in vitro showed that purified virions need 
reticulocyte lysate for the transcription of complete mRNA. This activity can be blocked by the 
same set of translation-inhibiting drugs (Bellocq et al., 1987).  
Studies on Germiston virus transcription revealed that scanning of the nascent mRNA by 
the small 40S subunit is sufficient to avoid premature termination (Vialat and Bouloy, 1992). 
This model was later confirmed by the introduction of additional translational stop codons into 
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BUNV genomic RNA (Barr, 2007). It is suggested that the role of the scanning ribosome is to 
grab the emerging viral mRNA, and to avoid RNA-RNA interaction between mRNA and the 
template. Another obvious advantage of this model is the efficient directing of the emerging 
viral mRNA for protein translation.  
It cannot be excluded that additional mechanisms, other than RNA-RNA interactions, 
might cause the premature transcription termination. One possible mechanism could involve 
coating of the emerging mRNA by nucleoproteins like it happens in insect cells during persistent 
infection (Hacker et al., 1989). Interestingly, comparison of viral infections in both mammalian 
(BHK) and insect cells (C6/36) led to the intriguing discovery that translation requirement for 
complete viral mRNA synthesis is cell type dependent concerning only mammalian and not 
insect cells (Raju et al., 1989). 
 
1.1.12 Prime-and-realign model for replication initiation  
 
In contrast to primer-dependent transcription initiation, bunyaviral polymerases initiate 
replication de novo. Given that the conserved 3ʹ end of the template contains short, 
trinucleotide repeats (Fig. 1.1.C), the prime-and-realign strategy is proposed to facilitate the 
initiation step. In this model RNA synthesis is initiated internally – from the second terminal 
repeat – to generate a short primer, which is then shifted and positions on the first terminal 
repeat. Upon this initial release and re-annealing of the primer, polymerase proceeds to the 
elongation phase of RNA synthesis. 
Studies of HANV genomic sequence revealed that the terminal U residue instead of the 
5ʹ triphosphate has a single phosphate group. This suggests that replication starts with another 
nucleotide – possibly a GTP which could be placed opposite to C at position 3+ in the template. 
Following addition of few nucleotides, the short primer is realigned at the template terminus, 
resulting in an overhanging GTP which is removed later on (Garcin et al., 1995). Analysis of the 
3ʹ end sequence requirements for RVFV efficient RNA synthesis revealed that the terminal 
repeat GU can be omitted without affecting synthesis efficiency (Prehaud et al., 1997). Similar 
observations upon removal of a terminal nucleotide from the BUNV 3ʹ genomic end were made 
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(Kohl et al., 2004). This supports the prime-and-realign model and explains the importance of 
short terminal repeats in the template 3’ end. One or two nucleotides absent at the very 3ʹ 
template end do not affect internal initiation. Great advantage of such mechanism is that it 
ensures the preservation of genomic ends.  
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1.2 RNA-dependent RNA Polymerases 
 
1.2.1 Primordial polymerases – from RNA to protein 
 
It is very plausible that one of the first enzymatic reactions that appeared during early 
evolution of life was the genome replication ability of polymerases. It actually defined the 
frames for the evolution itself as we understand it today – the mutation-driven change in 
genomic sequences. Assuming that it was one of the core enzymatic activities one can presume 
that its chemistry is simple and universal. This hypothesis – proposed originally by Tom Steitz 
(Steitz, 1998) can be easily proven by high level of conservation in the polymerase reaction 
chemistry across different domains of life – prokaryotic, eukaryotic and viral, no matter if it 
concerns DNA or RNA polymerases. 
Before protein enzymes appeared the polymerization reaction – according to the RNA 
world hypothesis – could only by carried by the RNA itself, either replicating other RNA 
molecules or having the self-replication ability. Such pioneer ribozymes catalyzing RNA-
dependent RNA polymerization have gone extinct, or are still waiting to be discovered. 
However, successful attempts were pursued to artificially generate, using in vitro selection 
pressure, an RNA molecule able to catalyze repetitive formation of a 3’/5’-phosphodiester bond 
– the class I ligase ribozyme (Ekland and Bartel, 1996; Ekland et al., 1995). Structural studies of 
the class I ligase demonstrated compact and folded nature of this ribozyme and proved that 
catalytic magnesium ions are coordinated at the active site via backbone phosphates 
(Koldobskaya et al., 2011; Robertson and Scott, 2007; Shechner et al., 2009).  
Primordial ribozymes possibly, similar to the artificial class I ligase, had to face an 
important obstacle – their requirements for replication were fundamentally incompatible. On 
one hand it is favorable to perform such NTP condensation reaction within small compartments 
defined by fatty acids, which ensures high local NTP concentration. On the other hand 
chemistry of this reaction requires high concentration of divalent metal ions like Mg2+, which in 
turn disintegrate fatty acid vesicles causing their precipitation. This could be overcome – as 
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elegantly proposed in the screen of Mg2+ chelators – by adding citric acid to the equation 
(Adamala and Szostak, 2013). Two carboxyl groups of the citric acid establish a coordination 
network for magnesium ions preventing fatty acids from precipitation, but more importantly 
contributing to stabilization of the incoming NTP. It is not improbable that at the early days of 
life chelators like the citric acid were replaced by short acidic peptides – ancestors of the 
current polymerases (Milner-White and Russell, 2011). 
 
1.2.2 Nucleotidyl transfer reaction – chemistry 
 
All protein polymerases known to date share the same ‘two-metal-ion’ mechanism of 
nucleotide addition (Fig. 1.7.A). In most cases those metal ions are Mg2+. The first one – Mg2+ A 
– is always coordinated within the active site by catalytically important aspartic acids. The 
second one – Mg2+ B – is imported together with an incoming NTP. The role of the magnesium 
ion A is to decrease the affinity of the ribose 3’OH for its hydrogen atom within the growing 
RNA. This facilitates the 3’O- attack on the α-phosphate of an incoming NTP. Upon this 
nucleophile attack a pentacovalent transition state is formed, stabilized by both magnesium 
ions. Once the phosphodiester bound is formed, magnesium ion B remains bound to the 
released pyrophosphate group which leaves the polymerase catalytic site (Steitz, 1998). 
Polymerases build the nascent RNA/DNA strand in the RNA/DNA template dependent manner. 
The chemistry of the nucleotide addition defines the 5’-3’ directionality of the RNA/DNA chain 
extension. The template strand is ‘read’ in the reverse, 3’-5’ direction, and the incoming 
NTPs/dNTPs are stabilized via Watson-Crick nucleotide base pairing – hydrogen bonds formed 
between guanine and cytosine or adenine and uracil/thymine.   
 
1.2.3 Polymerases – overview and classification 
 
The first polymerase discovered and purified was the DNA polymerase I belonging to 
Escherichia coli (Bessman et al., 1958). For its identification and characterization of magnesium 
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ion and DNA template-dependent DNA synthesis Arthur Kornberg and Severe Ochoa obtained 
the Nobel prize in medicine in 1959. 30 years later the first crystal structure of a polymerase 
has been solved – the C-terminal part of DNA polymaresa I known as the Klenow fragment (Ollis 
et al., 1985). The structure revealed a general architecture which later on appeared to be 
shared between various polymerases. It can be described as the ‘right-hand’ fold composed of 
three subdomains – fingers, palm, and thumb. While fingers and thumb domain are mostly α-
helical, the palm subdomain comprises a β-sheet, similar to the RNA-recognition motif fold 
(RRM). The palm domain contains majority of the catalytic residues, thus defining the active site 
of the polymerase. Based on this features and structural characteristics of palm subdomains 
polymerases can be divided into two major groups – the DNA/RNA polymerase superfamily and 
the nuclotidyltransferase superfamily. The first group comprises DNA polymerase I, lesion 
bypass DNA polymerase, reverse transcriptase, T7 RNA polymerase, RNA-dependent RNA 
polymerase, and dsRNA phage RNA-dependent RNA polymerase.  
 
1.2.4 Cellular RNA-dependent RNA polymerases  
 
Cellular RNA-dependent RNA polymerases (cRdRp) play a role in RNA interference 
mechanism. They are supposed to amplify the RNAi signal producing dsRNA – substrate for 
Dicer – in the ssRNA template-dependent manner (Maida and Masutomi, 2011). Until now 
cRdRps have been found in fungi (QDE-1 in Neurospora crassa (Cogoni and Macino, 1999; 
Makeyev and Bamford, 2002), nematodes (EGO-1 in Caenorhabditis elegans (Maniar and Fire, 
2011), insects (D-elp1 in Drosophila melanogaster (Lipardi and Paterson, 2009)), yeast (Rdp-1 in 
Schizosaccharomyces pombe (Sugiyama et al., 2005)), and various plant species. Structural 
analysis of the fungi QDE-1 revealed striking similarity to the catalytic core of the DNA-
dependent RNA polymerases responsible for transcription (Salgado et al., 2006). It remains an 
open question whether analogical cellular RdRps exist in vertebrates.  
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Figure 1.7 A) Chemistry of the nucleotidyl transfer reaction, adapted from (te Velthuis, 2014). B) 
Poliovirus 3Dpol structure; fingers, palm, and thumb domains are highlighted in blue, red, and green 
respectively; PDB: 3OLB (Gong and Peersen, 2010); C) the same structure coloured in light grey with the 
RdRp catalytic motifs highlighted - F (dark blue), A (yellow), B (cyan), C (green), D (red), and E (brown); 
nucleotides of the template and product strands are marked as light grey sticks; the incoming NTP is 
marked as pink sticks; two catalytic metal ions are marked as grey spheres. 
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1.2.5 Viral RNA-dependent RNA polymerases 
 
Viral RNA-dependent RNA polymerases (RdRp) are essential during the viral cycle since 
they can both transcribe and replicate the viral genome, which can be a double or single 
stranded RNA molecule (dsRNA or ssRNA respectively). In case of ssRNA genome, the RNA can 
be either a positive or a negative strand. Positive strand RNA genome is in the same time the 
viral mRNA which can directly be used for translation of the viral proteins encoded in it (e.g. 
Flaviridae). In case of the negative strand RNA genome a transcription step is required in order 
to produce the viral mRNA before the translation can occur. Unlike majority of positive strand 
RNA viruses which genome is a single, long RNA molecule, the genome of negative strand RNA 
viruses can be either non-segmented (Mononegavirales, e.g Ebola virus), or divided into several 
segments. Based on the number of those segments (which could be regarded as viral 
chromosomes) the group of segmented negative-strand RNA viruses (sNSV) is further divided 
into Arenaviridae (e.g. Lassa virus), Bunyaviridae (e.g. Schmallenberg virus), and 
Orthomyxoviridae (e.g. Influenza A, B, and C virus), bearing two, three, or eight genomic 
segments respectively.  
What all these different viruses share are the specialized RNA-dependent RNA 
polymerases using specific strategies in order to transcribe and replicate the viral genome. The 
only exception from this rule is the Hepatitis D virus (HDV) – a small RNA virus which does not 
have its own RdRp (Abbas and Afzal, 2013; Lai, 2005). RNA-dependent RNA polymerases are the 
template-dependent nucleotide transferases. Despite very little overall sequence conservation, 
they are similar in length (400-700 aminoacids) and share the conserved 3D architecture (Černý 
et al., 2014; Ferrer-Orta et al., 2006; Ng et al., 2008; te Velthuis, 2014). RdRps all adopt the 
same, right-hand like architecture which comprise three main subdomains – fingers, palm, and 
thumb (Fig. 1.7.B). Unlike other polymerases presenting more open conformation, RdRps adopt 
a closed-hand conformation. This is achieved due to the fingertips – an RdRp specific loops 
emerging from the fingers subdomain and connecting it with the thumb subdomain. 
Up to date there is around 100 non-redundant, viral RdRp (EC=2.7.7.48) structures 
obtained by X-ray crystallography and deposited in the PDB database. This search has been 
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performed for polypeptide chains longer than 300 residues. Polymerase structures with 
sequence similarity higher than 90% are represented by one hit. The list comprises La Crosse 
bunyavirus polymerase structures obtained during this PhD thesis. Statistics presented in Figure 
1.8 highlight the number of RdRp structures from different viral source, protein sequence 
length, obtained resolution, and proportion of the structures containing protein alone or in 
complex with RNA. Table 1.1 gathers representative examples of those viral RdRp structures. 
 
 
STRUCTURES OF VIRAL RNA-DEPENDENT RNA POLYMERASES 
Virus Highlights PDB codes References 
Phage φ6 
Mn2+ ion role in transition from de 
novo initiation to elongation  4A8F – 4 A8Y (Wright et al., 2012) 
Impact of Mn2+ ion on the active site 2JL9, 2JLF, 2JLG (Poranen et al., 2008) 
Ca2+ inhibits the RdRp and allows to 
capture it at certain state  1UVI – 1UVM (Salgado et al., 2004) 
Mechanism of initiation 1HHS, 1HHT,  1HI0, 1HI1, 1HI8 (Butcher et al., 2001) 
Hepatitis C virus 
Detailed study of initiation and 
initiation-replication transition 4WTA – 4WTM  (Appleby et al., 2015) 
Elongation state; Δ-βhairpin construct 4E76, 4E78, 4E7A (Mosley et al., 2012) 
Resistance to non-nucleoside inhibitors 3GSZ (Rydberg et al., 2009)  
Non-nucleoside inhibitors profiling 3HKW, 3HKY (Nyanguile et al., 2010) 
Replication in strains J6 and JFH1  2XWH, 2XXD (Schmitt et al., 2011) 
Highly potent irreversible inhibitors 3TYQ (Chen et al., 2012) 
Evidence for de novo initiation 1NB4, 1NB6, 1NB7  (O’Farrell et al., 2003) 
Complex with nucleotides and m.ions 1GX5, 1GX6 (Bressanelli et al., 2002) 
HCV NS5B structure at 2.8 Å 1CSJ (Bressanelli et al., 1999) 
HCV NS5B structure at 2.5 Å 1QUV (Ago et al., 1999) 
HCV NS5B structure at 1.9 Å 1C2P (Lesburg et al., 1999) 
Poliovirus 
Motif B loop mediates translocation 4NLO – 4NLY  (Sholders and Peersen, 2014) 
Engineered RNA make crystal contacts 4K4S – 4K4W (Gong et al., 2013) 
Structural basis for active site closure 3OL6 – 3OL9, 3Ola, 3OLB 
(Gong and Peersen, 
2010) 
3CD – precursor of 3C(pro) and 3D(pol) 2IJD, 2IJF (Marcotte et al., 2007) 
Proteolysis-dep. Activation of 3D(pol) 1RAJ, 1RA6,  1RA7, 1TQL 
(Thompson and 
Peersen, 2004) 
Original 3D(pol) structure 1RDR (Hansen et al., 1997) 
Foot-and-mouth 
disease virus 
Mutant polymerases with reduced 
sensitivity to ribavirin 
3KLV, 3KMQ, 
3KMS, 3KNA, 3KOA (Ferrer-Orta et al., 2010) 
In crystallo RNA synthesis captured 2E9R, 2E9T, 2E9Z, 2EC0 (Ferrer-Orta et al., 2007) 
Apo / RNA-bound FMDV 3D structure 1U09, 1WNE (Ferrer-Orta et al., 2004) 
Simian rotavirus Apo / RNA-bound cage-like, 4-channel VP1 structure 2R7Q – 2R7X (Lu et al., 2008) 
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Norwalk virus 
RNA-polymerase complex with 
substrate analog – putative inhibitor 3H5X, 3H5Y (Zamyatkin et al., 2009) 
RNA-polymerase complex in closed 
conformation 3BSN, 3BSO (Zamyatkin et al., 2008) 
Original norovirus RdRp structure 1SH0, 1SH2, 1SH3 (Ng et al., 2004) 
Mammalian 
orthoreovirus RNA synthesis in a cage 
1N1H, 1N35,  
1N38, 1MUK (Tao et al., 2002) 
Human rhinovirus 
Common cold antiviral therapy target 1XR5, 1XR6, 1XR7 (Love et al., 2004) 
Engineered RNA make crystal contacts 4K50 (Gong et al., 2013) 
Japanese 
encephalitis virus 
Motif F ordering upon GTP binding 4HDG, 4HDH, 4MTP (Surana et al., 2014) 
JEV NS5 MTase RdRp interface 4K6M (Lu and Gong, 2013) 
Infectious pancreatic 
necrosis virus 
Covalent RNA-polymerase complex 
formation through N-terminal serine 
2YI8, 2YI9, 
2YIA, 2YIB (Graham et al., 2011) 
Infectious bursal 
disease virus 
Birnavirus VP1 polymerase shows re-
ordered catalytic motifs: C – A – B  2PGG (Pan et al., 2007) 
Bovine viral diarrhea 
virus 
Role of BVDV pol N-terminal domain 2CJQ (Choi et al., 2006) 
Role of GTP in de novo initiation 1S48, 1S49, 1S4F (Choi et al., 2004) 
Dengue virus 
DENV-3 polymerase/inhibitor structure 3VWS, 4HHJ (Noble et al., 2013) 
NS5 MTase requirements for cap 
analogs and capped RNA 
2P3L – 2P3Q,  
2P40, 2P41 (Egloff et al., 2007) 
DENV pol activity and atomic structure 2J7U, 2J7W (Yap et al., 2007) 
La Crosse virus First bunyavirus pol structure (3/4 of L protein); in complex with 3ʹ/5ʹ vRNA 5AMQ, 5AMR (Gerlach et al., 2015) 
Influenza B virus Structural insight into cap-snatching and RNA synthesis by influenza RdRp 4WRT, 4WSA (Reich et al., 2014) 
Influenza A virus Entire bat FluA heterotrimeric RdRp in complex with 3ʹ/5ʹ vRNA promoter 4WSB (Pflug et al., 2014) 
Coxsackievirus 
Engineered RNA make crystal contacts 4K4X – 4K4Z (Gong et al., 2013) 
Mutations in palm domain affetc 
fidelity of viral RdRps 4WFX – 4WFZ 
(Campagnola et al., 
2015) 
VPg peptide – primer for initiation 3CDU, 3CDW (Gruez et al., 2008) 
Rabbit Hemorrhagic 
fever virus First calcivirus RdRp structure 1KHV, 1KHW (Ng et al., 2002) 
Tomato mosaic virus Structural basis of viral superfamily 1 helicases 3VKW (Nishikiori et al., 2012) 
Phage Qβ 
EF-Tu, EF-Ts, and ribosomal S1 
are parts of Qbeta replicase 4Q7J (Takeshita et al., 2014) 
Elongation complexes with 
increasing length of the product 3AVT – 3AVY 
(Takeshita and Tomita, 
2012) 
Qbeta replicase composed of both 
viral and host proteins 3MMP (Kidmose et al., 2010) 
Infectious bursal 
disease virus 
Activation mechanism of the IBDV 
VP1 polymerase 
2R70, 2R72,  
2PUS, 2QJ1 (Garriga et al., 2007) 
West Nile virus Active and inactive WNV NS5(pol) 2HCN, 2HCS, 2HFZ (Malet et al., 2007) 
Sapporo virus First structure of sapovirus 3D(pol) 2CKW (Fullerton et al., 2007) 
 
Table 1.1 List of available viral RdRp X-ray structures 
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1.2.6 RdRp – catalytic motifs 
 
The central catalytic site of RdRp, unlike other regions of the polymerase, contains 
highly conserved elements also called the homomorphs – the catalytic motifs responsible for 
the chemistry of nucleotidyl transfer reaction (Fig. 1.7.C). Depending on the study up to seven 
motifs can be specified – G, F1-3 (pre-A), A, B, C, D, and E (Bruenn, 2003). Viruses belonging to 
Birnaviridae family (e.g. IBDV - infectious bursal disease virus, or IPNV – infectious pancreatic 
necrosis virus) are exceptional in having catalytic motif C preceding motif A (Gorbalenya et al., 
2002). Those catalytic motifs adopt conserved secondary structures, specific for each of them. 
The role of the motifs is to define the shape of the internal polymerase cavity. They are directly 
 
Figure 1.8 Statistics concerning viral RdRp structures available in the PDB database. Search has been 
performed asking for the EC=2.7.7.48 viral proteins longer than 300 residues. Polymerase structures 
with sequence similarity higher than 90% are represented by one hit 
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responsible for the proper selection of an incoming NTP, and they orchestrate the RNA 
synthesis, thus defining the polymerase fidelity and processivity. As shown by mutagenesis 
studies of several viral RdRps, point mutations within conserved palm domain residues can 
affect the fidelity and the reaction rate, resulting as well in the change of viral pathogenesis and 
fitness (Arnold et al., 2005; Campagnola et al., 2015; Pfeiffer and Kirkegaard, 2005). 
Motif A lies in the linker connecting one of the β-strands from the palm subdomain with 
an α-helix from the fingers subdomain. It contains a conserved, magnesium-binding aspartic 
acid which together with aspartic acids from motif C co-ordinates both divalent metal ions 
involved in catalysis. Studies of the poliovirus 3d polymerase suggests that only when the right 
incoming NTP, complementary to the template, is accommodated in the catalytic site, the 
proper coordination of both magnesium ions can be established. This in turn results in ordering 
of motif A β-strand, which can be aligned with the motif C β-strands, thus forming an RRM fold 
(Gong and Peersen, 2010). This elegant, structuring-driven mechanism, ensures that the 
catalytically competent state of the active site – often referred to as the ‘closed complex’ – can 
only be reached when the right NTP has entered the active site.  
Motif B is composed of a flexible loop followed by a long helix. It contains conserved 
asparagine forming hydrogen bond with the ribose 2’OH group of the incoming NTP, thus 
discriminating rNTPs over dNTPs (Gohara et al., 2000). The long helix of motif B builds the 
bottom of the active site cavity. It allows correct positioning of the incoming template, and 
provides a stabilizing platform for the template-product duplex. Finally, polymerase state-
dependent steric clashes between the template and the motif B, observed in Polio 3d(pol) 
structures (Sholders and Peersen, 2014), suggest that motif B mediates the polymerase 
translocation, contributing to the Brownian ratchet mechanism. Flexible nature of the motif B 
loop can be a drug target leading to mispositioning or the RNA template (Garriga et al., 2013)  
Motif C is located in the β-turn of the palm domain. It is composed of the GDD triplet in 
case of dsRNA and positive strand ssRNA viruses, the GDNQ in case of non-segmented NSV 
viruses, or the SDD triplet in case of segmented NSV viruses. In all those cases both aspartic 
acids participate in coordination of the two magnesium ions used by polymerase to catalyze the 
nucleotidyl transfer reaction. The amino-terminal aspartate is critical since apart from 
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positioning the α-phosphate of the incoming NTP via the magnesium ion, it also reduces the 
pKa of the 3’OH from the nascent strand. This facilitates the ribose attack on the incoming NTP 
α-phosphate and results in phosphodiester bond formation. 
Motif D contains positively charged residues that contribute in generation of the basic 
environment within the NTP entry channel and are directly involved in positioning of incoming 
NTPs. Some studies propose that a one of its conserved protonated lysines, positioned close to 
the β-phosphate of an incoming NTP, may play a role of a general acid and protonate the PPi 
group upon release from the incorporated NTP (Castro et al., 2007, 2009; Yang et al., 2012). 
Other studies revealed that mutation of conserved residues from motif D both affects the 
fidelity of the polymerase and lowers the reaction rate (Liu et al., 2013; Shen et al., 2012). In 
fact the conformational change of motif D mediated by the interaction with the β-phosphate is 
believed to be one of the checkpoint of the right incoming NTP selection.  
Motif E is located within a β-turn-β (similar to motif C). Its putative role is to position 
oligonucleotide primer or priming NTP. It does so by stabilization the NTP triphosphate like it 
was shown for Flaviviridae RdRp (Bressanelli et al., 2002; Choi and Rossmann, 2009)  
Motif F (in some studies called also preA) is located within the fingertips in an elongated 
β-loop-β structure. It contributes to the NTP entry channel formation and its conserved, 
positively charged residues are able to neutralize phosphate groups of the incoming NTPs. One 
of the main observations unraveled by LACV L-vRNA structure is the allosteric ordering of the 
motif F, driven by 5ʹ vRNA binding (Gerlach et al., 2015). Similar structuring has been observed 
in JEV NS5 polymerase upon GTP binding (Surana et al., 2014). This suggests that differently 
mediated motif F structuring might be a common feature of all RdRps. 
 
1.2.7 De novo initiation – different strategies 
 
Most of the RNA (and DNA) polymerases when they commence to build the nascent 
nucleic acid strand do not actually start from scratch. Instead, they extend an existing RNA (or 
DNA) strand which serves a role of the primer. Viral RdRps are the exception to that rule. They 
are indeed able to initiate the RNA synthesis de novo in absence of the primer. This very 
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initiation step is critical and difficult to establish. It requires both priming and incoming NTPs 
properly positioned in the active site with all its elements in the exact orientation in order to 
allow the first nucloetidyl transfer reaction to happen. After this rate limiting step which results 
in the formation of a dinucleotide primer the polymerase can carry on with the RNA synthesis 
through the standard strand elongation.  
Various RdRps have established different approaches to facilitate the de novo initiation. 
Flaviviridae for instance have a specific loop emerging from the thumb subdomain - β-hairpin in 
HVC (Hong et al., 2001), β-thumb in BVDV (Choi et al., 2004) – that occludes the active site 
cavity. The very tip of this structural element contains an aromatic residue – a tyrosine or a 
histidine – which by stacking interactions between its aromatic ring and the base of the priming 
NTP helps to hold this it in position.  
Similar approach – utilizing the C-terminal domain to facilitate initiaton – is used by the 
dsRNA bacteriophage φ6 (Butcher et al., 2001). The template 3ʹend CTP (position T1) is initially 
locked in the pocket. A conserved aromatic amino acid (tyrosine or tryptophan) is a platform, 
providing stacking interaction to stabilize the incoming GTP, opposite to the T2 template-CTP. 
In the following step the template ratchets back, making the T1 template-CTP accessible for 
another incoming GTP. Following the phosphodiester bond formation, template-2xGTP duplex 
ratchets down displacing the C-terminal domain, and the elongation phase starts. 
 
1.2.8 Additional domains and multimerisation   
 
Transcription and replication of viral RNA genomes often require additional enzymatic 
activities beyond the ordinary nucleotide extension. In order to acquire them many viral 
polymerases possess extra domains flanking the RdRp domain. Segmented negative strand 
viruses from Bunya- and Arenaviridae families are very good example. Their single chain, 250 
kDa or bigger, polymerases (also named L proteins) apart from having the RdRp in the middle, 
possess the N-terminal cap-snatching endonucleases providing capped RNA primers for 
transcription, derived from the host mRNA (Morin et al., 2010; Reguera et al., 2010). As 
discussed in ‘Results’ of this thesis – apart from the endonuclease domain, bunyaviral L protein 
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contains as well domains responsible for genomic RNA ends recognition, and others 
contributing to RNA channels formation and stabilizing the RdRp domain itself  (Gerlach et al., 
2015).  
Slightly different approach – for which Orthomyxoviridae Influenza virus is the best 
example – is to assemble the polymerase complex from several protein subunits. Segmented 
genome of Influenza virus codes for three such subunits – PA, PB1, and PB2 – each 
approximately 80 kDa in size. All subunits are transported inside the host cell nucleus (PA-PB1 
as dimer separately from the PB2) where they assemble into heterotrimeric functional 
polymerase. Structural studies have shown the identity of the PA N-terminal cap-snatching 
endonuclease domain (Dias et al., 2009), PA-C domain which function was initially unclear (He 
et al., 2008), but also domains belonging to the PB2 subunit – cap-binding domain (Guilligay 
2010), 627 domain, and NLS domain (Tarendeau et al., 2008). What for some time remained 
unclear was the organization of the PB1 subunit – predicted to contain the RdRp domain, and 
the overall architecture of entire heterotrimer. Structures of Influenza A and B complete 
heterotrimeric polymerases in complex with their vRNA promoters allowed to answer these 
questions (Pflug et al., 2014; Reich et al., 2014) (Fig. 1.9). Firstly it became clear that all three 
subunits are greatly intertwined, with the PB1 subunit containing indeed the classical RdRp 
domain, although with some sNSV specific structural elements. All three subunints participate 
in vRNA 3ʹ and 5ʹ ends binding with great contribution from the PA-C domain. PA-N 
endonuclease and PA-C domain are separated by the long flexible linker allowing to position 
them on the opposite sides of the PB1 RdRp. Tightly bound PA-C domain and PB1 subunit, 
together with the PB2 N-terminal region, constitute the rigid core of the Influenza polymerase. 
Other domains – PA-N endonuclease and PB2 C-terminal cap-binding, mid, 627, and NLS 
domains are flexibly attached and can be oriented differently according to the polymerase state 
(Reich et al., 2014)(Cusack et al., unpublished data).  
Other good examples of multidomain polymerases are those of the Vesicular stomatis 
virsus (VSV) or Ebola virus (EBOV) from the order Mononegavirales, or the positive RNA strand 
flaviviruses like Dengue virus (DENV) and Hepatitis C virus (HCV). Unlike segmented NSV these 
viruses are able to perform all the post-transcriptional RNA 5’-end modifications necessary for  
Introduction 
 
47 
 
 
the cap formation. Their polymerases contain a 2’-O-methyltransferase (MTase), a guanine-N7-
MTase, and a polyribonucleotidyltransferase (PRNTase) or a guanylyltransferase (GTase) in case 
of Mononegavirales (Li et al., 2005; Ogino et al., 2010) or flaviviruses (Egloff et al., 2002; Issur et 
al., 2009) respectively.     
Another example of complex polymerase is the HIV-1 reverse transcriptase, an RNA-
dependent DNA polymerase (RdDp). In this case polymerase is a heterodimer composed of viral 
p66 subunit, containing RNase H and RdDp domains, and its processed version p51 bearing only 
the RdDp domain (Hostomsky et al., 1992; Wang et al., 1994). In consequence the HIV-1 RT 
complex contains two RdDp domains of which only the one belonging to the p66 is active. 
Moreover the heterodimer can bind randomly the viral RNA/DNA duplex and  reorient itself 
based on what enzymatic activity is needed (Abbondanzieri et al., 2008; Liu et al., 2008). 
 
Figure 1.9 Comparison of the heterotrimeric polymerases from Influenza A and Influenza B virus (Pflug 
et al., 2014; Reich et al., 2014). PA, PB1, and PB2 subunits are coloured with different shades of green. 
Genomic 3ʹ and 5ʹ RNA is coloured in cyan and yellow respectively.  
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The HIV-1 RT with its dual RdDp complex is not a unique case among polymerases of 
RNA viruses. The oligomerisation of polymerases has been observed as well for RdRps of 
Poliovirus (PV), FMDV, HCV, Norovirus (NV), and IBDV. The role of such assembly is not clear 
but some evidences suggest that it might facilitate template binding, increase polymerase 
activity, or basically stabiles the RdRp (Lyle et al., 2002; Spagnolo et al., 2010). Studies on 
Influenza virus revealed a possibility of dimer formation or oligomerization of the RdRps (Chang 
et al., 2015; Jorba et al., 2008). It was proposed that binding of an inactive secondary RdRp to 
the cRNP can stimulate vRNA synthesis – which suggests a cooperative functioning of both 
polymerases during replication (York et al., 2013). No evidence for such cooperation between 
two polymerases was found in case of Influenza virus transcription (Jorba et al., 2009).  
Another strategy to form a functional polymerase – instead of using multisubunit or 
multidomain enzyme of viral origin – is to hijack host factors. The best studied example of such 
strategy adopted by an RNA virus is the replicase of bacteriophage Qβ (Kidmose et al., 2010; 
Takeshita et al., 2014). The replicase complex is composed of the viral β-subunit being the 
catalytic RdRp, two bacterial translation elongation factors – EF-Tu and EF-Ts, and the third 
bacterial protein – ribosomal protein S1. Translation factors contribute to the general 
architecture of the replicase. On one hand they stabilize the β-subunit, playing the role of 
chaperons, on the other they contribute in defining RNA tunnels leading in and out from the 
catalytic site. EF-Tu is a ubiquitous GTPase whose role is to bind aa-tRNA and deliver it to the 
translating ribosome. By chance the highly structured genome of bacteriophage Qβ possesses a 
tRNA-like structure at its 3ʹ end which is recognized by the EF-Tu, and after de novo initiation 
exits through the EF-Tu-formed template exit tunnel. Other, yet not structurally proven 
examples, exist for viral RdRps binding host translation elongation factors. Studies revealed that 
an eukaryotic counterpart of the EF-Tu, eEF1A, participates in formation of the RdRp complexes 
belonging to bovine viral diarrhea virus (Johnson et al., 2001), polio virus (Harris et al., 1994), 
and tobacco mosaic virus (Yamaji et al., 2006) 
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1.3 Aim of the thesis 
 
The PhD thesis project aimed to study the structure and function of a bunyavirus L 
protein alone and in complex with vRNA in order to better understand mechanisms that drive 
sNSV polymerases and to provide knowledge that could be extrapolated to other polymerases 
of this group of viruses, comprising Arenaviridae, Bunyaviridae, and Orthomyxoviridae. As a 
model in our studies we used the L protein from La Crosse virus belonging to the 
Orthobunyavirus genus. The project was designed based on the initial assumption that 
Bunyaviridae LACV and Orthomyxoviridae Influenza virus polymerases share similar domain 
organization. This hypothesis was strengthen by: (1) the similar size of the monomeric LACV L 
protein and the Influenza polymerase heterotrimer, (2) the linearity of the PA, PB1, and PB2 
Influenza polymerase subunits, mediated by the head-to-tail interactions, (3) the same position 
of the central, catalytic RdRp motifs and the N-terminal endonuclease domains of both LACV L 
protein and Influenza PA subunit, whose structures were previously obtained in the Cusack 
group (Dias et al., 2009; Reguera et al., 2010). Based on this hypothesis, the identification and 
structural studies of the Influenza PB2 subunit cap-binding domain performed in the Cusack 
group (Guilligay et al., 2008) indicated that a homologous domain could be located within the C 
terminus of the LACV L protein. 
The goal of the PhD thesis project was to: 
 
1.  Identify and characterize both structurally and functionally a putative cap-binding 
domain of the LACV L protein.  
2. Study the nature of the vRNA binding by the full length LACV L protein or its truncated 
forms. 
3. Establish the in vitro assays for studying replication and transcription activity of the 
LACV L protein. 
4. Characterize structurally the LACV L protein or its truncated forms either as an apo form 
or in complex with the vRNA. 
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2. METHODS 
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2.1 Protein expression and purification 
 
2.1.1 Constructs for the bacteria expression 
 
The La Crosse virus strain LACV/mosquito/1978 L protein sequence was used in all 
construct preparations (GenBank code: EF485038.1, UniProt code: A5HC98). The synthetic, 
codon-optimized constructs (DNA 2.0) bearing N-terminal His-tag followed by TEV protease 
cleavage site (MGHHHHHH6xHis-tagDYDIPTTENLYFQTEVG) were used. The initial constructs already 
available in the lab at the beginning of the PhD project were designed based on the ESPRIT 
approach (Yumerefendi et al., 2010) performed on the last 800 residues of the L protein, 
followed by limited proteolysis with papain. They were later re-designed according to 
secondary structure prediction softwares: Prof prediction, GOR4 (Sen et al., 2005), and Porter 
(Pollastri and McLysaght, 2005). DNA oligos (Invitrogen) used for cloning are listed in the Tabale 
2.1 below. 
All the L protein C-terminal constructs were cloned via NdeI and NotI into the pESPRIT, a 
pET-derived high copy number plasmids. Generation of new constructs with modified 
boundaries was achieved in a two-step PCR. During the first one the NotI restriction site was 
introduced by the overhang of the reversed primer. During the second step the nested forward 
primer allowed to reintroduce the NdeI restriction site followed by the His-tag and TEV 
cleavage site. The PCR reactions were carried in 50 μL volumes using either Pyrobest 
polymerase (TaKaRa) or PFU polymerase (produced in house). The reaction mixtures and 
temperature cycle are presented below:  
 
Reagent Amount  Temp. Time Cycles 
Polymerase 0.02 U / μL  95°C 1 min 1 
DNA template 10 ng / μL  95°C 30 sec 
35 F/R primer 2 μM  55°C 30 sec 
dNTPs 0.25-1 mM  72°C 1 min  
Pol. buffer 1X  72°C 5 min 1 
H2O up to 50 μL  4°C - - 
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PCR products were than purified using PCR Purification Kit (Qiagen), and cleaved with 
restriction enzymes (1 hour at 37°C). Next they were resolved on agarose gel, purified with Gel 
Extraction Kit (Qiagen), and ligated with the vector in 4:1 molar ration using 2X Ligation Kit 
(TaKaRa). Following 2-3 hours of incubation, ligation mixtures were directly used to transform 
Escherichia coli TOP10. Amplified DNA plasmids were extracted using Miniprep Kit (Qiagen). 
Those with bearing proper insertions were sent for sequencing (Eurofins MWG Operon).   
 
PCR PRIMERS 
NdeI-His-TEV-F 
(2nd PCR) 
GCGGATCCATATGGGCCACCATCATCACCACCATGATTATGATAT
TCCAACTACCGAGAATTTGTATTTTCAGGGG 
  
L-LKVA--180-F GAATTTGTATTTTCAGGGGCTGAAGGTCGCACATGG 
L-MPNY--900-F GAATTTGTATTTTCAGGGGATGCCGAATTACACCGATT 
L-LPGQ-1310-F GAATTTGTATTTTCAGGGGCTGCCGGGTCAGAGCA 
L-ALEK-1536-F GAATTTGTATTTTCAGGGGGCTCTGGAAAAGGAACCGG 
L-LKEM-1685-F GAATTTGTATTTTCAGGGGCTGAAGGAGATGACGCGC  
L-VFIL-1708-F GAATTTGTATTTTCAGGGGGTCTTCATCCTCCCCGCG 
L-SGGH-1746-F GAATTTGTATTTTCAGGGGTCCGGTGGCCATAAGGC 
L-ATSE-1757-F GAATTTGTATTTTCAGGGGGCGACCAGCGAGCAGAAC 
L-SEQN-1759-F GAATTTGTATTTTCAGGGGAGCGAGCAGAACATCGC 
L-IAFE-1763-F GAATTTGTATTTTCAGGGGATCGCTTTTGAGTGCTTC 
L-RIYN-1960-F GAATTTGTATTTTCAGGGGCGTATCTACAATGAGATTACG 
L-YRNA-2110-F GAATTTGTATTTTCAGGGGTACCGTAATGCGATTAAACTG 
  
L-RNAM--900-R AGCTCGCGGCCGCTCATTACATTGCGTTACGGAGCAT 
L-YNML-1310-R AGCTCGCGGCCGCTCATTACAGCATATTGTAAGTCAGG 
L-GGHK-1750-R AGCTCGCGGCCGCTCATTACTTATGGCCACCGGACA 
L-TDFI-1819-R AGCTCGCGGCCGCTCATTAGATGAAATCGGTACGGTTG 
L-LMKS-2039-R AGCTCGCGGCCGCTCATTAGCTCTTCATCAGCTCGG 
L-DLLN-2044-R AGCTCGCGGCCGCTCATTAATTCAACAGATCCTGGCTC 
L-DNIR-2051-R AGCTCGCGGCCGCTCATTAGCGAATGTTGTCGTAATTC 
L-EFLS-2078-R AGCTCGCGGCCGCTCATTAGCTCAGGAACTCCAGAC 
L-DDPM-2082-R AGCTCGCGGCCGCTCATTACATCGGATCGTCGCTCA  
L-NFTE-2086-R AGCTCGCGGCCGCTCATTACTCGGTGAAATTCATCGG 
L-EAIH-2091-R AGCTCGCGGCCGCTCATTAGTGGATTGCCTCGCCCTC 
L-HSTP-2094-R AGCTCGCGGCCGCTCATTACGGGGTGCTGTGGATTG 
L-PIFN-2097-R AGCTCGCGGCCGCTCATTAATTGAAAATCGGGGTGCTG 
L-NIYY-2100-R AGCTCGCGGCCGCTCATTAATAGTAAATATTGAAAATCGGG 
L-IYYS-2101-R AGCTCGCGGCCGCTCATTAAGAATAGTAAATATTGAAAATCG 
L-LLIE-2119-R AGCTCGCGGCCGCTCATTACTCGATCAGCAGTTTAATC 
L-EEAF-2129-R AGCTCGCGGCCGCTCATTAGAAGGCCTCCTCAAAGAT 
L-FTFS-2132-R AGCTCGCGGCCGCTCATTAGCTAAACGTGAAGGCCTC 
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L-IKLL-2155-R AGCTCGCGGCCGCTCATTACAGCAGCTTGATGAGGC 
L-STVI-2164-R AGCTCGCGGCCGCTCATTAGATCACGGTAGACCACTC 
L-VIDK-2166-R AGCTCGCGGCCGCTCATTATTTGTCGATCACGGTAGAC 
L-DHMY-2181-R AGCTCGCGGCCGCTCATTAGTACATGTGATCCATTCCG 
L-SFDV-2186-R AGCTCGCGGCCGCTCATTACACGTCGAAGCTGTGGT 
L-PKCF-2190-R AGCTCGCGGCCGCTCATTAAAAACATTTCGGCACGTCG 
L-IALI-2234-R AGCTCGCGGCCGCTCATTAAATCAGAGCGATACATTTCTTC 
L-EFTK-2249-R AGCTCGCGGCCGCTCATTATTTCGTAAACTCAGAGAAGT 
L-KLMK-2252-R AGCTCGCGGCCGCTCATTATTTCATCAGTTTCGTAAACTC 
Table 2.1 DNA oligos used for cloning of the L protein C-terminal constructs. NdeI and NotI 
restriction sites are highlighted in red in forward (F) and reversed (R) primers respectively. 
Sequences corresponding to the newly established constructs are highlighted in blue. The 
nested region for the second PCR is highlighted in grey.  
 
2.1.2 Constructs for the insect cell expression 
 
The same LACV L protein sequence and N-terminal tag as described above has been 
used for the L full length and L1750 (ΔCterm construct covering residues 1-1750) constructs. L1750 
construct was designed based on limited proteolysis with trypsin performed on the L full length 
protein. Its C-terminal end corresponds to the boundaries of soluble domains derived from 
ESPRIT approach (Yumerefendi et al., 2010). Both L full length and L1750 constructs were cloned 
via NdeI and NotI (New England Biolabs) into the pFastBac vector. 
Based on in vivo minireplicon studies on LACV transcription and replication, performed 
by the Cusack group in collaboration with Dr. Friedmann Weber (Klemm et al., 2013) a single 
H34K mutation has been introduced to inactivate the endonuclease in L and L1750 constructs. 
The mutated L constructs were supposed to remain replication but not transcription activity, 
and should not degrade RNA oligos used in various binding and activity in vitro assays.  
Based on L1750 structure in complex with 3ʹ and 5ʹ vRNA (Gerlach et al., 2015), full length 
L and L1750 constructs with major deletions were designed. The ‘clamp’ deletion removes 
residues 355-400, introducing two glycines instead. The ‘α-ribbon’ deletion removes residues 
848-905, introducing one glycine instead. The ‘finger node’ deletion removes residues 1105-
1135, introducing one glycine instead. The ‘priming loop’ deletion removes residues 1408-1424, 
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introducing two glycines instead. Detailed list of DNA oligos used for mutagenesis and deletions 
is given in the Table 2.2 below.  
The 25 μL PCR reactions were performed with Phusion High-Fidelity polymerase (New 
England Biolabs). Primers introducing mutation and temperature cycles were designed based 
on the QuickChange site-directed mutagenesis protocol (Stratagene). The reaction mixtures and 
temperature cycle are presented below:  
 
Reagent Amount  Temp. Time Cycles 
Polymerase 0.04 U / μL  98°C 30 sec 1 
DNA template 50-100 ng   98°C 10 sec 
20 F/R primer 0.5 μM  45°C 30 sec 
dNTPs 0.2 mM  72°C 10 min 
Pol. buffer 1X  72°C 10 min 1 
DMSO 3%  4°C - - 
H2O up to 25 μL     
 
PCR products were than treated with DpnI restriction enzyme (1 hour at 37°C) used directly to 
transform the Escherichia coli TOP10 cells. 
 
  
SITE DIRECTED MUTAGENESIS PCR PRIMERS 
L-H34K-F CTGCTGATGGCCCGTAAGGACTATTTCGGACGC 
L-H34K-R GCGTCCGAAATAGTCCTTACGGGCCATCAGCAG 
L-ΔClamp-F GCAAAATGATGGATATTGGTGGTGGTATCAACAATGACCTGATCG 
L-ΔClamp-R CGATCAGGTCATTGTTGATACCACCACCAATATCCATCATTTTGC 
L-ΔαRibbon-F GCAAGTCTTGTCTGAAGATTGGTGGTTACATTTCCACCAAGGTC 
L-ΔαRibbon-R GACCTTGGTGGAAATGTAACCACCAATCTTCAGACAAGACTTGC 
L-ΔFNode-F CATGGACAAGGAGCTGATCGGTACCGTGCTGATTAAACGTAAC 
L-ΔFNode-R GTTACGTTTAATCAGCACGGTACCGATCAGCTCCTTGTCCATG 
L-ΔPLoop-F GCTACTTGGTTCTGGATGCGGGTGGTAGCATTCTGACGCCACG 
L-ΔPLoop-R CGTGGCGTCAGAATGCTACCACCCGCATCCAGAACCAAGTAGC 
Table 2.2 DNA oligos used for site directed mutagenesis and deletions. Nucleotides introducing 
H34K mutation are highlighted in red. Nucleotides replacing deleted region with glycines are 
highlighted in blue. 
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2.1.3 Bacteria expression 
 
L protein C-terminal constructs were expressed in Escherichia coli BL21 strain 
transformed with pESPRIT plasmid, a pET-derived high copy number plasmids, carrying 
appropriate inserts. Bacteria were grown in suspension in LB + kanamycin media at 37°C to 
reach the OD600 = 0.6 – 0.8. Expression was induced with 1 mM IPTG, and carried over night at 
20°C. 
 
2.1.4 Insect cells expression 
 
The Bac-to-Bac insect cell expression system (Invitrogen) was used for expression. 
Briefly, the pFastBac donor plasmid and Escherichia coli TOP10 were used to clone and amplify 
desired vectors. They were than transformed into DH10Bac competent cells containing the 
bacmid and the helper plasmid. Cells with successfully performed transposition were selected 
on LB agar plates containing kanamycin, gentamycin, tetracycline, Bluo-gal, and IPTG. Freshly 
isolated recombinant bacmids were transfected into 0.5x106/mL of adherent Sf21 cells 
(Spodoptera frugiperda) in Sf-900 II SFM medium (Life Technologies), using the X-tremeGENE 
HP transfection agent (Roche), and 3 ml 6-well plates. V0 baculoviruses were than amplified in 
bigger volumes of suspension Sf21 cells, collected, and stored at 4°C. Proteins were expressed 
High Five insect cells grown in Express Five SFM medium (Life Technologies). After reaching 
desirable volume at 0.5x106/mL concentration, cells were infected with 0.5% (v/v) of the 
baculovirus and incubated for additional 3-4 days. Cells were harvested by centrifugation (10 
min, 4°C, 5000 G) and were either used directly for purification, or stored at -80°C. 
Selenomethionine derivative of L1750 was expressed in High Five insect cells grown in ESF 
921 medium (Expression Systems). 8 hours post infection medium was replaced by ESF 921 
methionine-free medium (Expression Systems) and after additional 16 hours (24 hours post 
infection) selenomethionine (ACROS Organics) was added (100 mg/L). 
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2.1.5 L protein C-terminus constructs purification 
 
Bacterial pellets were re-suspended in lysis buffer (20 mM Tris-HCl pH 7, 150 mM NaCl, 
10 mM βMe, 20 mM imidazole) supplemented with protease inhibitors (ROCHE, complete mini, 
EDTA-free) and lysed by sonication. Cell debris was spun off (30 min, 4 °C, 35000 G) and 
clarified supernatant was loaded onto immobilized nickel ion affinity chromatography (IMAC) 
column and washed with the lysis buffer supplemented with 1 M NaCl. Proteins were eluted 
using the lysis buffer supplemented with 300 mM imidazole. Appropriate fractions were 
merged and dialyzed overnight against the lysis buffer but without the imidazole. During this 
step TEV protease (home source) was added to the protein solution to remove the N-terminal 
His-tag. Following dialysis sample was loaded on the 2nd Ni column to separate the cleaved 
protein from the the His-tagged TEV protease. Finally samples were subjected to size exclusion 
chromatography (GE, Superdex S75). 
 
2.1.6 L and L1750 proteins purification 
 
Pellets of High Five cells were re-suspended in buffer A (50 mM Tris-HCl, 500 mM NaCl, 
20 mM imidazole, 0.5 mM TCEP, pH 8) supplemented with protease inhibitors (ROCHE, 
complete mini, EDTA-free) and lysed by mild sonication (3 min on ice in 10 sec pulses). Cell 
debris was spun off (30 min, 4 °C, 35000 G) and clarified supernatant was filtered with 0.22 μm 
cut off in order to enhance the flow through chelating sepharose (GE Healthcare) in upcoming 
chromatography steps. After filtration the protein was salt out of solution by adding ammonium 
sulfate to the supernatant (0.5 g/ml) and incubating 1 hour at 4 °C.  The precipitated protein 
was collected by centrifugation (30 min, 4 °C, 70000 G) and re-suspended in the same volume 
of buffer A. Following final centrifugation step (30 min, 4 °C, 70000 G) the protein solution was 
loaded onto immobilized nickel ion affinity chromatography (IMAC) column and washed with 
buffer A supplemented with 1 M NaCl. Polymerase was eluted using buffer A with 300 mM 
imidazole. Appropriate fractions were merged and dialyzed overnight against buffer B (50 mM 
Tris-HCl, 250 mM NaCl, 0.5 mM TCEP, pH 8). Next the polymerase solution was loaded on a 
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heparin column (GE, HiTrap Heparin HP, 2 x 5ml) and eluted by a gradient of buffer B 
supplemented with 1 M NaCl. This step allowed further purification and concentration of the 
polymerase in the same time. At this stage RNA-free-sample was either supplemented with 
10% glycerol, aliqouted, flash-frozen in liquid nitrogen and stored at -80 °C, or was directly 
subjected to size exclusion chromatography (GE, Superdex S200) in buffer C (20 mM Tris-HCl, 
150 mM NaCl, 2 mM TCEP, pH 8).  
In case of L full length protein purified for co-crystallization with vRNA, a modification of 
that procedure was used. Namely an excess of the appropriate RNA oligo (or pre-annealed 
oligos) was added to the polymerase sample eluted from the heparin column. Mild, stepwise 
dialysis against buffer B with decreasing concentration of NaCl (from 600 mM to 150 mM) 
allowed polymerase-vRNA complex formation, preventing protein precipitation from low salt 
solution.  
 
2.2 RNA oligos  
 
2.2.1 Synthetic RNA oligos 
 
All synthetic RNA used for co-crystallization experiments, activity assays and 
radiolabelling were initially acquired from Sigma-Aldrich and later on from GE Healthcare 
Dharmacon. Fluorescently labelled RNA oligos were initially acquired from Sigma-Aldrich and 
later on from IBA. RNA oligos with 5ʹppp modification used for capping with VCE were acquired 
from ChemGenes. Table below lists all the RNA oligos used: 
 
3′1-56 WT GGUUUGAUUCAAAACUUUAAUAUUCAAACGUUAUCUAUACUUGGUAGUACACUACU 
3′1-25 WT UAUCUAUACUUGGUAGUACACUACU 
3′1-22 WT CUAUACUUGGUAGUACACUACU 
3′1-20 WT AUACUUGGUAGUACACUACU 
3′1-18 WT ACUUGGUAGUACACUACU 
3′1-17 WT CUUGGUAGUACACUACU 
3′1-16 WT UUGGUAGUACACUACU 
3′1-16 cRNA UUGGUAGCACACUACU 
3′1-15 WT UGGUAGUACACUACU 
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3′1-14 WT GGUAGUACACUACU 
3′1-12 WT UAGUACACUACU 
3′1-10 WT GUACACUACU 
3′1-8 WT ACACUACU 
3′9-17 WT CUUGGUAGU 
3′9-16 WT UUGGUAGU 
3′9-15 WT UGGUAGU 
  
3′1-11WT-12-20mut UAUGAACCAAGUACACUACU 
3′1-17 mut CUUGGUAAAGUUCUACU 
3′1-16 mut UUGGUAAAGUUCUACU 
3′1-15 mut UGGUAAAGUUCUACU 
3′1-17 FLUmut CUUGGUGCUACAGCUAC 
3′1-16 FLUmut UUGGUGCUACAGCUAC 
3′1-15 FLUmut UGGUGCUACAGCUAC 
  
3′5A(6-14WT) GGUAGUACAAAAAA 
3′(1-5WT)4G(10-14WT) GGUAGGGGGCUACU 
3′(1-9WT)5A AAAAAUACACUACU 
3′3A(1-14WT)3A AAAGGUAGUACACUACUAAA 
3′5G(6-9WT)5C CCCCCUACAGGGGG 
  
5′p1-59 WT pAGUAGUGUGCUACCAAGUAUAAAAUAAUGUUUGCAAAAUAAAUUUACGCUGUUGUUAGU 
5′1-25 WT AGUAGUGUGCUACCAAGUAUAAAAU 
5′ppp1-25 WT pppAGUAGUGUGCUACCAAGUAUAAAAU 
5′p1-17 WT pAGUAGUGUGCUACCAAG 
5′p1-16 WT pAGUAGUGUGCUACCAA 
5′p1-15 WT pAGUAGUGUGCUACCA 
5′p1-14 WT pAGUAGUGUGCUACC 
5′p1-13 WT pAGUAGUGUGCUAC 
5′p1-12 WT pAGUAGUGUGCUA 
5′p1-11 WT pAGUAGUGUGCU 
5′p1-11 cRNA pAGUAGUGUACU 
5′p1-10 WT pAGUAGUGUGC 
5′p1-10 cRNA pAGUAGUGUAC 
5′p1-8 WT pAGUAGUGU 
5′9-25 WT GCUACCAAGUAUAAAAU 
5′9-22 WT GCUACCAAGUAUAA 
5′9-20 WT GCUACCAAGUAU 
5′9-18 WT GCUACCAAGU 
5′9-17 WT GCUACCAAG 
5′9-16 WT GCUACCAA 
5′9-16 cRNA ACUACCAA 
5′9-15 WT GCUACCA 
5′9-14 WT GCUACC 
5′8-16 WT UGCUACCAA 
5′7-16 WT GUGCUACCAA 
5′6-16 WT UGUGCUACCAA 
5′12-16 WT ACCAA 
5′11-16 WT UACCAA 
5′10-16 WT CUACCAA 
  
5′p1-16 mut pGACCGUGGGUCACCAA 
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5′p1-11 mut pGACAGUGUGUC 
5′p1-10 mut pGACAGUGUGU 
5′p1-17 BPmut pACGAGUGUCGUACCAAG 
5′p1-16 BPmut pACGAGUGUCGUACCAA 
5′p1-15 BPmut pACGAGUGUCGUACCA 
  
3′1-16 WT[Br] U(U5Br)GG(U5Br)AG(U5Br)ACAC(U5Br)ACU 
5′9-16 WT[Br] GC(U5Br)ACCAA 
  
3′1-25 WT[Cy5] [Cy5]-UAUCUAUACUUGGUAGUACACUACU 
3′1-25 WT[DY647] [DY647]-UAUCUAUACUUGGUAG(U4S)ACAC(U4S)ACU 
3′1-25 WT[FAM] [FAM-EX-5]-UAUCUAUACUUGGUAGUACACUACU 
3′1-25 A6C[FAM] [FAM-EX-5]-UAUCUAUACUUGGUAGUACCCUACU 
3′1-25 A8C[FAM] [FAM-EX-5]-UAUCUAUACUUGGUAGUCCACUACU 
  
5′ppp1-25 WT[Cy5] pppAG(U4S)AGUGUGCUACCAAGUAUAAAAU-[Cy5] 
5′p1-25 WT[FAM] pAGUAGUGUGCUACCAAGUAUAAAAU-[FAM-EX-5] 
5′p1-25 cRNA[FAM] pAGUAGUGUACUACCAAGUAUAAAAU-[FAM-EX-5] 
5′9-25 WT[FAM] GCUACCAAGUAUAAAAU-[FAM-EX-5] 
5′8-25 WT[FAM] UGCUACCAAGUAUAAAAU-[FAM-EX-5] 
5′7-25 WT[FAM] GUGCUACCAAGUAUAAAAU-[FAM-EX-5] 
5′6-25 WT[FAM] UGUGCUACCAAGUAUAAAAU-[FAM-EX-5] 
  
α-globin ppp mRNA ppp(Am)CACUUCUGGUCCAGUCCGA 
α-globin mRNA ACACUUCUGGUCCAGUCCGA 
  
 
2.2.2 T7 transcription of RNA oligos  
 
T7 in vitro transcription was used to produce radioactively labelled RNA oligos for 
electrophoretic mobility shift assays (EMSA). Non labelled long RNA oligos for RNP assembly 
were also T7-transcribed. 2 μM DNA oligos were preheated and annealed in order to form 
double stranded T7 promoter with long overhang being the reaction template, depicted below.  
MECHANISM: 
5′ TAATACGACTCACTATAGGGXXXXXXXXXXXXXXXXXXXXXX 3′ 
3′ ATTATGCTGAGTGATATCCCYYYYYYYYYYYYYYYYYYYYYY 5′ 
 
OLIGOS TO ORDER: 
5′ TAATACGACTCACTATAGGG 3′ 
5′ YYYYYYYYYYYYYYYYYYYYYYCCCTATAGTGAGTCGTATTA 3′ 
 
RNA PRODUCT: 
5′ GGGXXXXXXXXXXXXXXXXXXXXXX 3′ 
 
Methods 
 
61 
 
Reactions were carried in 10 μl or 10 ml volume for radioactively labelled or non-
labelled RNA respectively. DNA templates were mixed with 4 mM ATP/UTP/CTP/GTP (Jena 
Bioscience) and, if needed, [α32P]-GTP (PerkinElmer) in the TDMST buffer containing 40 mM 
Tris pH 8.0, 5 mM DTT, 1 mM spermidine, 0.01% Triton X-100, 30 mM MgCl2, and 1% PEG8000. 
To start the transcription 50 μg/ml of the home source T7 polymerase was added. Reactions 
were incubated in 37°C for 3-5 hours. RNA products were than resolved on big urea TBE 15-20% 
polyacrylamide gels. Silica gels (Merck) were used to visualize RNA bands by 254 nm UV light 
shadowing. Bands were then cut from the gel and incubated overnight in the RNA elution 
buffer containing 0.5 M ammonium acetate pH 5.0, 1 mM EDTA pH 8.0, and 0.1% SDS.  
DNA oligos comprising various TATA promoters and templates used in T7 transcription 
reactions are listed in the table below: 
T7prom+AGT TAATACGACTCACTATAAGT 
T7prom+GTG TAATACGACTCACTATAGTG 
T7prom+GCT TAATACGACTCACTATAGCT 
T7prom+GCC TAATACGACTCACTATAGCC 
T7prom+GAG TAATACGACTCACTATAGAG 
T7prom+GGA TAATACGACTCACTATAGGA 
T7prom+GGG TAATACGACTCACTATAGGG 
T7prom+GGT TAATACGACTCACTATAGGT 
T7prom+CGT TAATACGACTCACTATACGT 
T7prom+TGT TAATACGACTCACTATATGT 
T7prom+AAT TAATACGACTCACTATAAAT 
T7prom+ACT TAATACGACTCACTATAACT 
T7prom+ATT TAATACGACTCACTATAATT 
T7prom+AGA TAATACGACTCACTATAAGA 
T7prom+AGG TAATACGACTCACTATAAGG 
T7prom+AGC TAATACGACTCACTATAAGC 
  
mRNA50/T1  CATATCGTGTCATATCGTGTCATATCGTGTCTTAACGTGTCAATTCATCCTAT
AGTGAGTCGTATTA 
mRNA40/T1 CATATCGTGTCATATCGTGTCTTAACGTGTCAATTCATCCTATAGTGAGTCGT
ATTA 
mRNA30/T1 CATATCGTGTCTTAACGTGTCAATTCATCCTATAGTGAGTCGTATTA 
mRNA20/T1 CTTAACGTGTCAATTCATCCTATAGTGAGTCGTATTA 
mRNA10/T1 CAATTCATCCTATAGTGAGTCGTATTA 
  
3′1-30(GG) AGTAGTGTACTACCAAGTATAGATAACGTTCCTATAGTGAGTCGTATTA 
3′1-25(GG) AGTAGTGTACTACCAAGTATAGATACCTATAGTGAGTCGTATTA 
3′20wt(GG) AGTAGTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′15wt5mut(GG) AGTAGTGTACTACCATTCTCCCTATAGTGAGTCGTATTA 
3′10wt10mut(GG) AGTAGTGTACCCTTCTTCTCCCTATAGTGAGTCGTATTA 
3′5wt15mut(GG) AGTAGCTCCTCCTTCTTCTCCCTATAGTGAGTCGTATTA 
  
5′1-30 ACATTATTTTATACTTGGTAGCACACTACTTATAGTGAGTCGTATTA 
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5′1-25 ATTTTATACTTGGTAGCACACTACTTATAGTGAGTCGTATTA 
5′20wt ATACTTGGTAGCACACTACTTATAGTGAGTCGTATTA 
5′15wt5mut(GA) CCTTCTGGTAGCACACTACTTATAGTGAGTCGTATTA 
5′10wt10mut(GA) CCTTCCTTCCGCACACTACTTATAGTGAGTCGTATTA 
5′5wt15mut(GA) CCTTCCTTCCTTCTCCTACTTATAGTGAGTCGTATTA 
  
PH:3′20(7G)5′1-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGT
GAGTCGTATTA 
PH:3′20(7G)5′5-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTATAGTGAGT
CGTATTA 
PH:3′20(7G)5′7-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACTATAGTGAGTCG
TATTA 
PH:3′20(7G)5′9-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCTATAGTGAGTCGTA
TTA 
PH:3′20(7G)5′12-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGCTATAGTGAGTCGTATTA 
PH:3′20(7G)5′15-20 AGTAGTGTACTACCAAGTATCCCCCCCATACTCTATAGTGAGTCGTATTA 
PH:3′1-20(7G)5′20 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGT
GAGTCGTATTA 
PH:3′3-20(7G)5′20 TAGTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGA
GTCGTATTA 
PH:3′5-20(7G)5′20 GTGTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGT
CGTATTA 
PH:3′7-20(7G)5′20 GTACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGTCG
TATTA 
PH:3′9-20(7G)5′20 ACTACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGTCGTA
TTA 
PH:3′11-20(7G)5′20 TACCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGTCGTATT
A 
PH:3′13-20(7G)5′20 CCAAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGTCGTATTA 
PH:3′15-20(7G)5′20 AAGTATCCCCCCCATACTTGGTAGCACACTACTTATAGTGAGTCGTATTA 
PH:3′20(7G)5′9 AGTAGTGTACTACCAAGTATCCCCCCCATACTTGGCTATAGTGAGTCGTATTA 
PH:3′20(7G)5′6 AGTAGTGTACTACCAAGTATCCCCCCCATACTCTATAGTGAGTCGTATTA 
  
3′20:U4A AGTTGTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:U4G AGTCGTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:U4C AGTGGTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C5A AGTATTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C5G AGTACTGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C5U AGTAATGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A6G AGTAGCGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A6C AGTAGGGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A6U AGTAGAGTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C7A AGTAGTTTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C7G AGTAGTCTACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:C7U AGTAGTATACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A8G AGTAGTGCACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A8C AGTAGTGGACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:A8U AGTAGTGAACTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:U9A AGTAGTGTTCTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:U9G AGTAGTGTCCTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:U9C AGTAGTGTGCTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:G10A AGTAGTGTATTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:G10C AGTAGTGTAGTACCAAGTATCCTATAGTGAGTCGTATTA 
3′20:G10U AGTAGTGTAATACCAAGTATCCTATAGTGAGTCGTATTA 
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5′20:A1G ATACTTGGTAGCACACTACCTATAGTGAGTCGTATTA 
5′20:A1C ATACTTGGTAGCACACTACGTATAGTGAGTCGTATTA 
5′20:A1U ATACTTGGTAGCACACTACATATAGTGAGTCGTATTA 
5′20:G2A ATACTTGGTAGCACACTATTTATAGTGAGTCGTATTA 
5′20:G2C ATACTTGGTAGCACACTAGTTATAGTGAGTCGTATTA 
5′20:G2U ATACTTGGTAGCACACTAATTATAGTGAGTCGTATTA 
5′20:U3A ATACTTGGTAGCACACTTCTTATAGTGAGTCGTATTA 
5′20:U3G ATACTTGGTAGCACACTCCTTATAGTGAGTCGTATTA 
5′20:U3C ATACTTGGTAGCACACTGCTTATAGTGAGTCGTATTA 
5′20:A4G ATACTTGGTAGCACACCACTTATAGTGAGTCGTATTA 
5′20:A4C ATACTTGGTAGCACACGACTTATAGTGAGTCGTATTA 
5′20:A4U ATACTTGGTAGCACACAACTTATAGTGAGTCGTATTA 
5′20:G5A ATACTTGGTAGCACATTACTTATAGTGAGTCGTATTA 
5′20:G5C ATACTTGGTAGCACAGTACTTATAGTGAGTCGTATTA 
5′20:G5U ATACTTGGTAGCACAATACTTATAGTGAGTCGTATTA 
5′20:U6A ATACTTGGTAGCACTCTACTTATAGTGAGTCGTATTA 
5′20:U6G ATACTTGGTAGCACCCTACTTATAGTGAGTCGTATTA 
5′20:U6C ATACTTGGTAGCACGCTACTTATAGTGAGTCGTATTA 
5′20:G7A ATACTTGGTAGCATACTACTTATAGTGAGTCGTATTA 
5′20:G7C ATACTTGGTAGCAGACTACTTATAGTGAGTCGTATTA 
5′20:G7U ATACTTGGTAGCAAACTACTTATAGTGAGTCGTATTA 
5′20:U8A ATACTTGGTAGCTCACTACTTATAGTGAGTCGTATTA 
5′20:U8G ATACTTGGTAGCCCACTACTTATAGTGAGTCGTATTA 
5′20:U8C ATACTTGGTAGCGCACTACTTATAGTGAGTCGTATTA 
5′20:G9A ATACTTGGTAGTACACTACTTATAGTGAGTCGTATTA 
5′20:G9C ATACTTGGTAGGACACTACTTATAGTGAGTCGTATTA 
5′20:G9U ATACTTGGTAGAACACTACTTATAGTGAGTCGTATTA 
5′20:C10A ATACTTGGTATCACACTACTTATAGTGAGTCGTATTA 
5′20:C10G ATACTTGGTACCACACTACTTATAGTGAGTCGTATTA 
5′20:C10U ATACTTGGTAACACACTACTTATAGTGAGTCGTATTA 
  
3′52wt AGTAGTGTACTACCAAGTATAGATAACGTTTGAATATTAAAGTTTTGAATCCT
ATAGTGAGTCGTATTA 
3′53wt AGTAGTGTACTACCAAGTATAGATAACGTTTGAATATTAAAGTTTTGAATCCC
TATAGTGAGTCGTATTA 
3′54wt AGTAGTGTACTACCAAGTATAGATAACGTTTGAATATTAAAGTTTTGAATCAC
CTATAGTGAGTCGTATTA 
3′55wt AGTAGTGTACTACCAAGTATAGATAACGTTTGAATATTAAAGTTTTGAATCAA
CCTATAGTGAGTCGTATTA 
3′56wt AGTAGTGTACTACCAAGTATAGATAACGTTTGAATATTAAAGTTTTGAATCAA
ACCTATAGTGAGTCGTATTA 
  
5′55wt ACAACAGCGTAAATTTATTTTGCAAACATTATTTTATACTTGGTAGCACACTA
CTTATAGTGAGTCGTATTA 
5′56wt AACAACAGCGTAAATTTATTTTGCAAACATTATTTTATACTTGGTAGCACACT
ACTTATAGTGAGTCGTATTA 
5′57wt TAACAACAGCGTAAATTTATTTTGCAAACATTATTTTATACTTGGTAGCACAC
TACTTATAGTGAGTCGTATTA 
5′58wt CTAACAACAGCGTAAATTTATTTTGCAAACATTATTTTATACTTGGTAGCACA
CTACTTATAGTGAGTCGTATTA 
5′59wt ACTAACAACAGCGTAAATTTATTTTGCAAACATTATTTTATACTTGGTAGCAC
ACTACTTATAGTGAGTCGTATTA 
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2.3 Functional characterization  
 
2.3.1 Limited proteolysis experiments 
 
Papain limited proteolysis of the L7 C-terminal construct was carried for 1-2 hours at 
room temperature with 1:500 (w/w) papain-L7 ratio and stopped by addition of the SDS-PAGE 
loading buffer and sample boiling, and visualized on SDS-PAGE. 
Trypsin protection assays were performed on both L1750 and full length L proteins using 
25-nucleotide long 3ʹvRNA or 5ʹvRNA ends. 1 mg/ml of protein sample was incubated with the 
vRNA for 1-2 hours prior to trypsination. 1:1 protein-RNA ratio or a slight excess of RNA to 
ensure saturation were used. Apo protein was used as a reference. Trypsin limited proteolysis 
was carried for 1 hour at room temperature with 1:1000 (w/w) trypsin-L protein ratio and 
stopped by addition of the SDS-PAGE loading buffer and sample boiling. Products of L1750 or L 
tripsination in presence or absence of the vRNAs were visualized on gradient SDS-PAGE (Bolt 4-
12% Bis-Tris Plus Gel, Life Technologies). The cleavage products were identified and analysed by 
various techniques, including western-blot, ESI-TOF-MS, MALDI-TOF-MS, MALDI-TOF-MS with 
N-termini acetylation, and Edman degradation.  
 
2.3.2 RNA-protein UV crosslinking 
 
Prior to UV crosslinking 1μM of L1750 or full length L protein was saturated with 2 μM of 
3ʹ or 5ʹvRNA bearing 2 or 1 photo-activable 4-thio-uracil (4SU) respectively (Kramer et al., 
2011). In some cases excess of polyU RNA was used to minimize non-specific L protein – vRNA 
interactions. Both vRNAs were additionally labeled with a fluorophore on their non-interacting 
ends for tracking protein-RNA crosslinks. 5’vRNA was labelled with Cy5 and 3’vRNA with DY647 
– an analog of Cy5. Following incubation vRNA – protein mixtures were loaded inside inverted 
caps of the Eppendorf tubes, placed on ice, and exposed to 365 nm UV light. Distance from the 
UV lamp was approximately 1 cm. Samples were crosslinked for 5-10 min (1min on / 1min off). 
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Following crosslinking samples were tripsinated as described above. Cleavage products were 
visualized on gradient SDS-PAGE (Bolt 4-12% Bis-Tris Plus Gel, Life Technologies). Prior to 
Coomasie staining gels were scanned for fluorescence signal using Typhoon. Images resulted 
from gel staining and fluorescence scanning were superposed in order to identify cleavage 
products crosslinked to vRNA. Selected bands were analysed by MALDI-TOF-MS, MALDI-TOF-
MS with N-termini acetylation. 
 
2.3.3 RNA-protein binding studies – radioactive EMSA assays 
 
For each RNA-binding experiment 10 μM of L1750 in 10 μl buffer (100 mM Tris, 100 mM 
NaCl, 0.5 mM DPBA, 5 mM βME, pH 8) was mixed with radioactive RNA and 1 μl of non-specific 
polyU RNA (Sigma). In order to maintain similar amount of radioactive RNA in each mixture the 
volumes added were scaled based on ImageQuant and Geiger counter measurements 
performed prior to the experiment. Mixtures were incubated at RT for several hours and 
resolved on native TG gels (top and bottom part of the gel – 10 and 20% polyacrylamide 
respectively). Radioactive signal from shifted bands was recorded with Typhoon and quantified 
with ImageQuant. In each case the amount of bound RNA was measured in reference to the 
control RNA of known strong affinity to the protein. 
A modification of the EMSA method was used with the synthetic, fluorescently-labelled 
RNA oligos. RNA-protein binding analysis was analysed by gel EMSA as described above. 
Fluorescence signal was scanned with Typhoon. 
 
2.3.4 RNP assembly 
 
Trials were made in order to assemble in vitro the L or L1750 protein together with single-
stranded vRNA and nucleoproteins (NP). Buffer for the assembly contained 20 mM Tris ph 8.0, 
150 mM NaCl, and 0.5 mM TCEP. The following vRNA, either T7 in vitro transcribed or synthetic, 
were used: 3ʹ52nt, 3ʹ53nt, 3ʹ56nt, 5ʹ55nt, 5ʹ56nt, and 5ʹ59nt. Nucleoprotein samples were 
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provided by Dr. Juan Reguera and were purified using thiocyanate as described previously 
(Reguera et al., 2013). Prior to the assembly N proteins were subjected to the size exclusion 
chromatography. In case of full length L protein the vRNA was added directly to the high salt 
heparin elution protein samples (see L purification procedure) and mixtures were dialysed 
against the assembly buffer. In both cases – L and L1750 – either the polymerase was pre-
incubated with vRNA before N protein addition, or all three components were mixed together 
from the start. In this later scenario the assembly buffer was implemented with 1M NaCl and 
the cocktail was gradually dialysed down to 150 mM NaCl. This approach was similar to the L 
full length purification procedure, and was performed to force proper order of assembly, with 
vRNA binding first to the polymerase due to the affinity higher than vRNA-N protein affinity. 
Components for assembly assay were mixed at 1:1:4 ratio of polymerase, vRNA, and NP, and at 
low μM concentrations. Knowing the length of vRNA 3ʹ and 5ʹ ends specifically bound by the 
polymerase to be ~8 and ~11 nucleotides respectively (Gerlach et al., 2015), as well as the 
length of nucleotides accommodated by single NP (Reguera et al., 2013), the properly formed 
RNPs should contain four NP per a single polymerase-vRNA complex. Assemblies were carried 
at 4°C with long incubation times up to 48 hours. To verify whether complexes were formed 
samples were subjected to the size exclusion chromatography and collected fractions resolved 
on gradient SDS-PAGE (Bolt 4-12% Bis-Tris Plus Gel, Life Technologies) 
 
2.3.5 Isothermal titration calorimetry 
 
Isothermal titration calorimetry (ITC) is a quantitative technique based on heat 
consumption or heat release generated upon titration of a ligand into sample solution. Each 
time the change in heat is encountered the system must apply a certain amount of μcal/sec in 
order to restore the temperature. ITC allows accurate determination of the binding affinities 
(Ka) between analysed molecules in solution. It also provides information concerning enthalpy 
changes (ΔH) and binding stoichiometry (n). Set of these experimentally measured parameters 
allows calculation of changes in Gibbs energy (ΔG) and entropy (ΔS) using the following 
formula: 
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ΔG = -RTlnKa = ΔH-TΔS 
  
All measurements were performed at 25°C, using the ITC200 Microcalorimeter 
(MicroCal Inc.). L1750 protein sample at 0.015 – 0.03 mM was titrated with 3ʹ-OH or 5ʹ-ppp 25 
nucleotide long vRNA at approximately 10 x higher concentration (RNA oligos with triphosphate 
modification were obtained from Chemgenes). Prior to a single titration experiment 200 – 250 
μl of protein sample in buffer containing 20 mM Tris ph 8.0, 150 mM NaCl, and 5 mM βME was 
loaded inside the sample cell. In order to overcome protein precipitation during the 
experiment, buffer containing 300 mM NaCl was also used. Syringe was filled with 40 – 50 μl of 
titrant vRNA. In order to minimize the buffer-related effects both sample and ligand solutions 
were dialysed against the same buffer. Moreover a blank measurement was performed in 
which vRNA was titrated into the sample buffer alone. Results of such control titration were 
later on subtracted form experimental data. During single experiment a total of 26 injections, 
1.5 μl each, were made. Injections lasted 3 sec each, and were separated by 180 sec spacing. 
Reference power was set up to 5 μcal/sec. Obtained binding isotherms were analysed by 
Levenberg–Marquardt nonlinear regression using the ITC-adapted Origin Software (MicroCal 
Inc.). In each case a simple one binding-site fitting strategy was adopted.  
 
2.3.6 Microscale thermophoresis 
 
Microscale thermophoresis (MST) is a technique allowing to measure binding affinities 
(Kd) between analysed molecules in solution. As a principle it uses microscopic temperature 
gradients which trigger movements of molecules. Experiments are easy to perform and they 
consume very little material. For a single run 16 two-fold dilutions of the ligand (small molecule, 
RNA) are mixed with fluorescently-labelled molecule (protein) usually at nM concentration, in 
the final volume of 15-20 μl. Following incubation the mixtures are loaded into separate glass 
capillaries within which the measurement is performed. Infra-red (IR) laser heats sequentially 
the capillaries, thus increasing locally sample temperature by few Celsius degrees.  
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   MST experiments were performed using the Monolith NT.115 Green/Red device 
(NanoTemper Technologies GmbH). L1750 protein was fluorescently labelled using amine 
reactive MO-L002 Monolith™ Protein Labeling Kit GREEN-NHS. 50 nM of labelled L1750 protein 
was than incubated with 25 nucleotide long 5ʹ vRNA end bearing either mono- or triphosphate 
modification at the very 5ʹ end. 16 dilutions of vRNA ranging from 40 μM to 1 nM were used. IR 
irradiation lasted 50 sec per one capillary, and the 15% of IR laser power was used. 
Experimental points were analysed and the binding curve fitted using NanoTemper software.    
 
2.4 Structural characterization 
 
2.4.1 SAXS – data collection and analysis 
 
Small angle X-ray scattering (SAXS) is a technique that allows low resolution structural 
analysis of a macromolecular sample in solution. The intensity of the X-ray scattered during an 
experiment depends on the scattering angle. The signal generated by differently oriented 
molecules is averaged and becomes proportional to the scattering from a single molecule. Since 
different shapes of molecules generate characteristic scattering curves, SAXS can usually 
provide helpful information concerning the overall shape and dimensions of the analyzed 
object (Guinier plot, Rg – radius of gyration). SAXS 3D models can be used to fit in more 
accurate atomic structures. 
Both L1750 and L were subjected to the SAXS analysis, either as apo or vRNA bound 
proteins. Samples were prepared in buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, 5 mM 
βME, and 2.5% glycerol. In one set of apo protein samples a buffer with stabilising additives was 
tested – 500 mM NaCl and 200 mM arginine. For each sample a series of four two fold dilutions 
were tested starting from the following concetrations: L-apo 1.83 mg/ml, L-3ʹ 1.3 mg/ml, L-5ʹ 
1.7 mg/ml, L-additives 0.5 mg/ml, L1750-apo 7.2 mg/ml, L1750-3ʹ 25.0 mg/ml, L1750-5ʹ 16.4 mg/ml, 
L1750-additives 3.5 mg/ml. Results obtained for different concentrations were used to correct 
for oligomerization or other inter particle effects.  
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Data were collected at the ESRF BioSAXS beamline BM29 having wide energy range (7.0 
– 15.0 keV) and equipped with a PILATUS 1M detector (Pernot et al., 2013). 35-40 μl samples 
were loaded into 2 mm quartz capillaries, and ISPyB BioSAXS interface (De Maria Antolinos et 
al., 2015) and BsxCuBE software were used to conduct the experiment and automatically 
process the images. Background buffer scattering was subtracted from each sample 
measurement using EMBL-developed PRIMUS program (Konarev et al., 2003). Ab-inition 
models were generated using programs DAMMIF (Franke and Svergun, 2009).  
 
2.4.2 X-ray crystallography – protein crystallization 
 
L1750 protein in buffer C was adjusted to a concentration of 10 mg/ml and mixed in 3:4 
ratio with vRNA. The vRNA used was an equimolar mixture of nucleotides 1-16 from the M-
segment vRNA 3ʹ end (3ʹ-UCAUCACAUGAUGGUU-5ʹ) and nucleotides 9-16 from M-segment 
vRNA 5ʹ end (5ʹ-GCUACCAA-3ʹ)(GE Dharmacon), preheated to 90°C and annealed by slow 
cooling down. Sitting drops were prepared by mixing equal volumes (100 nl each) of the sample 
and reservoir solution using a Cartesian PixSys 4200 crystallization robot (Genomic Solutions). 
Crystallization trials were performed by vapor diffusion at 20°C. The brush-like needle clusters 
emerged after 2-3 days from several conditions containing 15% (w/v) of PEG 4000 or 20% (w/v) 
of PEG 3350 as precipitant and 0.2 M of various sulfate or citrate salts (Crystal Screen Lite and 
PEG/Ion from Hampton Research). After an additive screen and several rounds of pH and 
precipitant/salt concentration optimization the most convenient conditions were narrowed 
down to: 0.1 M Hepes, 0.2 M sodium citrate tribasic dihydrate, 0.3 M ammonium sulfate, 15% 
PEG 3350, pH 7. Despite decreasing crystallization temperature to 4 °C to reduce nucleation 
and growth speed crystals maintained tendency to form multicrystal clusters. Finally the 
microseeding procedure allowed to obtain the rod-shaped single crystals. In brief the best 
single-like looking clusters were transferred to the fresh drop of mother liquor, crushed with 
microseeding tools, and used to prepare a series of seeds dilutions, which were then added 
directly to the new crystallization drops (1 μl protein-RNA sample + 1 μl of mother liquor + 0.25 
μl of seeds dilution).  
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Selenomethionine derivative crystals were grown in the same conditions as native ones, 
using initially native seeds and then switching to selenomethionine seeds if necessary. Heavy 
metal derivatives were prepared by soaking native crystals in mother liquor supplemented with 
either 2.5-5 mM K2PtCl4 (1-2 hours soaking) or with 5-10 mM Ta6Br12 tantalum cluster (Jena 
Bioscience)(1-2 days soaking). The tantalum cluster soaked crystals became visibly green. Prior 
to cryo-cooling the crystals were soaked in the mother liquor supplemented with 20-30% 
glycerol but without the heavy metal. This back-soaking step was performed in order to 
decrease the amount of heavy metal ions which did not bound the crystallized protein, but 
which would increase the X-ray absorption and radiation damage.   
In order to obtain crystals containing missing 5ʹ end, the initial L1750-vRNA crystals were 
soaked with nucleotides 1-8, 1-10, 1-11, and 1-12 from M-segment vRNA 5ʹ end (5ʹ-
pAGUAGUGUGCUA-3ʹ and shorter)(GE Dharmacon).  
L1750-vRNA crystals (both native and selenomethionine derivative) started to grow 
overnight at 4 °C, but they required at least 3 days to reach their maximum size. Prior to the X-
ray diffraction experiment they were cryo-cooled to minimize the radiation damage caused by 
the free radicals and positive ionization. All crystals were cryo-protected in mother liquor 
supplemented with a cryo-protectant. While 20-30% glycerol proved to be the most efficient, in 
some cases ethylene glycol or PEG 400 were also tested. After few seconds of soaking in the 
cryo-protectant solution, crystals were quickly plunged and flash-frozen in liquid nitrogen at 
approximately -196 °C. 
In order to obtain L-vRNA crystals the RNA oligos used for co-crystallization were added 
during the L full length purification procedure (see above). Based on previous experience with 
L1750-vRNA co-crystallization the following lengths of partially double-stranded 3ʹ vRNA were 
tested: 3ʹ1-15/5ʹ9-15, 3ʹ1-16/5ʹ9-16, and 3ʹ1-17/5ʹ9-16 (GE Dharmacon). Following L-vRNA 
complex purification on the size exclusion chromatography, samples were concentrated to 5 
mg/ml and supplemented with fresh vRNA to ensure that all L proteins are saturated with 
vRNA. Initial, precipitate-like hits obtained in presence of pre-annealed, partially double-
stranded 3ʹ1-16/5ʹ9-16 vRNA in buffer containing 100 mM Tris buffer pH 8.0, 100 mM NaCl, and 
8% PEG 4000, were manually reproduced and optimized in hanging drops. During soaking with 
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the glycerol cryo-protectant a dehydration approach was used in order to rigidify the crystals 
and increase their diffraction capacities. It was achieved by the stepwise exchange of the cryo-
protectant solution with increasing concentration of glycerol from 5 to 30%. Crystals were 
incubated 0.5-1 hour at each glycerol concentration point, and flash-frozen at the end.   
 
2.4.3 X-ray crystallography – data collection  
 
All data collection experiments were performed at the European Synchrotron Radiation 
Facility (ESRF) on ID29 and ID23-1 beamlines both equipped with Pilatus 6M-F detectors. 
MxCuBE software was used to conduct the diffraction experiments (Gabadinho et al., 2010). 
Following the collection of 2-4 initial images 90° from each other, the strategy was designed 
based on the EDNA (Enhanced automateD collectioN of datA) diffraction plan (Incardona et al., 
2009). In some cases additional, manual investigation of the frames in the Mosflm software was 
needed (Leslie, 2006). Data collection strategy is planned based on initial autoindexing 
performed by EDNA which estimates the crystal orientation, its space group, and probable 
dimension of the unit cell. To design the data collection set of parameters need to be specified. 
Listed below are example parameters for a standard data collection at ID29: oscillation start 
(defines the starting angle at which the crystal is held by the goniometer arm); oscillation range 
= 0.1 (a single frame will be collected every 0.1°); number of images = 2000 (together with 
oscillation defines the angle of rotation during entire data collection, here 2000 x 0.1° = 200°); 
exposure time = 0.03 sec (time used to expose a single frame – in this case entire experiment 
last 2000 x 0.03 sec = 60 sec); transmission given in % (allows to set up beam attenuators 
according to the current machine power [mA]). In special cases a mesh scan was performed 
covering entire crystal in order to define the position resulting in the highest diffraction (Bowler 
et al., 2010). The helical data collection was frequently used in case of long bar-like crystals. It 
allows to define two points at the crystal edges between which the data collection will be done. 
While collection proceeds, the goniometer apart from rotating the crystal is sliding it from one 
end to the other. This minimizes the radiation damage by spreading it throughout the whole 
crystal, which usually results in better data quality. It is particularly helpful during anomalous 
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data collection. Another useful device available at some ESRF beamlines is the MiniKappa 
goniometer (Brockhauser et al., 2013). After performing initial characteristics of the crystal 
MiniKappa can align the crystal along its longest axe, which results in recording the Bijvoet 
mates (a reflection and the Friedel pair of its symmetry equivalent) on the same image.  
 
2.4.4 X-ray crystallography – data processing 
 
Data collection experiment results in a set of diffraction images. They need to be 
processed in order to obtain a list of Miller indices (hkl) with their corresponding intensities. To 
achieve this data was integrated and scaled with XDS and XSCALE (Kabsch, 2010). XDS is a 
command line program composed of several subprograms which are run in a row unless 
defined otherwise (XYCORR, INIT, COLSPOT, IDXREF, INTEGRATE, CORRECT). The first three 
prepare diffraction images date for actual analysis – they correct image axes, calculate the 
background, correct for beam deviations, and finally localize the spots. The IDXREF performs an 
indexing step – it calculates crystal orientation, matrix and symmetry of its lattice and refines 
parameters defined in the XDS.INP input file. If IDXREF succeeds in indexing majority of the 
spots according to the space group chosen, the XDS pipeline can proceed. The next step is the 
spot integration performed by INTEGRATE. Unlike Mosflm who implements a two-dimensional 
integration, XDS performs a three-dimensional integration. Tight spacing of frames results in 
many spots spread not only in two dimensions on a single image, but also in the third 
dimension which results in the same spot appearing on several images. XDS INTEGRATE takes 
this into account and sums up all the recorded signal belonging to the same spot into a single 
intensity. Finally XDS runs CORRECT in order to introduce correction factors to the intensities, 
determined space group if remained unknown so far, and refine the unit cell parameters. Final 
statistics inform about the completeness and quality of the data. Integrated intensities are 
saved in the XDS_ASCII.HKL file 
XDS generated intensities are not free from some systematic measurement errors – 
deviation  in beam intensity, different exposed crystal volume due to rotation, radiation 
Methods 
 
73 
 
damage decreasing the signal in the later part of the data, and detector-related errors. All those 
errors need to be corrected by scaling the data. This was done by XSCALE programme.   
 
2.4.5 L1750-vRNA structure solution and model building 
 
L1750-vRNA complexes crystallize in P212121 space group with one complex per ASU 
(unit cell dimensions: 102.5, 141.0, and 165.5 Å). The first native crystals diffracted to 3.1 Å, but 
it turned out the resolution can be improved to 2.8 Å when native data was collected from 
crystals soaked with 2 or 5 mM tantalum clusters. In order to obtain experimental phases 
anomalous datasets from platinum, tantalum, and selenomethionine derivatives were 
collected. Due to radiation damage and metal-specific limitation none of those datasets had 
anomalous signal that would be strong enough in high resolution shells to allow structure 
solution. Two of the best selenomethionine datasets scaled together gave anomalous signal at 
4.0-4.5 Å with overall resolution at 3.5 Å. Exceptionally good 5 mM tantalum cluster derivatives 
after scaling four datasets, measured at the absorption peak, gave strong anomalous signal in 
the 4.5-5.0 Å resolution range, with overall resolution at 3.5 Å and 13x multiplicity. This dataset 
was used to localize four sites for tantalum clusters in SAD experiment at autoSHARP (Vonrhein 
et al., 2007). These initial substructure was subjected to SHARP together with previously 
collected selenomethionine, platinum, and native datasets and refined using multiple 
isomorphous replacement with anomalous signal approach (MIRAS). The map obtained was of 
very good quality and – as it turned out once the model was built – only less than 10% of the 
protein was not visible in the density.   
Initially the automatic fitting of the endonuclease domain (PDB 2XI5) did not work. Its 
position became clear only after fitting of FluB PB1 subunit (PDB 4WSB) and it had to be further 
split within the hinge region in order to properly place both lobes in the electron density. 
Methionine positions were located using the anomalous differences from selenomethionine 
crystals. The model was iteratively built with Coot (Emsley and Cowtan, 2004) and refined with 
REFMAC (Murshudov et al., 1997). Autobuilded models done in Buccaneer (Cowtan, 2006) were 
used to extend the model in previously unbuilt regions and to verify the ones already built. 
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Exceptionally good quality of the RNA electron density allowed unambiguous building of co-
crystallized vRNA and revealed its critical role in crystallization. Apart from the single-stranded 
overhang buried in the protein cavity, the solvent-exposed short helix is on its blunt end 
interacting with the neighbouring protein molecule, thus greatly contributing to the crystal 
packing. 
Native L1750-vRNA crystals soaked with missing 5ʹ ends diffracted to the following 
resolutions: 5ʹp1-8 – 2.8 Å, 5ʹp1-10 – 2.8 Å, and 5ʹp1-11 – 3.1 Å. L1750-vRNA crystal soaked with 
5ʹp1-12 showed no RNA density in the appropriate binding site, but since it diffracted to 2.8 Å 
the dataset was still useful in building and refining previous models. Structures from all those 
crystals were solved by subjecting processed data to REFMAC rigid body refinement and 
refining one the available models against them.  
PyMOL was used to draw all the structure figures (DeLano 2002).  
 
2.4.6 L-vRNA structure solution and model building 
 
L-vRNA complexes crystallize in C2 space group with two complexes per ASU (unit cell 
dimensions: 371.5, 145.2, 232.8 Å; 90°, 116°, 90°). Initially crystals diffracted to 8-9 Å. The 
resolution could be further improved applying the stepwise cryo-cooling procedure (described 
above), and using 100% ID29 transmission combined with helical data collection. The best 
dataset obtained reached 4.4 Å resolution. Structure was solved with MOLREP (Vagin and 
Teplyakov, 2010) using L1750-vRNA structure as a model.   
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3. RESULTS  
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3.1 LACV L protein C terminus – structural characterization  
 
3.1.1 L6 and L6-derived constructs – design, expression, and purification 
 
Prior to the PhD project described in this thesis The ESPRIT method (Yumerefendi et al., 
2010) performed by Dr. Juan Reguera from the Cusack group on the last 800 residues of the 
LACV L protein revealed candidates for potentially soluble constructs (Fig. 3.1.A). The longest 
one called 3A was expressed in E. coli and treated with papain by Dr. Juan Reguera in order to 
define the edges of the structured domain (Fig. 3.1.B). The following L6 construct served as a 
starting point to establish a high yield purification protocol (Fig. 3.1.C). Initially, a significant 
 
Figure 3.1 A) ESPRIT technique-derived soluble constructs from La Crosse polymerase C-terminal 800 
residues-long region (performed by Juan Reguera); B) L6 – a papain resistant fragment derived from 3A 
(performed by Juan Reguera); C) S75 size exclusion chromatography of purified L6.
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Amount of protein was precipitating, especially during final concentration steps after size 
exclusion chromatography. Thermal stability assays (TSA) were performed in order to define 
the melting temperature of the construct and to screen for the optimal buffer and salt 
concentration.  The TSA results showed that the L6 construct has a melting temperature below 
45°C which decreases the chances for obtaining a diffracting crystal (Dupeux et al., 2011), and 
that higher salt concentration and phosphate buffer tend to improve the stability of the protein 
(Fig. 3.2). It is worth noting that the L6 gives a well-defined unfolding curve meaning that the 
protein is at least partially structured.  
Based on these results and following three different 2nd structure prediction software 
outputs and the multiple alignment of Orthobunyavirus L proteins, a new set of constructs were 
designed in order to refine the domain boundaries (Fig. 3.3). Among those constructs four were 
not soluble, one was not susceptible for TEV cleavage, two were precipitating heavily during 
purification, and the last two – 7AR and 8SR – gave a high yield of expression and could be 
finally concentrated up to 25 mg/ml. Several purification trials testing different buffer 
composition led us to the optimization of the 8SR purification protocol. Final buffer contained:  
 
Figure 3.2 Thermal stability assays performed on L6 showing the impact of different phosphate and Tris 
buffer, pH, and salt concentration on the melting point of the protein. 
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Figure 3.3 A) Initial constructs after ESPRIT technique and papain digestion (Juan Reguera); B) Constructs 
designed based on <Prof prediction>, <GOR 4> and <Porter> softwares. 
 
 
Figure 3.4 A) SDS-PAGE  showing improved purification protocol for 8SR: T – total fraction after 
sonication, S – soluble fraction, Ni – nickel column, FT – flow through, 1M – 1 M NaCl washing step, E – 
elution, TEV – sample after dialysis with TEV, Hep – Heparin column; B) 8SR profile after 2x5ml Heparin 
column chromatography against NaCl gradient. 
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20 mM Tris pH 7.0, 0.4 M NaCl, 5% glycerol, 20 mM imidazole, and 10 mM βME. The 
substitution of the 2nd Ni column step by the Heparin affinity chromatography resulted in more 
efficient purification and increased the final amount of protein sample. The NaCl gradient used 
during Heparin chromatography ranged from 0,4 M to 1 M with an elution peak at around 0,66 
M concentration (Fig. 3.4). 
 
3.1.2 7AR and 8SR constructs – crystallisation trials 
 
Both 7AR and 8SR samples were used to set up crystallisation trials at the HTX facility. 
The crystal hits appeared in conditions containing sulphate anions. The most promising crystals 
grew after 1 week in 4°C from 8SR sample mixed with 100 mM tri-sodium citrate dihydrate pH 
5,6 and 1 M magnesium sulfate heptahydrate (Fig. 3.5.A). They were flash-cooled in the same 
buffer supplemented with 20% glycerol but showed no diffraction pattern. These initial 8SR 
crystals could not be further improved by an additive screen or seeding. The remaining crystal 
hits were circular-shaped packs of clusters (Fig. 3.5.B). They tend to appear in 1/3 of additive 
screen drops but they also gave no diffraction pattern. To check whether they were protein 
crystals they were boiled in Laemmli buffer and analysed on the SDS-PAGE (Fig. 3.5.C). As 
mentioned above it was not possible to reproduce the initial 8SR crystals either in the sitting 
 
Figure 3.5 A) 8SR initial crystal hit; B) Multiple 8SR circle-shaped packs of clusters obtained from additive 
screens; C) SDS-PAGE gel of 8SR pure liquid sample (L) and a ‘circular crystal’ boiled in the Laemmli 
buffer (C). 
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drop or hanging drop vapour diffusion experiments performed in the 24-well plates. However, 
the shower of tiny 8SR crystals of similar three dimensional shape appeared in the MPCS 
microfluidic experiment (Gerdts et al., 2008). Initially this experiment was supposed to screen 
for a proper magnesium sulphate concentration, where the range from 0,5 M to 1,25 M was 
tested. Unfortunately those crystals also did not diffract. 
 
3.1.3 8SR construct – CD and 1D 1H-NMR analysis 
 
Taking all previous results into account, a possible scenario has raised, saying that 8SR – 
being a derivative of the papain resistant and at least partially structured L6 construct – is 
either too flexible to be a promising candidate for crystal screening or it contains only part of 
the domain or even lies in between two domains. Circular dichroism spectroscopy and 1D 1H-
NMR have been used to further investigate the conformational state of this construct. For both 
techniques the concentration of chloride anions had to be decreased as much as possible. This 
resulted in a very low protein solubility that lowered the concentration of the analyzed 
samples. In case of the CD experiment the remaining chloride anions at 200 mM concentration 
masked the far UV spectrum which is crucial to define with high accuracy the secondary 
structure of the protein and to calculate the α-helix/β-strand ratio. Nevertheless, the CD 
spectrum showed a peak characteristic for α-helical structures, and it was possible to conclude 
that ~20% of the protein is α-helical, ~40% is composed of random coils, and the rest of the 
protein is non-structured (Fig. 3.6.A).  
In spite of the partial precipitation of the 8SR sample during 1D 1H-NMR experiment, the 
data obtained further confirmed the CD analysis conclusions. By using 1D 1H-SOFAST 
experiment it was possible to observe that detectable 1H resonances of the sample are mostly 
located in the random coil regions (Fig. 3.6.B). Moreover, the 1H Hetnoe-SOFAST experiment 
showed that the protein detectable by 1H-NMR had a relatively low proton density and 
behaved rather like an unfolded protein with only few elements of regular folding (λ=0,46) (Fig. 
3.6.C).   
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Figure 3.6 A) 8SR circular dichroism spectra, the signal in far UV region highlighted in violet is masked by 
chloride anions; B) 1D 1H-SOFAST – distribution of NH and CH3 hydrogens between random coils (red) 
and structured regions (blue); C) 1H Hetnoe-SOFAST – ratio (λ) between NH – CH3 NOE with irradiated CH3 
(NOE ‘off’) and the regular NH – CH3 NOE signal (NOE ‘on’). 
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3.1.4 3A and L7 and other C-terminal construct – expression and purification 
 
The E. coli expression and purification trials were performed for 3A and L7 constructs – 
the first one being the initial ESPRIT-derived construct and later one sharing with the L6 the 
same N terminus and going downstream untill the C terminus of the L protein (aa 1751-2263). 
In case of the 3A it occurred that the C-terminal biotin tag of around 20 aa, added for ESPRIT 
technique purposes (Yumerefendi et al., 2010) has a huge impact on the protein solubility. 3A 
construct bearing only the original L protein sequence was completely insoluble. This could 
suggest that there is a structured region downstream to the C-terminus of 3A, which when 
removed impairs protein solubility and capability of crystallization. In order to verify this 
hypothesis the L7 – the longest C-terminal construct analyzed so far – was expressed and 
purified from the Hi5 insect cells. Purification protocol already established for the 8SR was 
implemented with one modification – the lysis buffer contained additional 200 mM NDSB – a 
non-ionic detergent used to stabilize proteins (Fig. 3.7.A-B). 
 
3.1.5 L7 C-terminal construct – limited proteolysis 
 
The L7 construct was further treated with papain in the limited proteolysis experiment 
in order to define autonomous well-structured domains. The L7-papain ratio was 500:1 (w/w). 
The digestion was held for 2 hours in room temperature and reaction was stopped after each 
10 min by adding Laemmli loading buffer and boiling the sample in 100°C. The new papain-
resistant fragments resolved on SDS-PAGE suggested the presence of two main species of 
around 40 kDa and 15 kDa (Fig. 3.7.C). In the next step papain-treated L7 sample was loaded 
onto S200 size exclusion chromatography column. Surprisingly the uncleaved L7 co-eluted 
together with 40 kDa and a smaller 15 kDa digestion products (Fig. 3.7.D). This suggests a 
presence of an internal loop, connecting these two fragments. Apparently cleaving-off the loop 
does not lead to the disassembly of the two subunits. 
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Figure 3.7 A) SDS-PAGE showing purification protocol for L7. B) L7 profile after HiLoad S200 size 
exclusion chromatography. C) time course of L7 limited proteolysis with 500:1 (w/w) papain, each line 
represents 10 min interval. D) papain-treated L7 profile after S200 size exclusion chromatography. E) 
ESI-MS results for L7-derived fragments; F) list of detected masses and identifications. 
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Figure 3.8 A) Overview of the LACV L protein C-terminal constructs. B) Summary of the C-terminal 
protein fragments derived from trypsin or papain limited proteolysis. C) Overview of constructs designed 
based on limited proteolysis and tested for expression, solubility and crystallization, and a cartoon 
proposing the possible domain architecture of the C terminus 
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In order to define the exact sequence and mass of the 40 kDa fragment different 
analytical techniques were used. Trypsin digestion followed by MALDI-TOF analysis showed 
sequence coverage for this fragment from Ala-1751 to  Ser-2101. Molecular mass calculated for 
such a construct equals 40,5 kDa. N-terminal sequencing has revealed that 60% of the analysed 
40 kDa fragment starts from the Ala-1751, the N terminus of the L7 construct. Another 40% 
start from the His-1755. In parallel papain-treated L7 sample was analyzed by ESI-MS in 
denaturing conditions in order to define the mass of all species that appeared after digestion. 
ESI-MS analysis did not provide an unequivocal answer suggesting that there are numerous 
papain cleavage sites ~160 aa upstream from the L7 C terminus. The largest mass detected was 
40,14 kDa which would match with the construct starting at the Ala-1751 and ending at the 
Asn-2097 (Fig. 3.7.E-F and Fig 3.8.B). This might confirm the 3A disrupted C-terminus hypothesis 
and explain the decrease of its solubility by the lack of a structured region situated 
downstream. 
 
3.1.6 L7-derived 2nd set of C-terminal constructs 
 
Based on data derived from the L7 papain limited proteolysis and followed by 2nd 
structure prediction and multiple sequence alignment a new set of constructs was designed. 
They start from the Ser-1759, like in case of the 8SR construct, and they differ in C termini with 
the shortest ending at the Ser-2078 and the longest going up to the Phe-2190 (Fig. 3.8.A). 
Majority of these constructs could not be expressed or purified from E. coli.   
In general whenever the C-terminal construct could be purified and remained soluble, it 
was subjected for crystallization trials. The most promising were the 3A and the L7 constructs, 
which could be concentrated up to 5 mg/ml and remained soluble. Nevertheless, apart from 
initial crystallization hits for the 8SR construct, none of the following C-terminal constructs 
could be crystallized.  
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3.2 LACV L protein C terminus – functional studies and binding 
assays  
 
3.2.1 L protein C terminus nuclease activity assays 
 
The 3A-RNA interaction experiments with the set of different RNAs previously 
performed by Dr. Juan Reguera have led to the observation that this region of the L protein may 
contain a nuclease activity. In order to confirm this hypothesis and to define the substrate 
specificity of this putative nuclease as well as its metal ion dependence a set of RNA and DNA 
digestions has been performed (Fig. 3.9.A-C) Reactions were held in room temperature for 1-2 
hours. For each construct the last purification step buffers were used. Reactions were stopped 
by adding the loading buffer containing 8M urea. Samples were analyzed by 15% urea PAGE. 
Provided results show no divalent metal ion dependence (Fig. 3.9.B). The DNA substrates 
remained uncleaved. The RNA substrates, both single- and double-stranded revealed a weak 
digestion pattern which most likely can be explained by the contaminations that remain in the 
sample after purification procedure (Fig. 3.9.A). There is no significant difference between the 
L7, the 3A and the 8SR construct RNA digestion ability (Fig. 3.9.C). Presented results lead to the 
conclusion that there is no nuclease activity within the LACV L protein C terminus. 
 
3.2.2 8SR cap-binding assays 
 
The 7mGTP sepharose resin was used to test the cap-binding activity of the LACV L 
protein C terminus. 0,25 mg of the 8SR in 1 ml sample buffer was loaded on the 0,1 mL of the 
resin. The washing buffer contained 20 mM Tris pH 7,0 and 200 mM NaCl. After three rounds of 
washing the elution was performed by implementing the washing buffer with 1 mM 7mGTP. 
Collected fractions were analyzed by SDS-PAGE. No 7mGTP-binding activity was detected (Fig. 
3.10.A).  
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Figure 3.9 A) 8SR nuclease assays – substrate specificity: 1 hour digestion of Alu dsRNA, polyU ssRNA, 
ssDNA and dsDNA; B) 8SR nuclease assays – divalent metal ion dependance: 1 hour digestion of Alu 
dsRNA, polyU ssRNA C) comparison of nuclease activity of L7, 3A and 8SR 
 
 
 
 
Figure 3.10 A) 8SR construct binding to the 7mGTP sepharose resin. L – sample loaded on the resin; FT – 
flow through of the protein unbound to the resin; W1-W3 – washing with 200 mM NaCl; E1-E3 – elution 
with 1 mM 7mGTP. B) L7 construct RNA binding by electrophoretic mobility shift in native PAGE. 
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Figure 3.11 A) L7-N interaction analyzed by S200 SEC; B) L7-L9 interaction analyzed by S200 SEC 
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3.2.3 RNA binding assays  
 
In order to test whether the C-terminal region of L protein has any RNA-binding activity, 
L7 construct was mixed either with polyU ssRNA or with dsRNA ‘262’ containing two hairpin 
structures. MDA-5 protein was used as a positive control (both ‘262’ RNA and MDA-5 samples 
were kindly provided by Dr. Emiko Uchikawa). Incubation was held on ice for 1 hour. After that 
samples were analyzed by 8% native PAGE and stained with methylene blue. No RNA-binding 
activity has been noticed for L7 construct (Fig. 3.10.B). 
 
3.2.4 Protein-protein interactions 
 
In parallel the possibility of protein-protein interaction between L7 and nucleoprotein 
(N) as well as between L7 and L9 (aa 1-1750) has been tested. Appropriate pairs of proteins 
have been mixed together and left for 1 hour incubation on ice. Samples were than analyzed by 
S200 Sepharose size exclusion chromatography. The results obtained indicate that either in 
case of L7-N (Fig. 3.11.A) or L7-L9 (Fig. 3.11.B) the proteins migrate separately. This suggests 
that for these pairs of proteins there are no interactions detectable by size exclusion 
chromatography.  
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3.3 LACV full length L protein and L1750 construct – RNA binding  
 
3.3.1 L protein and L1750 – expression and purification 
 
The L1750 construct (also called L9) comprises residues 1-1750 of the full length L protein 
and lacks C-terminal 513 residues. It was designed following trypsin limited proteolysis of the 
full length L protein performed by Dr. Juan Reguera. Its C-terminal end was also confirmed by 
the ESPRIT analysis. Both L1750 and L protein constructs were expressed in Hi5 insect cells using 
baculovirus expression system (a detailed description of the purification protocols can be found 
in ‘Methods’). Following sonication, the proteins were purified from the insect cell lysate using 
nickel affinity column, heparin column, and size exclusion column as the final step. Later on the 
purification procedure was extended by addition of the ammonium sulfate precipitation step 
performed before the nickel column. This allowed to remove cellular nucleotides and nucleic 
acids at the beginning of the purification. Unlike the L1750, L protein had tendency to precipitate 
during final purification steps and could not be concentrated to the satisfactory concentrations, 
required for crystallization experiments. To overcome this L protein sample eluted from the 
heparin column by the buffer containing ~1M NaCl was supplemented with the vRNA and after 
dialysis against the buffer containing 150 mM NaCl purification was continued. Addition of the 
vRNA led to L-vRNA complex formation which stabilized the protein. Figures 3.12.A and 3.12.B 
present the examples of purified full length L protein and L1750 respectively.  
 
3.3.2 Electrophoretic mobility shift assays  
 
The 3ʹ and 5ʹ ends of bunyavirus genomic RNA segments are highly conserved and 
exhibit extended complementarity to each other. In order to study the nature of interaction 
between vRNA ends and the full length L protein or the L1750, various RNA-protein binding 
experiments and competition assays were done.  
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Figure 3.12 L full length and L1750 purified proteins are presented in panel A and B respectively; upper 
part of each panel represents the size exclusion profile, marked in green are fractions used for negative 
stain EM analysis; bottom left part of each panel represents SDS-PAGE; bottom right part of each panel 
represents the micrograph from negative stain EM 
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In electrophoretic mobility shift assays (EMSA) both radioactively and fluorescently 
labelled RNA were used. Labelled vRNA at low concentrations were mixed with the excess of 
the protein. An excess of the non-labelled poly-uracil RNA (polyU) was added in the assays to 
minimize unspecific binding of the vRNA by the protein. In the competition assays the non-
labelled vRNA was used. Upon several hours of incubation mixtures were resolved in the native 
PAGE.  
EMSA assay with 0.1 μM of the fluorescently labelled 3ʹ vRNA and 2 μM of the L1750 
revealed that all vRNA binds to the protein. Since it could not be competed by the polyU RNA, it 
suggested strong and specific interaction. The binding was partially competed by the same but 
non-labelled 3ʹ vRNA. Trials to compete the labelled 3ʹ vRNA by the non-labelled 5ʹ vRNA 
resulted in dsRNA formation. In native PAGE this dsRNA was migrating slower than ssRNA, as 
expected, but could not be bound efficiently by the polymerase (Fig. 3.13.A). Reciprocal 
experiments performed with the labelled 5ʹ vRNA revealed similar effect (data not shown). 
These results suggest that the L1750 efficiently binds the 3ʹ and 5ʹ vRNA ends as single-stranded 
and not double-stranded molecules. 
 
3.3.3 Fluorescence anisotropy 
 
Fluorescence anisotropy technique was used to determine precise affinity values of the 
3ʹ and 5ʹ vRNA ends binding by the L1750 protein. As in case of the EMSA experiments, 
fluorescently labelled single-stranded 3ʹ and 5ʹ vRNA were used either alone or in presence of 
competing, non-labelled RNA. Labelled RNAs at fixed concentration were titrated with the L1750 
protein. Experimental data was used to calculate the dissociation constants (Kd). Results are 
presented in Figure 3.13.B, and in the supplementary material of the attached publication 
(Gerlach et al., 2015).  
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Figure 3.13 L1750-vRNA binding studies: A) EMSA assay in the native PAGE using fluorescently labelled 3ʹ 
vRNA. B) Fluorescence anisotropy with fluorescently labelled 3ʹ and 5ʹ vRNA; top panel represents 
results obtained for the 5ʹ vRNA, bottom panel represents results obtained for the 3ʹ vRNA; Influenza B 
3ʹ and 5ʹ end genomic sequences were used as control RNA. C) ITC experiments with 25 nucleotide-long 
3ʹ and 5ʹppp vRNA; results presented in two right panels were obtained using 300 mM NaCl buffer. D) 
MST experiments with 25 nucleotide-long 5ʹppp and 5ʹp vRNA; non-specific polyU and Alu SRP RNA were 
used as negative controls.  
Structure and function of the La Crosse orthobunyavirus polymerase 
94 
 
 Both single-stranded 3’ and 5’ vRNA exhibit very strong, nanomolar affinity to the L1750 
protein. When competition assays with polyU RNA or non-labelled 3ʹ and 5ʹ vRNA were 
performed, both RNA were mixed together prior to L1750 titration. It revealed that, at the initial 
phase of the titration, both 3ʹ and 5ʹ vRNA compete more for the L1750 than the non-specific 
polyU RNA, resulting in increased Kd values. The Influenza B vRNA sequences have the same 
nucleotides as LACV vRNA in some positions (Fig. 3.13.B – nucleotides highlighted in red). As 
expected, the Influenza B 3ʹ vRNA exhibits much weaker affinity to the L1750 than its LACV 
homolog. Interestingly, this is not the case for the Influenza B 5ʹ vRNA, which is bound by L1750 
with similar affinity than the LACV 5ʹ vRNA.   
 
3.3.4 Isothermal titration calorimetry 
 
Isothermal titration calorimetry was also used to determine affinities between 3ʹ or 5ʹ 
vRNA and L1750. Due to ITC requirements protein concentration was at 30 μM, and the 
concentration of titrated vRNA was 10 times higher. At these conditions, and performing the 
experiment at room temperature, protein tends to precipitate, biasing the results. 
Nevertheless, measurement performed with the 3ʹ vRNA revealed significant affinity, with 
Kd=460 nM. To overcome protein precipitation the NaCl concentration in the protein buffer 
was increased to 300 mM. Higher salt prevents protein precipitation but it disrupts RNA-protein 
interactions mediated mostly by salt-bridges. The results obtained at these conditions do not 
reveal exact affinities but allow to compare the binding of various vRNA by the L1750. Data 
obtained revealed that the 5ʹppp vRNA binds weaker to the L1750 than the 3ʹ vRNA (Fig. 3.13.C).  
 
3.3.5 Microscale thermophoresis 
 
The L1750-vRNA binding was also analysed by the microscale thermophoresis. This 
technique requires much lower concentration of the protein. However, a significant drawback is 
the fluorophore labelling of one of the interacting molecules, which might affect the binding. 
Results 
 
95 
 
During the experiments fluorescently labelled L1750 at 50 nM concentration was incubated with 
the vRNA at 16 different concentrations, ranging from 40 μM to 1 nM. In ths case both 5ʹppp 
and 5ʹp vRNA were tested. Calculated Kd were 73 nM and 399 nM for 5ʹppp and 5ʹp vRNA 
respectively (Fig. 3.13.D). These values are drastically different from the ones obtained by ITC, 
but they resemble the Kd range obtained by fluorescence anisotropy experiments. Difference 
between binding affinities of the 5ʹppp and 5ʹp vRNAs to the L1750 suggests the importance of 
the triphosphate group in efficient recognition of the 5ʹ genomic end.    
 
3.3.6 vRNA protection during L1750 and L protein trypsination  
 
To further characterize the effect of the vRNA-L1750 binding on the protein conformation 
comparative limited tripsination assays were performed with eiher apo form of the L1750, or in 
complex with the 3ʹ or 5ʹ vRNA end. Following L1750-vRNA incubation the trypsin was added in 
the 1:1000 trypsin – L1750 ratio (w/w). Reactions were carried at room temperature and were 
stopped every 20 minutes by addition of the SDS-PAGE loading buffer. Upon SDS-PAGE analysis 
it was noticed that the interaction with vRNAs induces changes in the trypsin digestion pattern. 
Moreover, these changes were 3ʹ and 5ʹ vRNA specific (Fig. 3.14.A). Similar effects were 
observed when the full length protein was used. L protein trypsination products were further 
analysed by western-blot with antibodies recognizing the N-terminal His-tag, the N-terminal 
endonuclease or the C terminus of the protein (Fig. 3.14.C). Mass spectrometry analysis and 
Edman degradation allowed to assign vRNA-mediated differences in the trypsination pattern to 
the N-terminal region of the protein.  
Tryspin digestion fragments are summarized in the supplementary material of the 
attached publication (Gerlach et al., 2015). Upon interaction with the 3ʹ vRNA the N-terminal 1-
368 trypsin digest observed in the apo polymerase profile is extended to 1-430. On the other 
hand upon adding the 5ʹ vRNA trypsin cleavage at K430 disappears and the 431-862 fragment is 
extended to 377-862. These results together strongly suggest that the region in the polymerase 
between residues K368 and K430 changes its conformation or at least becomes inaccessible for 
the trypsin upon 3ʹ or 5ʹ vRNA binding (Fig. 3.14.A). 
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Figure 3.14 A) Trypsin limited proteolysis of the apo-L1750, L1750-3ʹvRNA, and L1750-5ʹRNA (1:1000 w/w 
trypsin-L1750 ratio). B) L1750-vRNA 4SU crosslinking. RNA-fluorescence has been scanned with Typhoon 
before the Coomasie staining. Selected gel lines are duplicated next to each other for easier comparison 
of L1750-cRNA crosslinks. C) Western-blot of the full length L protein after trypsin digestion. Various 
patterns exhibited by anti-HisTag, anti-Nterm and anti-Cterm antibodies. 
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3.3.7 L1750 – vRNA UV crosslinking 
 
The vRNA protection assay, which allowed to identify that the N-terminal region of the L 
protein interacts with the vRNA, was further modified in order to narrow down which part of 
the N-terminal region is involved. To do so RNA-protein UV crosslinking step was performed 
prior to the trypsination. Specially designed, synthetic 3ʹ or 5ʹvRNA were bearing two or one 
modified, photoactivable 4-thio-uracil (4SU) respectively (Kramer et al., 2011). Both vRNAs 
were additionally labelled with a fluorophore on their non-interacting ends – DY647 in case of 
3ʹvRNA and Cy5 in case of 5ʹvRNA. Fluorescence allowed to track the protein-RNA crosslinks. 
Like described previously, following trypsination samples were subjected to SDS-PAGE. A single 
3ʹvRNA-protein crosslink was noticed. It migrated like the N-terminal trypsin digestion 
fragments (Fig. 3.14.B). In contrast no 5ʹvRNA-protein crosslink was observed.  
The 3ʹvRNA-L1750 protein crosslink was cut out from the gel and subjected to mass 
spectrometry analysis. No specific mass, different from the reference sample, could be 
detected. This is most likely due to very low efficiency of RNA-protein crosslinking resulting in 
low amount of the RNA-protein crosslinks, below mass spectrometry detection capacities.   
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3.4 LACV full length L protein and L1750 construct – structural 
characterization 
 
3.4.1 L1750 and L protein – SAXS analysis 
 
SAXS measurements have been performed on both the full length L protein and the 
L1750. Different concentrations of samples were analysed. We noticed that radius of gyration 
(Rg) raises together with sample concentration suggesting oligomerization or other non-specific 
intermolecular interactions. These interactions can be diminished upon addition of the 3ʹ or 5ʹ 
25-nucleotide long vRNA. The 5ʹ vRNA contained 5ʹppp modification. Rg for such samples are 
4.1 nm and 5.5 nm for L1750 and L protein respectively. Similar effect was obtained in absence of 
vRNA but upon addition of stabilizing agents to the buffer, namely 500 mM NaCl and 200 mM 
arginine.  
Because of the data quality reasons Guinier plots were fitted only for the L1750 sample. 
They suggest the presence of cavities or a hole inside the protein which can be seen in the ab 
initio models. Results of the SAXS analysis are summarized in Figure 3.15. 
 
3.4.2 L1750-vRNA co-crystallization experiments 
 
Both the full length L and the L1750 protein were subjected to many crystallization trials. 
Co-crystallization trials were performed with either separate 3ʹ or 5ʹ vRNA ends, or both ends 
mixed together. Initially all these trials were fruitless leading to the protein precipitation in 
majority of crystallization conditions. Following detailed studies of L1750 and L-vRNA binding, 
described in more details above and in the attached publication (Gerlach et al., 2015), new set 
of RNA oligos, representing partially double-stranded 3ʹ vRNA end, was used in co-
crystallization experiments with more stable L1750 protein. Detailed composition of tested RNA 
is presented in Fig. 3.16. 
Results 
 
99 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 SAXS measurements of the full length L protein and the L1750 construct (L9). Table in the top 
right part of the figure summarizes differences between L protein and L1750 Rg values; Chart in the 
bottom right represents Guinier plot fitting of the L1750 sample derived data; Left part of the figure 
represents slices through the ab initio models showing overall shape and cavities of three different L1750 
samples. 
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The L1750-vRNA crystals appeared only in presence of the partially double-stranded RNA 
composed of the oligo representing nucleotides 1-16 from 3ʹ vRNA pre-annealed to the oligo 
representing nucleotides 9-16 from 5ʹ vRNA. This combination of RNAs allowed to have an 
eight-nucleotide overhang of conserved 3ʹ vRNA terminal nucleotides, and a blunt dsRNA end 
on the opposite site. Other combinations bearing one nucleotide overhang instead of a blunt 
end were also giving crystals but of lower quality (Fig. 3.16). The L1750-vRNA crystals in the form 
of brush-like clusters of thin needles grew in the narrow range of conditions containing 0,2 M 
sulfate or citrate salts, and 20% PEG 3350 or 15% PEG 4000 (Fig. 3.17.A). Additive screen was 
performed to optimize these initial crystals (Fig. 3.17.B). It revealed that 10 mM Mn2+ but not 
Mg2+ affects the crystal growth. It allowed also, by using both citrate and sulfate salts in the 
mother liquor, to separate the clusters of needles into single thin needles. Screening of the 
citrate and sulfate concentrations allowed to find the optimal mother liquor composition: 0.1 M 
Hepes, 0.2 M sodium citrate tribasic dihydrate, 0.3 M ammonium sulfate, 15% PEG 3350, pH 7 
(Fig. 3.17.C). The final bar-like single crystals were obtained using microseeding procedure, 
which allowed to control the nucleation and greatly improved quality of the crystals. Figure 
3.18 presents example of a single L1750-vRNA crystal and the diffraction pattern it generated.  
As described in the attached publication (Gerlach et al., 2015) it was also possible to 
soak the L1750 – 3ʹ vRNA crystals with the missing 5ʹ vRNA end (8, 10, and 11 nucleotide-long) 
which resulted in another structure revealing two, separate binding sites for the 3ʹ and 5ʹ vRNA 
ends. However, due to the co-crystallization strategy involving partially double-stranded 3ʹ 
vRNA, it was impossible to track the continuity between 5ʹ vRNA hook and the short 5ʹ vRNA 
strand involved in formation of the partial 3ʹ vRNA duplex. Also, due to the conformation in 
which L1750 crystallized, 5ʹ vRNA end longer than 11 nucleotides could not be soaked into the 
crystal most likely because of the steric clashes that would appear between nucleotide 12 of 
the 5ʹ vRNA and neighbouring protein residues.  
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Figure 3.16 Partially double-stranded RNA used in co-crystallization experiments with L1750. Initial, 
conserved 11 nucleotides are marked in red, following duplex region (Barr and Wertz, 2004) is marked in 
green. RNA optimal for crystallization is marked with blue rectangle. RNAs that also allowed co-
crystallization, but resulting in lower quality crystals, are marked with blue dashed rectangles. 
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Figure 3.17 Summary of the L1750-vRNA crystallization: A – initial crystals in conditions containing sulfate 
or citrate salts and PEG 3350 or PEG 4000; B – additive screen; C – citrate and sulfate concentration 
optimization; red rectangle highlights the best combination. 
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Figure 3.18 L1750-vRNA crystals: A – a single bar-like crystal inside the cryo-loop during diffraction 
experiment at the beamline; B – example of the diffraction pattern 
 
 
Figure 3.19 Modified double-stranded RNA used in co-crystallization experiments with L1750. In the two 
top RNA sets the 3ʹ vRNA end is mutated to disrupt base-pairing with the 5ʹ vRNA end. In the two 
bottom RNA sets 5ʹ vRNA is mutated in order to maintain its secondary hook structure and to disrupt 
base-pairing with the 3ʹ vRNA. Mutated nucleotides are marked in violet. 
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Various sets of modified vRNA ends were used in order to examine whether it is possible 
to co-crystallize the L1750 with both 5ʹ and 3ʹ RNA in a different conformation, which would 
allow accommodation of both vRNA ends during the crystallization process. The main obstacle 
is that the wild type vRNA ends are fully complementary to each other resulting in formation of 
the double-stranded RNA, which cannot interact with the polymerase and has the propensity to 
crystallize on its own (data not shown). To avoid this scenario vRNA ends were mutated 
following different strategies in order to diminish the double strand formation (Fig. 3.19). 
Firstly, the 3ʹ vRNA was mutated to impair the sequence-specific binding within its binding site, 
and thus to facilitate its positioning inside the template entry tunnel. Secondly, the 5’ vRNA was 
mutated within its hook base-pairing region in order to maintain the 5ʹ vRNA hook structure, 
but to reduce its propensity for annealing with the 3ʹ vRNA end. The 3ʹ and 5’ vRNA ends were 
either mixed together before being added to the L1750 sample, or they were added sequentially, 
with the 5ʹ vRNA added first so it could form stable hook structure and induce freely all the 
conformational changes within the L protein. We assumed that this could affect structural 
protein elements around the template entry tunnel allowing the 3ʹ vRNA entry into this tunnel. 
Until now the co-crystallization experiments with these modified RNAs were not successful.  
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SUMMARY
Segmented negative-strand RNA virus (sNSV) poly-
merases transcribe and replicate the viral RNA
(vRNA) within a ribonucleoprotein particle (RNP).
We present cryo-EM and X-ray structures of, respec-
tively, apo- and vRNA bound La Crosse orthobunya-
virus (LACV) polymerase that give atomic-resolution
insight into how such RNPs perform RNA synthesis.
The complementary 30 and 50 vRNA extremities are
sequence speciﬁcally bound in separate sites on
the polymerase. The 50 end binds as a stem-loop,
allosterically structuring functionally important poly-
merase active site loops. Identiﬁcation of distinct
template and product exit tunnels allows proposal
of a detailed model for template-directed replication
with minimal disruption to the circularised RNP.
The similar overall architecture and vRNA binding
of monomeric LACV to heterotrimeric inﬂuenza poly-
merase, despite high sequence divergence, sug-
gests that all sNSV polymerases have a common
evolutionary origin and mechanism of RNA synthe-
sis. These results will aid development of replication
inhibitors of diverse, serious human pathogenic
viruses.
INTRODUCTION
Arenaviridae, Bunyaviridae, and Orthomyxoviridae, the principal
families of segmented negative single-stranded RNA viruses
(sNSV), each include serious human pathogens such as Lassa
fever, Crimean-Congo haemorrhagic fever, and inﬂuenza vi-
ruses, respectively. Orthomyxoviruses have six to eight genome
segments, whereas Bunyaviridae (reviewed in Elliott, 2014)
have three, and Arenaviridae two. For each segment, transcrip-
tion, generating capped viral mRNAs, and replication, generating
full-length genome or antigenome copies (vRNA and cRNA,
respectively), are performed by the same virally encoded RNA-
dependent RNA polymerase (RdRp). For arena- and bunyavi-
ruses, which replicate in the cytoplasm, the RdRp is the single-
chain L protein, whereas for orthomyxoviruses, which replicate
in the nucleus, it is a hetero-trimeric complex, formed by the
PA, PB1, and PB2 subunits (Fodor, 2013; Guu et al., 2012; Morin
et al., 2013; te Velthuis, 2014). vRNA genome segments are al-
ways packaged by multiple copies of the viral nucleoprotein
(NP) together with one copy of the RdRp into ﬁlamentous ribonu-
cleoprotein particles (RNPs), which are the functional replication
and transcription units (Reguera et al., 2014).
sNSV polymerases have two unique features. First, they per-
form transcription by the ‘‘cap-snatching’’ mechanism, whereby
short 50 capped RNA fragments are cleaved from host cell
mRNA by an endonuclease intrinsic to the RdRp and then used
to prime synthesis of viral mRNAs (Morin et al., 2010; Plotch
et al., 1981; Reguera et al., 2010; Reich et al., 2014). Second,
they recognize each genome segment via their highly conserved,
quasi-complementary 30 and 50 extremities (over a length of 13–19
nucleotides), known as the promoter (Barr and Wertz, 2004).
Correlated with this, sNSV RNPs are generally circularized, which
is thought to occur by base pairing between the genome ends
(forming a double-stranded ‘‘panhandle’’) and/or the simulta-
neous binding of both ends to the polymerase (Reguera et al.,
2014). vRNA promoter binding to inﬂuenza polymerase was visu-
alized recently for the ﬁrst time in a co-crystal structure. This
revealed that each vRNA extremity binds sequence speciﬁcally
as a single strand to distinct sites on the polymerase but then
come together to form a short duplex of about four base
pairs (Pﬂuget al., 2014). Furthermore, thismodeof promoter bind-
ing is required for activation of diverse inﬂuenza polymerase
functions (Fodor, 2013). For bunyaviruses, exact self-complemen-
tarity of the genome ends extends for 15–19 nts (except for
only one G-U mismatch in the case of orthobunyaviruses
[Barr and Wertz, 2004; Kohl et al., 2004]), potentially allowing
formation of a much more stable panhandle than for inﬂuenza
vRNA. However, the exact nature of the vRNA-vRNA and vRNA-
L interactions that circularize bunyavirus RNPs are not known.
Cross linking suggests that the vRNA ends within bunyavirus
RNPs are base paired at least partially (Raju and Kolakofsky,
1989) and a distal duplex region is essential for RNA synthesis
by bunyavirus (Barr andWertz, 2004; Kohl et al., 2004) and arena-
virus (Kranzusch et al., 2010) polymerases. The absence of signif-
icant sequence similarity, outside of the cap-snatching endonu-
clease (Reguera et al., 2010) and the conserved RdRp motifs
(Mu¨ller et al., 1994), between Arenaviridae and Bunyaviridae L
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Figure 1. Overall Structure of LACV Polymerase
(A) Schematic representation of the domain structure of the monomeric LACV polymerase (top) aligned to that of heterotrimeric (PA-PB1-PB2) inﬂuenza poly-
merase (bottom). Structurally or functionally equivalent domains are similarly colored. A notable difference with the inﬂuenza polymerase is the clamp (magenta),
involved in 30 vRNA end binding, which is inserted into the LACV PA-C like domain. The LACV a-ribbon (orange) is structurally equivalent to the inﬂuenza b-ribbon
(legend continued on next page)
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proteins and Orthomyxoviridae heteotrimeric polymerases also
poses the question as to whether all sNSV have a structurally
and evolutionary conserved architecture to match their functional
similarity.
To answer this question and those related to promoter binding,
we determined the crystal structure of 77% of the L protein from
La Crosse orthobunyavirus (LACV) in complex with just the 30 or
both 30 and 50 conserved genomic RNA ends and the cryo-EM
structure of the apo-form. LACV is a potentially serious but rare,
mosquito-transmitted human pathogen that causes 50–100
cases of encephalitis per year in the USA (http://www.cdc.gov/
lac/) (Elliott, 2014; Haddow andOdoi, 2009). The structure reveals
high similarity, but also interesting differences, to the equivalent
inﬂuenza complex (Pﬂug et al., 2014; Reich et al., 2014). In partic-
ular, it shows the structural basis of the speciﬁc recognition of the
vRNA 30 end, the allosteric regulation mediated by vRNA 50 end
binding, and the likely path of the template into the polymerase
active site cavity and out again. These ﬁndings, combined with
those gained from the inﬂuenza polymerase structures, provide
new insight into the commonmechanism of action, the conserved
features, and the diversity among sNSV polymerases.
RESULTS
Structure Determination of the LACV L1750 Protein
L1750, a construct comprising residues 1–1750 (out of 2263)
of the LACV L protein, was expressed in insect cells and puri-
ﬁed to homogeneity in milligram amounts (Figure S1A, Figures
S2A and S2B). In vitro RNA-protein interaction experiments
show that the separated single stranded LACV genomic ex-
tremities each bind with high afﬁnity and speciﬁcity to the po-
lymerase with dissociation constants of 13.8 ± 2.6 nM and 9.3
± 1.6 nM for the 50 and the 30 ends, respectively, whereas the
polymerase only has low afﬁnity (1.5 mM) for the pre-an-
nealed double stranded panhandle (Figure S3A). However,
as shown by mobility shift assays, the polymerase still binds
with high afﬁnity to partially double stranded 30 vRNA provided
the ﬁrst eight nucleotides from the 30 end are single stranded
(Figure S3B). Similar conclusions were previously found for
Machupo arenavirus polymerase (Kranzusch et al., 2010). Us-
ing these results, co-crystals of L1750 diffracting up to 2.6 A˚
resolution were obtained with nucleotides 1–16 of the genomic
30 vRNA (30OH-UCAUCACAUGAUGGUU), to which was an-
nealed a complementary 8-mer (50OH-GCUACCAA), corre-
sponding to nucleotides 9–16 from the 50 vRNA extremity.
The structure was solved by multiple isomorphous replace-
ment with anomalous scattering (Figures S1B–S1D). Soaking
the ﬁrst 10 nucleotides of the 50 vRNA (50p-AGUAGUGUGC)
into the crystals gave a new structure at 3.0 A˚ resolution
that revealed the 50 end in a distinct binding site. Crystallo-
graphic statistics are given in Table S1 and a sequence
alignment of representative orthobunyavirus polymerases, an-
notated with the secondary structure, is shown in Data S1. The
L1750 model contains 1652 residues (94.4% complete) with
several connecting loops missing, some of which become or-
dered upon 50 vRNA binding (Figure 1, Data S1). The structure
of apo-L1750 was determined from cryo-EM images by single
particle 3D reconstruction at 8.3 A˚ resolution and allows visu-
alization of secondary structure elements in most of the pro-
tein (Figure 2, Figure S2).
Overall Structure of LACV Polymerase
The RNA-bound and apo-LACV L1750 structures display the
same overall shape with a large globular central core and a
ﬂexible protrusion (Figures 1 and 2). The overall structural
organization is strikingly similar to that of the inﬂuenza polymer-
ase (Pﬂug et al., 2014) despite the complete lack of extended
sequence homology (Figures 1A and 1C, Figure S4). In
fact L1750 corresponds precisely to PA, PB1, and PB2-N (resi-
dues 1–250 of PB2), conﬁrming the linear, head-to-tail mapping
of the inﬂuenza heterotrimeric polymerase onto the orthobu-
nyavirus L protein, as previously proposed (Reguera et al.,
2010). The central PB1-like RdRp region of L1750 (residues
758–1433) contains the canonical ﬁngers, ﬁngertips, palm,
and thumb domains with the conserved polymerase motifs
exposed into the internal RNA synthesis chamber. It is
buttressed on one side by the PA-C like region, which also
has distinct pockets for the 30 and 50 vRNA extremities, and
on the other by the PB2-N like region.
The previously described N-terminal endonuclease domain
(residues 1–184) (Reguera et al., 2010) is solvent exposed and
differently orientated compared to inﬂuenza polymerase (Fig-
ure 1C, Figure S4A). However, it is clearly ﬂexibly linked to the
central polymerase core, as revealed by its lack of density in
one 3D class of the EMmap (Figure 2B). An extended linker (res-
idues 185–270), analogous to the inﬂuenza PA-linker, that packs
on and stabilizes the ﬁngers and palm domains of the RdRp (Fig-
ure 1B, Figures S4A and S4B), connects the endonuclease to the
PA-C like domain (residues 271–759), which is divided into two
lobes (Figures 1A and 1B). The larger ‘‘core-lobe’’ is a-helical
and buttresses the thumb and palm domains of the RdRp. The
second lobe is mainly involved in vRNA promoter interactions
and is therefore called the vRNA binding lobe (vRBL). It has a
central b sheet with, on one side, a structure denoted the
‘‘clamp’’ (residues 355–400) that binds the 30 of the vRNA (see
below) and which has no equivalent in inﬂuenza PA. On the
opposite side is a long loop (residues 420–440), analogous to
the inﬂuenza PA-arch, which binds the vRNA 50 end (Figure 1B,
despite being inserted in a different loop of the ﬁngers domain. The LACV palm domain has an insertion speciﬁc for the California serogroup of orthobunyaviruses
(salmon). The LACV ﬁngernode (gray) is functionally equivalent to the inﬂuenza b-hairpin. The PB1 C-ext/PB2-Nterm interface is replaced by the LACV bridge
domain. The LACV thumb ring domain (yellow) is structurally homologous to the inﬂuenza PB2 N1 and N2 domains. L1750 lacks the last 518 residues of the L
protein currently of unknown structure (black stripes).
(B) Illustrated representation of two views of the crystal structure of L1750 in complex with the 3
0 (cyan) and 50 vRNA (yellow). Protein domains are colored as in (A).
(C) Structural comparison between L1750 and inﬂuenza (FluB2 structure, PDB: 4WRT) polymerases with equivalent PA-like, PB1-like and PB2-N like regions
colored green, blue, and red, respectively. The 30 (cyan) and 50 vRNA (yellow) vRNAs are indicated. A more detailed structural comparison is in Figure S4.
See also Figures S1 and S4.
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Figure S4). 3D classiﬁcation of the apo L1750 cryo-EMdata allows
generation of EMmaps corresponding to two states of the vRBL.
In the ﬁrst, the same conformation is observed as in the crystal
structure, but the arch is invisible, whereas in the second state,
the most of the vRBL is invisible, suggesting its enhanced ﬂexi-
bility in the absence of bound vRNA (Figures 2C and 2D). Two
speciﬁc insertions emerge from the ﬁngers domain, the partially
ordered ‘‘a-ribbon’’ (residues 847–905), structurally equivalent to
the inﬂuenza PB1 b-ribbon (but emerging from a different ﬁngers
domain loop, Figure S4B) and the ‘‘ﬁngernode’’ (residues 1105–
1135), functionally equivalent to the PB1 b-hairpin. The ﬁnger-
node folds into two a helices (a43–44) linked by a ﬂexible loop,
and together with the vRBL arch, it plays a central role in
Figure 2. Cryo-EM Reconstruction of
Apo-L1750
(A) 3D reconstruction of the apo-L1750 containing
the entire dataset of cryo-EM imaged particles,
determined at 8.3 A˚ resolution. The dataset can be
separated into three distinct states:
(B) A 3D class displaying only partial density for the
endonuclease (9.7 A˚ resolution).
(C) A 3D class displaying density for all regions of
the polymerase (9.7 A˚ resolution).
(D) A 3D class lacking density for most of the vRBL
domain and California insertion (9.3 A˚ resolution).
Flexible regions are indicated with dotted lines.
The domains are colored as in Figure 1.
See also Figure S2.
sequence speciﬁc binding of the vRNA
50 end (see below). The palm domain ap-
pears unusually elongated, partly due to
the insertion of a solvent exposed helical
hairpin of unknown function that is spe-
ciﬁc for the California orthobunyavirus se-
rogroup including LACV (Figure 1B, Data
S1). The thumb domain is surrounded
by the PA-C like domain core lobe and a
set of helices (a58–62 and a67) and
strands (b31–34), denoted the thumb
ring which is structurally homologous to
the inﬂuenza PB2 N1 and N2 domains.
A loop (residues 1402 to 1422) at the
C-terminal end of the thumb is likely de-
ployed into the polymerase cavity but
lacks electron density map, indicating
mobility. It is analogous to the inﬂuenza
PB1 putative priming loop but is signiﬁ-
cantly shorter. The thumb domain is fol-
lowed by a helical bundle called the
bridge (residues 1433–1503), which re-
places the helical PB1-PB2 interface
and closes the circular architecture of
the polymerase around its internal cavity.
The highly conserved connection be-
tween the bridge and the thumb ring (res-
idues 1498–1506) partly deﬁnes the tem-
plate entry channel (see below). Inserted
in the thumb ring is the lid (residues 1614–1703) which as in inﬂu-
enza PB2, borders the exit channel.
vRNA Promoter 30 End Recognition
Nucleotides 1–8 from the vRNA 30 end are bound in an extended,
single-stranded conﬁguration in a narrow cleft over which the
clamp closes (Figure 3A). Diverse regions of the polymerase
contribute 30 end RNA binding loops, including both lobes of
the PA-C like domain, the thumb (residues 1307–1315) and
the thumb ring domain (residues 1513–1517). The protein-RNA
interface buries a total of 3460 A˚2 of surface area and includes
>30 protein-RNA hydrogen bonds, indicating a high degree of
sequence speciﬁcity (Figure S5A, Table S2). Nucleotides U1,
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C2, and A3 are orientated into individual pockets by an extensive
hydrogen bond network with residues from helices a14 and a21
and two loops from the vRBL (residues 312–316 and 535–539)
and another loop from the core lobe (residues 469–473) (Fig-
ure 3B). The very 30 end is completely sequesteredby the stacking
of His312 onto the U1 ribose and hydrogen bonds from the 20 and
30 OH to Pro314 and Asn538 (Figure 3B). Nucleotides U4, C5, and
A6 are stacked on each other with their bases facing the protein
and their phosphates interacting with His1515 from the thumb
ring and Arg372 from the clamp (Figures 3B and 3C). Nucleotides
C7 and A8 are again orientated into separate pockets mainly
formed by clamp residues, with C7 stacking between conserved
Trp395 and Tyr524 as well as making base speciﬁc hydrogen
bonds to residues Gln398 and Arg531. A8 stacks on Ile 378 and
its N6 makes a base-speciﬁc hydrogen bond with the backbone
of Lys381 (Figure 3C). These structural observations are consis-
tent with RNA binding experiments with all possible single substi-
tutions in 30 end nucleotides 1–11, which show that nucleotides
6–8 are the most critical for sequence speciﬁc binding (Fig-
ure S3C). 30 end nucleotides 9-UGAUGGUU-16 form a duplex
with the co-crystallized complementary oligonucleotide 50OH-
Figure 3. 30 vRNA End Binding to LACV
Polymerase
(A) Overview of the 30 vRNA (cyan sticks) binding
site showing the clamp (magenta) and other in-
teracting loops colored as in Figure 1A. The distal
short complementary strand is in gray sticks. The
RNA electron density is from the ﬁnal 2Fo-Fc map
contoured at 1.5 s. K368 on helix a16 is protected
from trypsin cleavage upon 30 end binding.
(B) Protein-RNA interactions of nucleotides 1–6 of
the 30 vRNA extremity. Hydrogen bonds are shown
as green dotted lines.
(C) Protein-RNA interactions of the clamp with
30 vRNA nucleotides 6–9.
See also Figures S3 and S5.
GCUACCAA (Figure 3A) and the 30 end
backbone is neutralised by basic residues
Lys859, Lys862, Arg869, and Lys870 from
helix a33 of the a-ribbon (Figure S5A).
vRNA Promoter 50 End Recognition
and Induced Structural Changes
The 10 ﬁrst nucleotides of the 50 vRNA,
soaked into the crystal, binds as a stem-
loop to the polymerase in a similar conﬁg-
urationand location to the tennucleotide50
hook of inﬂuenza vRNA promoter (Pﬂug
et al., 2014) (Figure 4, Figure S6A). How-
ever, LACV 50 hook is less compact with
only two base pairs between G2-C10 and
U3-G9, compared to four in inﬂuenza.
Bases G5 and A4 are consecutively
stacked on U3, whereas U6, G7, and U8
are splayed out in the loop region, com-
pared with only one in inﬂuenza. The 50
vRNA interactionwith the polymerase bur-
ies a total of 3030 A˚2 of surface area and includes 37 protein-
RNA hydrogen bonds (Figure S5B, Table S2). Upon RNA binding
both the arch and the ﬁngernode are structurally reconﬁgured to
promoteprotein-RNA interactions (FiguresS6BandS6C).Anarray
of conserved, mainly positively charged, residues stabilizes the 50
vRNAbackbonephosphates (A1-Lys423,G2-Lys302/Arg592,U3-
His306, A4-Arg600/Thr642, G5-Lys643/Tyr677, U6-Arg292, G7-
Lys768, U8-His760/His761) (Figure S5B). Nucleotide A1 stacks
onto the planar backbone of Cys419 and Gly420 and consecutive
base stacking of nucleotides 1–5 is interrupted by conserved arch
residue Pro440, which stacks on base G5 forcing base U6 to ﬂip
out (Figures 4A and 4B). Highly speciﬁc, induced ﬁt interactions
are made from residues 1116–1123 of the ﬁngernode loop to ﬂip-
ped out bases G7 and U8. The loop structurally reconﬁgures to
allowG7 to stack on Tyr1120 andmake base speciﬁc interactions
with Gln1116, Asp1123, and Lys768 (a30). U8 stacks on Gln1116
and makes three base speciﬁc main-chain interactions with the
peptide 1118–1120 (Figure 4C, Figure S6C). Adjacent, conserved
His760 and His761 on a30, further stabilize the RNA loop confor-
mation by binding the U8 phosphate and by stacking onto the
G9 and G5 ribose moieties, respectively (Figures 4B and 4C).
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Biochemical evidence for the involvement of the clamp and
arch in, respectively, 30 and 50 end binding comes from proteol-
ysis experiments that show clamp residue Lys368 and arch res-
Figure 4. 50 vRNA End Binding and Induced
Structural Changes
(A) Overview of the 50 vRNA stem-loop (yellow
sticks) binding site with interacting loops colored
as in Figure 1A. The RNA electron density is from
the ﬁnal 2Fo-Fc map contoured at 1.5 s. K430
on the arch is protected from trypsin cleavage
upon 50 end binding.
(B) Protein-RNA interactions in the 50 vRNA stem
region with hydrogen bonds as green dotted lines.
(C) Protein-RNA interactions of the ﬁngernode
loop with 50 vRNA loop bases G7 and U8.
(D) Superposition of the L1750 30 vRNA structure
without (light green ribbons) and with (colored
as in Figure 1A) soaking of nucleotides 1–10 of the
50 vRNA. Upon 50 vRNA binding (yellow) the
backbone interactionwith His760 andHis761 pulls
helix a30 up allowing stabilization of an ordered
conﬁguration of the ﬁngertips residues 949–958
(blue sticks). Multiple new contacts are formed,
including hydrophobic interactions with a30 resi-
dues V762 and L766 and hydrogen bonds (dashed
green lines) with residues from the linker region
between PA-C like domain a29 and ﬁngers
domain a30, notably His757. Hydrogen bonds
between Arg958 and Glu959 to Gln1145 stabilize
polymerase active site motif B (dark red).
See also Figures S3, S5 and S6.
idue Lys430 are protected from trypsina-
tion by 30 and 50 end binding, respectively
(Figures 3A and 4A, Figure S3D). How-
ever, 50 vRNA binding not only induces
conformational changes in RNA binding
loops but also structures elements of
the polymerase active site (Figure 4D).
Most signiﬁcant is the complete ordering
of the ﬁngertips loop (residues 950–958),
which contains motif F. The interactions
of His760 and His761 pull helix a30 to-
ward the 50 vRNA, and the consequent
displacements of Val762 and Leu766
make room for the ﬁngertips to order
into a structured active form through
multiple contacts with residues from the
PA-C like domain a29, ﬁngers domain
a30 and the linker joining them (Fig-
ure 4D). Conserved His757 plays a key
role in stabilizing the ﬁngertips b-turn
through multiple hydrogen bonds to
backbone carbonyl groups (Figure 4D).
Fingertips ordering has a knock-on effect
on stabilization of motif B notably through
the interaction of conserved motif B
Gln1145 with Arg958 and Glu959 (Fig-
ure 4D). This is the ﬁrst observation of
functionally important allosteric effects
associated with 50 vRNA binding and is only observed when
10–11 50 end nucleotides are bound, but not eight (data not
shown). Interestingly, soaking in 50 cRNA nucleotides 1–10
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(which differ from vRNA only in the substitution G9 to A) shows
that the wobble base pair becomes canonical U3-A9 with no
discernible difference on the induced polymerase rearrange-
ments compared to vRNA (data not shown). This is consistent
with only the identity of 30 position 9 leading to a signiﬁcant dif-
ference in propensity for transcription between vRNA and
cRNA (Barr and Wertz, 2005). In the 50 vRNA end 1–11 soaked
structure, nucleotide U11 is only partially ordered and cannot
base pair with A1 without displacement of conserved Arg595
which hydrogen bonds to N1 of A1 (Figure S6D). Furthermore
soaking 50 RNAs longer than 11 nucleotides resulted in no bind-
ing in the crystal, suggesting that further rearrangements of the
polymerase (notably the a-ribbon) and probably a sharp turn in
the RNA (as observed in inﬂuenza 50 end between nucleotides
Figure 5. The LACV Polymerase Active Site
and Entrance and Exit Tunnels.
(A) The arrangement of the conserved RdRpmotifs
in the LACV active site colored gold, light blue,
green, red, brown, and blue for motifs A–F,
respectively. Additional sNSV speciﬁc motifs G
(from the PA-C like domain) and H are shown in
pink and gray (see Figure S7). Superposition of the
polio virus elongation complex structure (PDB:
3OLB, 3OL8) shows the positions of the catalytic
divalent cations (black spheres), the priming
nucleotide (N+1, gray) and incoming NTP (N+2,
magenta) and template strand (light gray sticks).
(B) The LACV polymerase structure (gray cartoon)
with the 50 and 30 vRNA in, respectively, yellow and
cyan is shownwith the tunnels (green) markedwith
arrows as template entry, NTP entry, product, and
template exit, as calculatedwithMOLE 2.0 (Sehnal
et al., 2013). The endonuclease, bridge, thumb-
ring and lid are, respectively, in forest green, blue,
gold, and brown.
(C) The same representation and orientation as (B)
for the inﬂuenza A polymerase structure (PDB:
4WSB) with additionally the PB2 cap-binding
domain in orange, the putative priming loop in
magenta and the PB1 C-extension in dark gray.
(D) Diagram showing the conserved residues
forming the template entrance in LACV polymer-
ase which is partially occluded by the ﬂexible
a-ribbon (orange). Colors are as in Figure 1A.
(E) As (D) but showing the putative template exit
channel in LACV polymerase.
See also Figure S7.
10–11) may be required to allow binding
of the complete 50 end, but which are
incompatible with the crystal packing
(Figure S6D).
The Active Site Cavity and Its
Entrance and Exit Tunnels
The L protein internal active site chamber,
where nucleotide addition occurs, is
formed by the conserved polymerase
motifs A-F and conﬁgured like other
RNA polymerases, notably inﬂuenza pol-
ymerase(Pﬂug et al., 2014; te Velthuis, 2014) (Figure 5A). Motif
F forms part of the ﬁngertips, the ﬂexible loop between ﬁngers
strands b20 and b21 that is only fully ordered when the 50
vRNA is bound (see above). The other conserved polymerase
motifs are all in the palm domain: motif A (1060-DMSKWS) be-
tween palm b22 and a41 with divalent cation binding D1060;
motif B (1145-QGNFNYTSSY) between b24 and the long a45
with conserved N1149; the catalytic motif C (1186-SDD) in the
turn between strands b25 and b26; motif D (1223-QANMKKTY)
just before b27 and motif E (1236-KEFVSLFN) forming the tight
loop between b28 and b29. Interestingly, structural alignment
with inﬂuenza polymerase allows identiﬁcation of two new active
site motifs, denoted G and H, which appear to be conserved
speciﬁcally in sNSV polymerases (Figure 5A, Figures S7A and
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S7B). Motif G (653-RYMI in LACV, 658-RKLL in inﬂuenza PA) is in
helix a24 in the core-lobe of the PA-C like domain (Figure S7A),
the conserved arginine being positioned to interact with the
priming NTP (Figure 5A). Motif H (1101-KELIL in LACV and
347-KVARL in inﬂuenza PB1) forms a b strand (b23 in LACV)
with the conserved lysine stabilizing the motif B backbone
conformation by hydrogen bonding to multiple carbonyl-oxy-
gens (Figure S7B).
Four positively charged solvent accessible tunnels, visualized
usingMOLE 2.0 (Sehnal et al., 2013) converge into a central inner
cavity where the RdRp motifs mediate template directed RNA
synthesis (Figure 5B, Figure S7C). The tunnels are delimited by
residues conserved among Orthobunyavirus polymerases (Fig-
ure S7D). The conﬁguration of the template entry channel, the
NTP entry channel and the nascent strand exit channel is similar
to that described for inﬂuenza polymerase (Figure 5C) (Pﬂug
et al., 2014). The template channel entrance is deﬁned by the
vRBL, ﬁngers and bridge and is partially obscured by the a-rib-
bon (Figure 5D), which together with several loops of the vRBL
b sheet that are deployed toward the entrance but disordered
in the structure, may modulate access. The NTP entry channel
is lined by conserved basic residues R287, K673 (PA-C like),
K956, R958 (ﬁngertips), K1063 (motif A), K1227, and K1228
(motif D), some of which are only positioned correctly upon 50
vRNA binding (Figure S7E). The product strand exit tunnel is sur-
rounded by the lid domain and the thumb ring mainly by the
extended joining linkers and by ﬁngers and palm opposite side
of the NTP entry channel (Figure S7F). In a LACV L there is a
more obvious extra channel that we postulate is for the template
to exit. In inﬂuenza polymerase the equivalent channel is present,
but narrowed by the presence of the putative priming loop (Fig-
ure 5C), which is 15 residues longer than in LACV L. The putative
template exit channel is deﬁned by the thumb, thumb ring,
bridge, and lid domains and lined by conserved basic residues
R1430, K1492, R1493, K1686, and R1690 (Figure 5E). As dis-
cussed below, the arrangement of the tunnels in LACV L protein
suggests an elegant strategy for RNA synthesis whereby the po-
lymerase forces separation of the template and product strands
and directs each down distinct exit channels on opposite sides
of the molecule.
DISCUSSION
Initiation of RNA Synthesis Requires Signiﬁcant
Conformational Changes in Protein and vRNA
In the L1750-vRNA complex, the 3
0 end of the template is tightly
and speciﬁcally bound but not accessing the entry tunnel, cor-
responding perhaps to the highly stable state that occurs in
inactive RNPs, for example within virions. For active RNA syn-
thesis, the 30 end clearly has to be relocated into the polymerase
active site (Figures 6A and 6B). Furthermore it has been shown
that complementarity and presumably base pairing between at
least 30 and 50 nucleotides 12 to 16 are required for RNA synthe-
sis by orthobunyavirus polymerases (Barr and Wertz, 2004;
Kohl et al., 2004). A pre-initiation conﬁguration, with the 30
end speciﬁcally bound on the outside but not entering the poly-
merase active site, was also visualized for inﬂuenza polymerase
(Pﬂug et al., 2014; Reich et al., 2014). However, whereas in the
inﬂuenza structures, both 30 and 50 extremities of the promoter
simultaneously bind their separate single-stranded binding
sites and form a distal duplex region (with 11–14 of 50 base
pairing with 10–13 of the 30 end), for LACV polymerase in
the crystallized conformation, this appears to be impossible.
First, nucleotides 11 of the 30 and 50 ends are around 25 A˚ apart,
too far to see how 30 and 50 nucleotides 12 to 16 could base pair
(Figure 6A). Second, in the all L1750 structures, bases 9–16 of
the 30 end are already base paired with the co-crystallized
cRNA, corresponding in sequence to 50 nucleotides 9–16.
Thus when 50 nucleotides 1–11 are soaked into the crystal, nu-
cleotides 9–11 are present in two distinct locations greater than
20 A˚ apart, which obviously cannot happen physiologically (Fig-
ure 6A). Given the similar mode of 50 end binding to both LACV
and inﬂuenza polymerases (and that the 50 end remains bound
as observed during initiation; Reich et al., 2014) and the similar
requirement of a short distal 30–50 duplex, we propose that an
alternative conﬁguration of the bound promoter likely exists
more analogous to the inﬂuenza pre-initiation conformation
(Figure 6B). Release and repositioning of the 30 end could
occur by swinging of the clamp, without necessarily letting
go of the 30 end RNA, with a concomitant reorientation of the
a-ribbon into a position analogous to the b-ribbon in inﬂuenza
polymerase (Reich et al., 2014), to stabilize duplex formation
(Figure 6B, Figure S6D). The ﬂexibility of the vRBL and a-ribbon
as seen by 3D classiﬁcation of the EM images, together with the
lower local resolution of these regions in the cryo-EM map,
shows that such movements are plausible (Figure 2, Fig-
ure S2F). In the case of inﬂuenza virus, extrapolation of the tem-
plate from the observed duplex region, based on the poliovirus
polymerase elongation complex model (Gong and Peersen,
2010), would result in the 30 end overshooting the polymerase
active site by three nucleotides as previously discussed (Reich
et al., 2014). For LACV, similar modeling suggests that this over-
shoot is accentuated. Assuming that for LACV the duplex is
from nucleotides 12–15 of both strands (Barr and Wertz,
2004; Kohl et al., 2004), based on the inﬂuenza/polio models,
the template would overshoot the polymerase active site by 5
or 4 nucleotides, depending on whether the LACV 30–50 12–12
base pair corresponds to inﬂuenza 30-50 10–11 or 11–12 base
pair, respectively (Figure 6B). In the case of cap-dependent
transcription, this overhang could favor base pairing with the
incoming capped primer. In the case of replication, this situa-
tion could be explained by (1) a different, less direct path of
the single stranded template, so that the 30 nucleotide 1 was
placed directly in the polymerase active site (i.e., the modeling
is misleading); (2) a mechanism of internal initiation followed by
realignment, dependent on the triplet repeat at the beginning of
the template (30-UCAUCA), as has been described for some bu-
nya- and arena-viruses (Guu et al., 2012) (i.e., internal initiation
at position 4 followed by realignment of the AGU triplet); or (3)
initiation starting at nucleotide 1 but duplex formation between
30 and 50 nucleotides 12 to 16 only occurring after 4–5 nucleo-
tides have been synthesized and the template has translocated
further into the active site cavity. This latter possibility would be
consistent with the observed position of LACV 30 end nucleotide
8 being close to that of the nucleotide 8 counting from the active
site along the polio template (Figure 6B).
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The Template Pathway through the Polymerase
Whatever mode of initiation, during elongation, a duplex formed
by template and nascent strands starts to grow in the active site
cavity as visualized in the structure of the poliovirus polymerase
elongation complex (Gong and Peersen, 2010) (PDB: 3OL7)
(Figure 6C). However, after a complete double-helical turn,
the nascent and emerging template strands would appear to
clash with the thumb and C-terminal lid domains, respectively,
as described for the inﬂuenza case (Reich et al., 2014). To
resolve this situation, we propose that the strands are forced
to separate and each is extruded along a separate exit tunnel
(Figure 6C). The nascent strand would exit to the rear of the
polymerase and, by analogy to the inﬂuenza case, the cap-
snatched transcription primer would probably enter by the
same route (Reich et al., 2014). The template would exit to the
front of polymerase through the template exit channel on the
same side and not far from the template entrance (Figure 6C).
The proximity of the entry and exit channels would allow reinte-
gration of the vRNA genome template into the RNPwith minimal
disruption (Figure 7). Modeling shows that the template path
through the entry channel, cavity, and the exit channel would
accommodate around 20 nucleotides. Given that 11 nucleo-
tides of the 50 and9 of the 30 ends directly bind the polymerase
in the pre-initiation state, and also a single LACV NP can
accommodate 11 nucleotides (Reguera et al., 2013), no free
RNA needs to be exposed, nor NPs removed or added, during
template reading. The mobile clamp together with the a-ribbon
Figure 6. Model of RNA Synthesis by LACV Polymerase
(A) Illustrated representation of the LACV polymerase (gray) looking down the
template entry channel showing the disposition of key structural elements
(arch, clamp, a-ribbon, ﬁngertips, ﬁngernode) colored as in Figure 1A. The
50 and 30 vRNA extremities are, respectively, yellow and cyan tubes, except
that nucleotide 11 in each case is in red highlighting their wide separation
(>20 A˚). The ﬁgure shows the impossibility of formation of a distal 50 and
30 duplex between nucleotides 12–15 of each strand, while maintaining the
single-stranded ends bound as in the observed conformation.
(B) Model for the initiation conformation of LACV based on superposition with
the inﬂuenza polymerase (PDB: 4WSB) and the poliovirus elongation complex
(PDB: 3OLB, 3OL8) structures. The observed 50 and 30 vRNAs are, respec-
tively, red and blue for inﬂuenza and yellow and cyan for LACV and numbered
accordingly. The LACV clamp binding to the 30 end is in magenta. The polio-
virus template strand is in gray and the active site is indicated by motif C
(green), the catalytic divalent cations (black) and the priming and incoming
NTPs (gray and magenta, respectively). The inﬂuenza vRNA distal duplex
starts with the 30-50 10:11 base pair (labeled). The template nucleotide
numbering in outline white counts back from the active site, assuming initiation
at position 1. The template nucleotide numbering in black numbers counts
along the LACV template assuming the ﬁrst LACV 30-50 base pair 12:12 aligns
with the inﬂuenza 10:11 base pair. This would allow for connectivity between
the distal LACV duplex and the observed 50 end hook binding but imply an
overshoot of the active site by 5 nucleotides. This is discussed further in the
text.
(C) Model of the elongation state showing trajectories of template RNA (cyan)
and product RNA (orange) and NTPs through the polymerase tunnels (green).
The observed positions of the 30 and 50 ends are shown as well as the position
of the active site. After a short template-product duplex, which is accommo-
dated in the interior cavity, each strand exits separately along different tunnels,
the template back to the front of the polymerase where it can re-integrate into
the RNP and the nascent strand to the rear where product processing occurs
i.e., progeny cRNP assembly in the case of replication or mRNP assembly or
translation coupling in the case of transcription.
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Figure 7. Schematic Model of vRNA Replication
An LACV RNP is schematically represented with the polymerase (purple or green), with template entrance (TEn), template exit (TEx), NTP entry and nascent
RNA exit channels as marked, interacting with the viral RNA (black or yellow) and proximal NPs (ellipses colored with a blue-to-red gradient). The complementary
50 and 30 vRNA ends are, respectively, cyan and red. The NPs form a chain linked together by ﬂexible NP-NP interactions involving the N-terminal arm (blue) and
the C-terminal arm (red) and each NP sequesters 11 nucleotides RNA (Reguera et al., 2014; Reguera et al., 2013). Small circles mark consecutive 11 nucleotide
segments of the vRNA. The polymerase itself can sequester around 20–22 template nucleotides.
(legend continued on next page)
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and proximal NPs could mediate the RNA template transloca-
tion driven by the polymerase motor.
CONCLUSION
Our structures of the LACV L protein in the apo-state and with
one or both vRNA ends bound suggest that assembly of a func-
tional initiation complex is a multistep process. The structures
clearly show that the polymerase has highly speciﬁc and
distinct sites for the single-stranded 30 and 50 vRNA ends, pre-
venting them from forming an extended panhandle. The mode
of 50 end hook binding is similar to that observed for inﬂuenza
polymerase, but here we directly observe the associated allo-
steric effects that are essential for structuring critical active
site loops. On the other hand the 30 end appears to be preferen-
tially and tightly bound in a groove closed by a clamp on the
side of the polymerase. Elucidation of the exact purpose of
this binding site and the mechanism for 30 end relocation into
the template tunnel for the initiation of RNA synthesis are
clear questions for future studies. Furthermore, the extended
complementarity of the LACV 30 and 50 ends appears to be a
major obstacle to reconstitute the LACV initiation complex
in vitro, since incubation, even sequentially, of the complete
30 and 50 ends leads to the preferred formation of a long, stable
duplex, which has low afﬁnity for the polymerase. Probably for
the same reason, we have not yet been able to demonstrate
robust template directed RNA synthesis activity for either
L1750 or full-length polymerase (see Supplemental Experimental
Procedures). It is therefore likely that in the case of bunya-, and
probably, arenavirus polymerases (Kranzusch et al., 2010), to
avoid stable base pairing of the highly complementary vRNA
promoter, the free ends are prevented from ever meeting
each other by the sequential mode of assembly of nascent
RNPs starting at one end of a growing replicate (Figure 7).
Thus it is plausible that, unlike the situation for recombinant
inﬂuenza polymerase, which is fully active when reconstituted
only with the vRNA promoter (Reich et al., 2014), NP-L and
NP-RNA interactions may be required for bunyavirus polymer-
ase activity.
The striking structural similarities between the single-chain
LACV and heterotrimeric inﬂuenza polymerases strongly support
the idea of an evolutionary common ancestor. Indeed, it now
seems plausible that all sNSV polymerases (i.e., from arena-, bu-
nya-, and orthomyxovirus families) have a similar architecture,
despite very low overall sequence homology, and this is sup-
ported by structure-based identiﬁcation of new common motifs
(Figures S7A and S7B). However, this does not mean that these
polymerases will not have idiosyncratic family and sub-family
differences. For example, whereas the arch and ﬁngernode
that bind the 50 hook have structural and functional homologs
in inﬂuenza, the LACV 30 end binding site and the clamp structure
that pins it in place has no such equivalent. Similarly, it is reason-
able to suppose that each polymerase is adapted to its cognate
nucleoprotein, whose size, structure, mode of RNA binding, and
number of nucleotides bound (e.g., 11 for orthobunyaviruses, 7
for phleboviruses), are very different for each sNSV family (Reg-
uera et al., 2014). In this context, it is intriguing that LACV and
inﬂuenza contain, respectively, an a- or b-ribbon, equivalently
located extended and ﬂexibly hinged structures that could
both play a role in both RNA and NP interactions and could be
adapted to the respective NP structures (Figure S6D) (Reich
et al., 2014). Finally, it is highly signiﬁcant that the L1750 construct
ends precisely at the same position as separates PB2-N and
PB2-C in inﬂuenza polymerase (Figure 1). PB2-C, which includes
the cap-binding domain and the C-terminal nuclear localization
motif (not relevant for cytoplasmic LACV), has already been
shown to be loosely associated with the rest of inﬂuenza poly-
merase (Reich et al., 2014). It remains open as to how much
the C-terminal residues 1751–2263 of LACV L, missing in L1750,
are structurally homologous to PB2-C. In particular it is still un-
known whether there is a cap-binding domain, for which there
is no direct evidence yet, but, in the case of Lassa arenavirus a
speciﬁc requirement for C-terminal residues for mRNA transcrip-
tion has been established (Lehmann et al., 2014).
(1) In the inactive state, whether after vRNP assembly or in virions, both ends of the genomic RNA are sequestered into the speciﬁc 50 and 30 RNA binding sites of
the polymerase, thus circularizing the RNP.
(2) For de novo RNA synthesis or cap-dependent transcription (not shown) the 30 end is relocated into the polymerase active site for initiation, by an unknown
mechanism. Distal 30-50 duplex formation may occur before or after initiation depending on whether initiation is internal (followed by prime and align) or at position
1 (see Figure 6B and main text). Duplex formation could bring the NPs at the 50 and 30 (NPa and NPz) closer enhancing the circularization of the NP scaffold but
would need to be dissociated to proceed with elongation.
(3) With the 50 end bound to the allosteric site for the activation of the RNA synthesis, a nascent cRNA begins to be synthesized.
(4) As elongation proceeds, the template dissociates from the proximal NP and is channelled into the active site. Because of the proximity of the entrance and exit
channels the disruption of the RNA-NP assembly may only affect one NP. Early on, the 50 end is detached from its speciﬁc binding site on the polymerase and
enters the RNP by loading onto NPz. As incoming template is released from NPy on one side, the outgoing 30 end is loaded on it from the other side. More
generally, the RNA being pulled into the cavity by the polymerase motor detaches from the proximal NP which is pulled to the left thus pushing the NP-RNA array
in the direction of the arrow. Thismodel would imply that 50 end binding is only required to activate initiation. This would be a difference from the inﬂuenza situation
where the maintenance of 50 end binding is required, at least during transcription, for self-polyadenylation to occur.
(5) Once the nascent c50 end emerges from the exit channel it can recruit an incoming apo-polymerase as the ﬁrst step in encapsidating the progeny cRNP with
incoming apo-NPs. This may be facilitated by polymerase dimer formation (see main text).
(6) Approaching termination the template 50 end would be copied and the template 30 end (bound to NPy) would approach its starting point.
(7a) At termination the template 30 end rebinds to its speciﬁc binding site on the polymerase to avoid base pairing with the emerging template 50 end which
subsequently rebinds to its polymerase binding site, thus completing the replication cycle.
(7b) Due to polymerase dimer formation, the nascent c30 end, which emerges last from the product exit channel, can easily ﬁnd and bind to speciﬁc 30 binding site
on the green polymerase, thus completing progeny cRNP formation. Without polymerase dimer formation being maintained throughout replication (or other
mechanism for keeping the polymerases in close proximity), it is unclear how the c30 could ﬁnd and bind to the correct polymerase which may have diffused far
away.
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Based on the L1750 structure, we propose a model for RNA
replication in which there are clearly separated exit tunnels for
the single-stranded template and product (Figure 6C, Figure 7).
The proximity of the template entrance and exit, on one side of
the polymerase, is compatible with processive template reading
with minimal disruption of the RNP. Template RNA would pro-
gressively dissociate from proximal NP as it translocates through
the entrance tunnel, into the polymerase internal chamber and
out again, to be reincorporated into the RNA free NP that
concomitantly translocates round the outside of the polymerase
between the entrance and exit tunnels, held together by ﬂexible
NP-NP interactions (Reguera et al., 2013) (Figure 7). Meanwhile,
the products exit to the other side of the polymerase, thus allow-
ing spatial separation of template translocation and product
processing. In the case of (anti)-genome replicates, product pro-
cessing involves assembly into progeny RNPs, possibly ﬁrst with
an incoming apo-polymerase binding speciﬁcally the emerging,
nascent 50 end and subsequently progressive packaging by
incoming NPs (Figure 7). We propose that robust polymerase
dimerization is necessary to ensure efﬁcient and correct circular-
isation of progeny RNP (Figure 7), and this is consistent with
some observations concerning replication by inﬂuenza polymer-
ase (Jorba et al., 2008; York et al., 2013), but other inﬂuenza
replication models involve more complicated higher order poly-
merization (Chang et al., 2015; Jorba et al., 2009). In the case of
transcription, as suggested by the structure of inﬂuenza poly-
merase, the cap-snatched primer would enter the internal cavity
via the product exit channel and then, upon elongation, extrude
out in the same direction, where it likely interacts with host trans-
lation factors (in the case of bunyaviruses, transcription is closely
coupled to translation; Barr, 2007). As suggested for inﬂuenza
polymerase (Reich et al., 2014), the main role of the PB2-C like
region may be in these product processing mechanisms. We
think these concepts are likely to be applicable to all sNSVs po-
lymerase and possibly those of nsNSV as well, which also oper-
ate in an RNP context.
EXPERIMENTAL PROCEDURES
Protein Production, Crystallization, and Structure Determination
Residues 1–1750 (L1750) of the polymerase (L protein) sequence of La Crosse
virus (LACV) were expressed in insect cells from a synthetic gene inserted in a
pFastBac vector. Puriﬁed protein at 5 mg/ml was crystallized with an equi-
molar mixture of nucleotides 1–16 from the 30 and nucleotides 9–16 from the
50 vRNA ends (Dharmacon). Crystals were improved by microseeding. Diffrac-
tion data were collected on beamlines ID23-1 or ID29 at the European
Synchrotron Radiation Facility and integrated with XDS (Kabsch, 2010). The
structure was solved by the multiple isomorphous replacement with anoma-
lous signal method using selenium, platinum, and tantalum cluster derivatives
with SHARP (Bricogne et al., 2003). LACV endonuclease (PDB: 2XI5) and inﬂu-
enza polymerase PA and PB1 subunits (PDB: 4WSB) were used as a guide to
model building. Selenomethionine positions from the anomalous difference
map helped align the sequence and autobuilding with BUCCANNEER (Cow-
tan, 2006) was useful to extend the model, which was reﬁned with REFMAC
(Murshudov et al., 1997) and PHENIX (Afonine et al., 2012). 50 end nucleotides
1–10 or 1–11 were soaked into pre-grown crystals to reveal the 50 end binding
site.
Electron Microscopy
Cryo-EM grids were prepared by applying 4 ml of L1750 at 0.2 mg/ml to a quan-
tifoil grid, blotting excess solution and then freezing in liquid ethane. Cryo-EM
images of apo-L1750 were collected on a Krios microscope at 80 kV with a
Falcon II direct detector (FEI) at magniﬁcation 138,129 times. FEI EPU autom-
atisation software was used to collect 6,129 micrographs with a defocus be-
tween 0.5 and 2 mm, an exposure time of 0.5 s and a dose of 14e/A˚2. After
contrast transfer function correction, 10,102 manually picked particles were
used to derive initial class averages with IMAGIC (van Heel et al., 1996). These
were then used to select 180,000 particles for input to 3D reconstruction
and reﬁnement with RELION 1.3 (Scheres, 2012), using as initial model the
L1750-vRNA crystal structure ﬁltered at 30 A˚ resolution, leading to a map at
8.3 A˚ resolution. The dataset was subsequently partitioned by 3D classiﬁcation
resulting into three structures which revealed the less well-deﬁned, ﬂexible
regions.
Polymerase-vRNA Binding Studies
For electrophoretic mobility shift assays, radioactively labeled RNAs were pro-
duced by in vitro transcription with T7 polymerase. For binding assays, 10 mM
of L1750 in 10 ml buffer was mixed with radiolabelled RNA and 1 ml of non-spe-
ciﬁc poly(U) RNA (Sigma). Mixtures were incubated at room temperature for
several hours and resolved on native TG gels. Radioactive signal from shifted
bands was recorded with a Typhoon and quantiﬁed with ImageQuant.
For ﬂuorescence anisotropy measurements, 5 nM 25-nucleotide long RNA
oligos corresponding to 30 or 50 vRNA (IBA), labeled with ﬂuorescein on the
appropriate non-interacting end, were titrated with L1750 in order to obtain
10–15 protein concentration points ranging from 3 nM to 1 mM. Fluorescence
and ﬂuorescence anisotropy measurements used 495 nm excitation and
515 nm emission wavelengths. KaleidaGraph (Synergy Software) was used
to evaluate the data and derive dissociation constants.
For proteolysis protection experiments, L1750 was incubated at 1mg/ml with
1:1 molar ratios of 25-nucleotide long 30 or 50 genomic ends and then digested
for 1 hr at room temperature with trypsin (1:1,000 w/w). Products of digestion
were analyzed by various techniques including: SDS-PAGE, western-blot,
ESI-TOF-MS, MALDI-TOF-MS, MALDI-TOF-MS with N-terminal acetylation,
and N-terminal sequencing of protein fragments by Edman degradation.
For more details see Supplemental Information.
ACCESSION NUMBERS
The accession number for the 8.3 A˚ cryo-EMmap of apo-LACV1750 reported in
this paper is EMDB: EMD-2930. The accession numbers for the L1750-3
0 end
and L1750-30/50 ends are PDB: 5AMR and 5AMQ, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven ﬁgures, two tables, one data ﬁle and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2015.05.006.
AUTHOR CONTRIBUTIONS
P.G. and J.R. did protein production, biochemistry, RNA binding studies, and
X-ray data collection and structural analysis. P.G. crystallized the L1750-vRNA
complex. J.R. identiﬁed the L1750 construct and solved the crystal structure.
H.M. did EM analysis. S.C. and J.R. co-directed the project and wrote the pa-
per with input from P.G. and H.M.
ACKNOWLEDGMENTS
We thank Wim Hagen and John Briggs for cryo-EM data collection at EMBL
Heidelberg, Leandro Estrozi, Irina Gutsche, and Guy Schoehn for advice on
EM image analysis; the staff of the EMBL Eukaryotic Expression and High
Throughput Crystallisation facilities, and the EMBL-ESRF JSBG staff for ac-
cess to ESRF beamlines. Darren Hart helped with construct design and
together with Philippe Mas and Damien Maurin with the ESPRIT analysis.
Mass-spectroscopy was performed by Joanna Kirkpatrick (EMBL Proteomics
Core Facility) and Luca Signor (IBS), Edman degradation by Jean-Pierre An-
drieu (IBS) and Stefan Reich (EMBL) helped with RNA binding studies. This
12 Cell 161, 1–13, June 4, 2015 ª2015 The Authors
Please cite this article in press as: Gerlach et al., Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter, Cell
(2015), http://dx.doi.org/10.1016/j.cell.2015.05.006
work used the platforms of the Grenoble Instruct Center (ISBG: UMS 3518
CNRS-CEA-UJF-EMBL) within the Grenoble Partnership for Structural
Biology (PSB), with support from FRISBI (ANR-10-INSB-05-02), GRAL (ANR-
10-LABX-49-01) and, for the EM facility, the Rhoˆne-Alpes Region and the
Fondation Recherche Medicale (FRM). H.M. and J.R. were supported by
EMBO long-term Fellowships for some of this work. S.C. acknowledges sup-
port by ANR grant ArenaBunya-L and ERC Advanced Grant V-RNA (322586).
Received: February 6, 2015
Revised: March 20, 2015
Accepted: April 7, 2015
Published: May 21, 2015
REFERENCES
Afonine, P.V., Grosse-Kunstleve, R.W., Echols, N., Headd, J.J., Moriarty,
N.W., Mustyakimov, M., Terwilliger, T.C., Urzhumtsev, A., Zwart, P.H., and
Adams, P.D. (2012). Towards automated crystallographic structure reﬁnement
with phenix.reﬁne. Acta Crystallogr. D Biol. Crystallogr. 68, 352–367.
Barr, J.N. (2007). Bunyavirus mRNA synthesis is coupled to translation to pre-
vent premature transcription termination. RNA 13, 731–736.
Barr, J.N., andWertz, G.W. (2004). Bunyamwera bunyavirus RNA synthesis re-
quires cooperation of 30- and 50-terminal sequences. J. Virol. 78, 1129–1138.
Barr, J.N., andWertz, G.W. (2005). Role of the conserved nucleotide mismatch
within 30- and 50-terminal regions of Bunyamwera virus in signaling transcrip-
tion. J. Virol. 79, 3586–3594.
Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M., and Paciorek, W. (2003).
Generation, representation and ﬂow of phase information in structure determi-
nation: recent developments in and around SHARP 2.0. Acta Crystallogr. D
Biol. Crystallogr. 59, 2023–2030.
Chang, S., Sun, D., Liang, H., Wang, J., Li, J., Guo, L., Wang, X., Guan, C., Bor-
uah, B.M., Yuan, L., et al. (2015). Cryo-EM structure of inﬂuenza virus RNA po-
lymerase complex at 4.3 A˚ resolution. Mol. Cell 57, 925–935.
Cowtan, K. (2006). The Buccaneer software for automated model building. 1.
Tracing protein chains. Acta Crystallogr. D Biol. Crystallogr. 62, 1002–1011.
Elliott, R.M. (2014). Orthobunyaviruses: recent genetic and structural insights.
Nat. Rev. Microbiol. 12, 673–685.
Fodor, E. (2013). The RNA polymerase of inﬂuenza a virus: mechanisms of viral
transcription and replication. Acta Virol. 57, 113–122.
Gong, P., and Peersen, O.B. (2010). Structural basis for active site closure by
the poliovirus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA
107, 22505–22510.
Guu, T.S., Zheng, W., and Tao, Y.J. (2012). Bunyavirus: structure and replica-
tion. Adv. Exp. Med. Biol. 726, 245–266.
Haddow, A.D., and Odoi, A. (2009). The incidence risk, clustering, and clinical
presentation of La Crosse virus infections in the eastern United States, 2003-
2007. PLoS ONE 4, e6145.
Jorba, N., Area, E., and Ortı´n, J. (2008). Oligomerization of the inﬂuenza virus
polymerase complex in vivo. J. Gen. Virol. 89, 520–524.
Jorba, N., Coloma, R., andOrtı´n, J. (2009). Genetic trans-complementation es-
tablishes a new model for inﬂuenza virus RNA transcription and replication.
PLoS Pathog. 5, e1000462.
Kabsch, W. (2010). Integration, scaling, space-group assignment and post-
reﬁnement. Acta Crystallogr. D Biol. Crystallogr. 66, 133–144.
Kohl, A., Dunn, E.F., Lowen, A.C., and Elliott, R.M. (2004). Complementarity,
sequence and structural elements within the 30 and 50 non-coding regions of
the Bunyamwera orthobunyavirus S segment determine promoter strength.
J. Gen. Virol. 85, 3269–3278.
Kranzusch, P.J., Schenk, A.D., Rahmeh, A.A., Radoshitzky, S.R., Bavari, S.,
Walz, T., andWhelan, S.P. (2010). Assembly of a functional Machupo virus po-
lymerase complex. Proc. Natl. Acad. Sci. USA 107, 20069–20074.
Lehmann,M., Pahlmann, M., Je´roˆme, H., Busch, C., Lelke, M., andGu¨nther, S.
(2014). Role of the C terminus of Lassa virus L protein in viral mRNA synthesis.
J. Virol. 88, 8713–8717.
Morin, B., Coutard, B., Lelke, M., Ferron, F., Kerber, R., Jamal, S., Frangeul, A.,
Baronti, C., Charrel, R., de Lamballerie, X., et al. (2010). The N-terminal domain
of the arenavirus L protein is an RNA endonuclease essential in mRNA tran-
scription. PLoS Pathog. 6, e1001038.
Morin, B., Kranzusch, P.J., Rahmeh, A.A., and Whelan, S.P. (2013). The poly-
merase of negative-stranded RNA viruses. Curr Opin Virol 3, 103–110.
Mu¨ller, R., Poch, O., Delarue, M., Bishop, D.H., and Bouloy, M. (1994). Rift Val-
ley fever virus L segment: correction of the sequence and possible functional
role of newly identiﬁed regions conserved in RNA-dependent polymerases.
J. Gen. Virol. 75, 1345–1352.
Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Reﬁnement of macro-
molecular structures by the maximum-likelihood method. Acta Crystallogr. D
Biol. Crystallogr. 53, 240–255.
Pﬂug, A., Guilligay, D., Reich, S., and Cusack, S. (2014). Structure of inﬂuenza
A polymerase bound to the viral RNA promoter. Nature 516, 355–360.
Plotch, S.J., Bouloy, M., Ulmanen, I., and Krug, R.M. (1981). A unique
cap(m7GpppXm)-dependent inﬂuenza virion endonuclease cleaves capped
RNAs to generate the primers that initiate viral RNA transcription. Cell 23,
847–858.
Raju, R., and Kolakofsky, D. (1989). The ends of La Crosse virus genome and
antigenome RNAs within nucleocapsids are base paired. J. Virol. 63, 122–128.
Reguera, J., Weber, F., and Cusack, S. (2010). Bunyaviridae RNA polymerases
(L-protein) have an N-terminal, inﬂuenza-like endonuclease domain, essential
for viral cap-dependent transcription. PLoS Pathog. 6, e1001101.
Reguera, J., Malet, H., Weber, F., and Cusack, S. (2013). Structural basis for
encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein.
Proc. Natl. Acad. Sci. USA 110, 7246–7251.
Reguera, J., Cusack, S., and Kolakofsky, D. (2014). Segmented negative
strand RNA virus nucleoprotein structure. Curr Opin Virol 5, 7–15.
Reich, S., Guilligay, D., Pﬂug, A., Malet, H., Berger, I., Cre´pin, T., Hart, D., Lu-
nardi, T., Nanao, M., Ruigrok, R.W., and Cusack, S. (2014). Structural insight
into cap-snatching and RNA synthesis by inﬂuenza polymerase. Nature 516,
361–366.
Scheres, S.H. (2012). RELION: implementation of a Bayesian approach to
cryo-EM structure determination. J. Struct. Biol. 180, 519–530.
Sehnal, D., Svobodova Varekova, R., Berka, K., Pravda, L., Navratilova, V., Ba-
nas, P., Ionescu, C.M., Otyepka, M., and Koca, J. (2013). MOLE 2.0: advanced
approach for analysis of biomacromolecular channels. J. cheminform. 5, 39.
te Velthuis, A.J. (2014). Common and unique features of viral RNA-dependent
polymerases. Cell. Mol. Life Sci. 71, 4403–4420.
van Heel, M., Harauz, G., Orlova, E.V., Schmidt, R., and Schatz, M. (1996). A
new generation of the IMAGIC image processing system. J. Struct. Biol.
116, 17–24.
York, A., Hengrung, N., Vreede, F.T., Huiskonen, J.T., and Fodor, E. (2013).
Isolation and characterization of the positive-sense replicative intermediate
of a negative-strand RNA virus. Proc. Natl. Acad. Sci. USA 110, E4238–E4245.
Cell 161, 1–13, June 4, 2015 ª2015 The Authors 13
Please cite this article in press as: Gerlach et al., Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter, Cell
(2015), http://dx.doi.org/10.1016/j.cell.2015.05.006
??????????????????????????????????????????????????????????????????????
??????????????????
?
?????????????????????????? ??????????????????????????????????????????????????
?
?????????? ?????????? ???????? ???????????? ????????? ???????????? ??? ??????? ???? ?????????
?????????????????????????????????????????
????????????????????????? ????????????????????????????????????????????????????????????
??????????? ?????????????????????????????????????????????????
?
????????????????????
???????????????????????
???????????????????
?????????????????????????????????????????
?
?????????????? ????????
?? ?????????????????????????????
?? ????????????????????????????
?? ?????????????????????????????????
?? ??????????????????????????
? ?
??????????????????????????????????? ?????????
??????????????????????????????
???????????????????????????????????????????????????????????????????????????
??? ?????????????????????????????????????????????????????????????
??? ??????? ???? ?????? ???????? ?????????? ????????? ??? ???? ?????? ???????? ?????? ?????????
??????????????????????????????????????????????????????
??? ?????????????????????????????????????????????????????????????????????????
??? ?????????????????????????????????????????????????????????????????
??? ??????????????? ??????? ???? ??? ????? ?? ??????????? ?????????? ??? ?? ?? ?????? ?????? ?????
????????????????????????????????????????????????????????????? ??????????????????????
?????? ?????????? ??? ???? ??? ????????????? ???? ???? ????????? ???????? ????????? ???????????
??????????????????????????????????????????? ???????
?
???????????????????? ?????????????????????????????????????????????
????????????????????? ??????????????????????????????????????????????????????
??? ??????????????? ??????????????????? ?????????? ??? ????? ??? ?? ?????? ??????????? ?????? ??
????????????????????????????????????????????????? ????????????????????
??? ??????????? ???????? ??? ??????? ??? ?????? ????????? ?????? ???? ?????????????? ??? ???? ???
??????????????? ?????????? ???????? ???? ???????????? ??? ???? ??? ???????????????? ?????? ?????
???????????? ?????????????????????????? ??????????????????????????? ?????????????????????????
?????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
??????????????????????
????????????????????????????????????????? ??????? ????????????????????????? ?????????????????????
????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
????? ???? ?????????????? ?????? ??? ???? ????? ???? ???? ???????? ??????????????? ????????? ???
????????????????????????????????????????????????????????????????????????????????????????????????
???? ????? ????????? ??????? ?????? ??????????? ??? ???? ????? ??????? ???? ???? ?????????? ????
????????????????????????????????????
?
??????????????????????????????????????????????????????????????????????????????????????
???????
??? ??????????????????????????????????????????????
???????????????????????????????????????????????????????????
????????????????????????????????????????
??????????????????????????????????????????????????????????????????
?????? ??????? ?????????????? ????????????????????? ????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
??? ?????? ?????? ???? ?????? ???????? ???????? ??? ?????? ????? ??????????????? ?? ???????? ????????
?????????????? ?????? ??????? ???????? ???? ??????????? ????????? ??????? ???? ?????????? ??? ???? ???????
????????
??? ?????????????????????????????????????????????????????????????????????????????????????????????
????????? ?????? ??? ??????? ???? ????? ????? ???? ?????????????? ???????????? ???????? ????
?????????? ???? ?????????? ???? ??????????? ???????????? ???????????? ??? ????? ???? ??????? ???????
???????????? ??? ??????? ???? ?????????????? ???????????? ??? ?????? ???? ???????? ??????? ??????????
???? ???????????? ???????? ?????????? ??? ???????? ?????? ????? ????????? ????? ?? ???????? ????
?????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
????????? ?????????? ????? ????? ???????????? ????????????? ???????????? ???? ???? ????
???????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????
????????????????????????????????????????????????????????????? ????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????? ?????????????????????????????????????????????????
???? ???????? ??????? ???? ????????? ??????????? ????? ????? ???????????? ????????????? ???? ????
???????????????????????????????????????????? ?????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????? ????????????????
???????????????????????? ??? ????? ????????? ??? ????????? ??????????? ??? ??????????????
????????? ????????? ????? ??????????? ??? ???????? ????? ????????????? ??? ?????????? ??????
??????????????????????????????????????????????????????????????????????????????????????????
?????? ???????????? ??? ????????? ??????????? ??? ????? ?????? ???? ????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????? ???????? ???????????????????? ??? ?? ??????????????????? ???? ??????????????? ?????????? ????
??????????????????????????????????????????????????????????????????????????????????????????????
???? ?????? ??????? ??????? ??? ???????? ???? ??????????????? ???????? ??????? ??? ???????????? ??? ????
??????? ???? ??????????????????????? ???????????????????? ??? ????? ??????? ?????????????????????
??????????????????????????????????????
?
?
?
??????????????????????????????????????????????????????????????????????????????????
??????????
??? ????? ?????? ??????????? ??????????? ????????? ???? ???????????? ???? ????? ??????? ????
?????????? ?? ????? ?????? ???????? ???????????? ?????? ??????????????? ???? ????? ????? ???????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????
???????????????????
????????????????????
??????????????????????
?
????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
?????????????????????????????
?
??????? ???? ??????????? ??? ??? ????? ???????? ??? ????? ???? ?????????? ???? ????????
??????????????????????????????????????????????? ??????????????????????
????????? ??????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????
??????? ??????????????????? ??????? ??????? ??????? ?????????? ?????????? ??? ?????????????? ????????
???????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
??? ???? ??????????? ????? ??????? ?????? ??????? ??? ????? ??????? ????????? ???? ????????? ???????????
???????????????????????????????????????????????????????????????????????????????????
?????????????????????????????? ????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
???? ??????????? ??? ???? ????????? ????? ??????? ?????????? ?????? ?????????????? ??? ???? ??????????
???????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
?????? ?????? ????? ?? ???????? ???????????? ??????? ??????????? ??? ??? ??????????? ???? ?????? ???????
?????????????????????????????????????????????????????????????????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????
??????????????????????? ??????????????????????????????????????????????????????????????????
????????? ??? ?????? ???????????????? ??????? ?????????? ????????????????? ??????????????????????
??????????? ?? ???? ???? ????????????? ???????? ????????????????? ??????? ???????????????
???????? ????? ??????? ????????????????? ??????? ?????????????? ????????????? ????????????
??????? ??????? ???????? ?????? ??????? ???? ?????????? ???? ??????????? ??????????????? ????
???????????? ??? ?????? ?? ??? ?????? ???? ????? ????????? ???? ?????????? ???????? ????? ????
??????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????
??? ???? ????? ?????????? ?? ???????? ???????? ???? ????? ????????? ???? ?????????? ???????? ????
????????????? ??? ???? ?????????? ???????????? ???? ????????? ??? ?????????? ?? ???????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????? ??????????? ????????? ??? ????? ?????? ???????????????????? ??? ??? ???? ?? ???? ????????
???????????????????????????????????????????????????????????????????
??? ???????? ???????? ???? ?????? ??????????? ?????????? ??? ???? ?????????? ???????? ???????????????
???????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
???????? ?????????????? ?????? ??????? ????????? ???? ???? ???? ???? ???????? ?????????? ????
???????????????????????????????????????????????????????????
??? ??? ?? ???? ???????? ??????????? ????????? ???? ????????? ?????????? ??? ?????? ??????? ???
????????????????????????????????????????????????????????????????????????????????????????
??? ???????? ?????? ???????? ??? ?????? ??? ?????????? ?????? ????????? ?????? ????? ?????? ???????
????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
??? ????? ????? ???? ???????? ????? ???????? ???????? ????????????? ?????????? ????????? ????? ????
????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????
?????? ???? ????????? ?????????? ??? ??????????????? ???????????????? ???????????? ?????
??????????? ?????????? ?????????? ??? ????? ??????????? ???? ???????? ?????????? ????
?????????????????????????????????
???????????????????????????????????????????????????????????
? ?
?????????????????????????????????
???????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????? ???? ??? ?????? ??? ??? ?????????? ???? ??? ?????? ??? ??? ????????????? ?????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
??????? ??? ???? ????? ???????? ???? ???????? ????????????? ????????? ??? ??????? ??????????????? ???
???????????????????????????????????????????????????????????????????????????????? ?????????????????
???????????????????????????? ????? ?????????????????????????????? ??????? ??????????????????????
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
????????? ?????????????????????????????????????????????? ????? ????????????????
?????????????????? ?????? ???? ????? ?????????????? ???? ????????????????? ????? ??????????
??????????????????????????????????????????????????????????????????????????????????????????
???????? ??????????? ??????????? ???? ?????? ??? ???? ????? ??? ???? ?????? ??? ???? ????? ???
???????????????????? ???????????????????????????????????????????????????????????????????????????
????????????????? ?????????????? ?????????????? ???? ???????? ???????????????? ?????? ??? ??? ??????
???????????????????????????????????????????????????????????????????????????????????????
??? ??? ????????????? ???????? ??????????? ??? ??????????? ??????? ????????? ????????? ???? ?????
??????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????? ?????
???????????? ????? ????????? ??? ???????? ??????? ????????? ??? ??????? ??????? ????????????? ?????
??????? ?????? ??? ???????? ???? ???? ??????? ??? ????? ????? ??? ???????? ????????? ???????? ??????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????
???????????????????????????????????????? ??????????????
???? ????????? ????? ?????????? ??? ??????? ???? ????? ?????????? ??? ?????? ????? ?????
???????????????????????????????????????????????
??????????? ?????????? ???????????? ??? ???? ???????? ?????? ?????? ???? ??????? ?????????
??????????????????????????????????????????????????????????????????????????????????????????
???????????? ??? ??????? ????????????? ??????? ?????????? ?????????? ????????? ????? ??????????
????????? ???? ????????????????? ???????????? ????? ?????????? ??? ????? ???????? ???? ???? ??
????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
?????????????????? ??? ???? ??????????? ?????? ??????????? ????? ?????? ???? ???????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
??????????????? ??????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
???? ??? ??????????? ????? ???? ??????? ????? ??? ????? ?? ???????????? ?????? ???????? ??????? ???
??????????????????????????????????????????????????????? ?????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????? ????????????? ????? ?????? ???? ?????????? ??????????? ??? ???? ???? ????????? ?????
?????? ?????? ??? ??????? ????? ???????? ??? ?? ?????? ????????? ????????? ?????? ?????? ???? ????? ???
??????????? ?????????????????? ???????????? ?????? ????? ????? ???????? ???????????? ??????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????? ????????????????????????????????????????????????????????????
?????????????????????????? ?????????? ???????????????????????????????????? ?????????????????
??????????????????????????????????????????????????????????????????????????????? ???????????
?????? ??????? ??????? ????? ???? ????????? ?????? ???? ??? ?? ????????????? ???????? ?????????? ?????
????????????????????????????????????????????????
??????? ??????????? ????????? ??????? ????? ???? ??? ???????? ????? ??????????? ??? ????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????
????????? ??????????
????????? ?????? ???? ?????????? ???????? ???? ???????????? ??? ????????? ?????? ?????????
???????????? ?? ??? ??? ????? ?????? ??? ??????? ???? ???????? ??? ???? ?????? ????? ??? ??????? ??? ??
???????????? ??????????????????????????????????????????????????????????????????????? ???????
????? ????????? ?????? ????????? ???????????????? ?? ????????????? ?????????????? ??? ???? ???
?????? ?? ???????? ?????????????? ??? ???????? ?????? ?????? ???????????? ???????? ?????
????????????????????????????????????????????????????????????????????????????????????????????
????????? ???? ???????? ????? ?? ???????????????? ???? ??????? ??????????? ????? ???? ????? ????
?????????????????? ?????? ???????????????? ??????? ????????????? ???????? ??????? ?? ?? ????? ??
????????????????????????????????????????????????????????????????????????????????????????????
????????????????? ????????? ??? ??? ??????????????????????? ????? ?????????? ??? ?? ??????? ???
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
????????? ???? ????????? ????????? ????????? ?????? ???? ????? ??????????? ???? ??????????? ?????
????????? ????????? ???????????????? ??????? ???? ????? ????? ????????????? ?????? ??????????
??????????? ???? ???? ????????? ????? ????? ???? ??????????? ?????? ???????????? ??????? ??????????
?????????????????????????????????????? ??????????????????????????????????????????????????
??????? ??????????????? ??? ???????????? ??? ??????? ?????????? ??? ????? ??????? ???? ??????????
???????????????????????????????????????????????????????????????????????????????????????????
??????????? ????????? ?????????? ????????? ???? ???????? ??????? ?????? ?????????? ????? ????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
???????? ??????????????? ??? ?????????? ?????????? ????????? ??? ???? ??????????? ?????? ?????? ???
???????? ??? ?????? ???? ?????????? ??? ?????????? ???? ??????????? ???????? ?????????? ??? ??? ??
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
??????????? ?????????????? ??? ?????????????????? ??????????????? ???????????? ??? ????? ??????? ??? ??
??????????? ??? ??????????????? ????? ??? ???????? ????????? ??? ?????? ???? ????????? ????? ??????
?????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???? ???????????????????????????? ???? ???????????? ??????????? ??????????????????????????????????
?????????? ??????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????? ???? ?? ?????? ?????????? ???? ???? ??????????? ???????? ????????? ???? ?????? ?????? ???
??????????????? ???? ?????????????????? ????????????? ????????? ???????????????????? ??? ????????
???? ??????????????????????? ??? ???? ????????????? ?????????? ??????? ???? ???? ??????????? ?????
??????? ???????????????? ?????????? ???? ????????????? ????? ????????????????????????????????
???? ????????????????????????????????
????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
????? ?????? ?????????????? ?? ??????????????????? ?????????? ???? ????????? ??? ?????? ??? ?????
???????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????? ????? ????????? ???? ????????? ????? ????? ???? ?????? ?? ??????????????? ?????? ???? ?????
?????????????????????????????????? ??????????????????????????????????????????????????
????? ???? ????????????? ???????????? ?? ??? ??????????????????? ??? ??? ???? ?????? ?????
?????????????????? ???? ?? ??? ??? ????????????? ???????????? ????????? ???????????? ?? ????????
??????? ??? ???????????? ???? ??? ????? ???????? ???? ???????? ?????? ????? ??????? ?????? ???
???????????????????????????????????????????????????????????????????????????????????????
????? ????????????? ????? ???????????? ???? ???????? ?????? ???? ??????????????????????????? ?????
?????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????? ???????????????????????????????????????????? ???????????? ????????
?????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
??????? ?????????????? ??? ??? ??? ??? ????? ??????? ?????????????? ???????????? ??? ???? ????????????
??????????????????????????????????????????????????????????????????????????????????????????
?????? ??? ?????? ??? ??????? ?????? ???????? ?????????????? ??????? ???????? ????? ?? ??? ??? ?? ????
???????????????????????????????????????????????????????????????????????????????????????????
?????? ???? ??? ??????????? ???? ???? ??? ????????? ????????????? ????????????? ?????????
????????????????????????????????????????????????????????????????????????????
???? ???????????? ??????????? ???????????? ?????? ?????? ?????????? ?????????? ??? ????????
???????????????????????????????????????????????????????????????????????????????????????????????
??? ????? ???????????? ????? ???????? ???????? ?????? ????????? ??? ?????????? ????? ????????? ???
???????? ??????????? ??????????? ?????????? ?????????????? ???????????? ??????????????
????????????? ????? ??????????? ????????????? ???? ?? ????????? ??????????? ??? ????????
????????????????????????????????
????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????????????? ??? ???? ???????? ???????? ???? ???????????? ??????? ????? ????? ??? ??? ??? ?????????
???????????????????????????????????????????????????????????????????????????????????
???????????????????????? ?????????????????? ???? ??????????? ??????????????? ??? ??????
???????????????????????? ??????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????? ???????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????????????? ??????????? ?????????? ???? ????????? ??? ??????????? ??? ???? ???? ????????? ????
????????????????????????????????????????????????????????????????????????????????????????????
???? ????????????? ??????????? ????????? ????????? ????? ?????? ?????? ?????????? ??? ????????? ????????
????????????????????????????????????????????? ?
?????????????????????????
???????????????????????????????????????????????????? ????????????????? ??????????????????????
??????????????? ???? ????? ??? ?????? ???????????? ??? ?????????? ??????????????? ???????
????????????? ??? ???? ??????????????????????? ?????????????????? ??????????????????????
???????????????????????????????
???????????????????????????????????????????????????????? ??????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
???????? ????? ???????? ?????? ?????????? ????????? ???????? ?????????? ??????? ???
???????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????
????????? ?????? ???? ???????? ??? ???????? ??? ??????? ???????????????? ???????????????? ???
????????????????? ???????????????????????????????????????????????????????????????????????
?????????
??????????? ???????? ????????????? ????????? ?????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????? ???????????? ??????????????????
??????????????????????????????????????? ????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????? ?????? ???? ???????????? ??? ???????? ????????? ?????????????? ??? ?????? ???????? ????
?????????????????????????? ???????????????????????????????????????????????????????
??????????? ?????? ??????? ?????? ???? ???????? ????? ???????? ??????????? ??? ???????????????
??????????? ??? ???? ??????????????????? ???????? ????? ?????????????????? ???????? ???
????????????????????????????????????????
???????????????????????????????????????????????????????????????????????? ??? ???????????????
???????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????
????????????????????????? ??????????????????? ????????????????????????????????????????????
??????????????????????????????????????????????????????????????
????????????? ?????????? ???????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
????????? ?????? ???? ?????? ??? ???????? ??????????? ??? ???????????? ??? ???????? ??????????
?????????????????????? ???????????????????
???? ?????? ???? ???????? ???? ???????? ?????? ????????? ???? ???? ???????? ??? ???????? ?? ????
?????????????? ???? ??????? ????????????????? ???????? ???????? ??? ??????????? ???????? ?????
???????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????? ??????? ??????????????????????
????????????????? ??????????? ????????? ?????? ??????????????? ???????? ???????? ??? ???????????
?????????????? ??????? ???? ???????? ???? ???????? ??????????? ??? ???????? ???????? ?????
???????????????????????????????????????????????????????????????
?
?
???
???
???
??
??
??
??
??
??
????? ???? ??????????????? ?
?????? ?????? ??
?????????????????
?????????? ??????
???????????
???????? ?????
??? ? ???????
??????????????
??????????????
????????????????
????????? ?????
??????
??? ? ???????
??????????????
?????
??????????????
???????????
??????
?? ? ??
??????????????
??? ????
? ??????????????
???????????????????????????????????????????
???????????????????????????????????????
???????????????????????????????????????
? ????? ???????????
???????????????????????????????????????????
??????????????????????????????????????
?????????????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????
??
?
??? ?? ????
?????? ?? ???
?????? ???? ??????
??????????
???????? ???????? ????????????????
? ?????? ????????????????? ???????????????? ????? ????????????????????????????????? ??????????? ??????????????? ????? ?????????????????????????????????? ??
?? ???? ????????????????? ????? ????????????????????????????????? ??????????? ??????????????? ????? ?????????????????????????????????? ??
?? ?????? ???????????? ???? ???????????????? ?????????????????????????? ??????????? ??????????????? ????? ?????????????????????????????????? ??
???
???
???
??
??
??
??
??
??
? ??????????
??? ?? ????
?????? ????? ???
?????? ?????? ???
?
????????????
??????
????
?????
????
????
????
????????????????
????
??????
??????
??????
????????????
????????????
?????????
?
?
?
?????
???????
??????????
????????
?????????????
?????????
??????????
??????
?????
????
???
????????????????? ????????????
???
??
??
??????
?????????
??????????
????
?????
???
???????
?????????
??????????
????????
??? ???
????
????
???????????????????????
????????????????????????????? ?????
?????????????????????
?????????????????????????????????????
??????????????
?????
????
???????
????????
??????????
?????
??????????
??????????
?????
?
?
?
? ??
???
?
??
?
?
? ?
????
????
????
????
????
????
????
????
?????
????
????
?????
?????
????
?????
?????
???????????????????????
????
????
????????
????
????
????
????
????????
???? ????
?????????????? ????
????????
????
????
????
?
?
?
? ? ??? ? ????????????????
?? ?? ?? ?? ?? ?? ?? ?
? ???? ? ?
?
?? ??? ???
? ? ? ?????
????
????
????
????
????
????
????
????
????
??????????????
????
????
????
????
????
????
????
????
????
?????
?????
????????????????
?????????
?????????
????
????
???? ????
????
????
????
????
????
????
????
????
???? ???????????
????
?????
????? ????
?????
?????
?????
????
?
????????
??????????
??
??????????????
????????
??
??
?? ?? ???
???
??
??
????
????
??
?? ?? ???
?
????
?????????
?????????
???????
????
???????
?????????
?????????
???????
??
??
?? ??
??
??
??
??
??
??
??
?????????
???????
???????????
????
????
????
????
????
????
???
????
?
??
??
?????
????? ?????
????????????????
??????????????????
????
?? ????
?????????
????????
????????????
???????
???????
???
?????
???????
????
????????????????
?????????????????????????????????
????????
????????????
???????
???????
???
?????
???????
????
?
???
??
???
??
?
????
????????
???
??
??
?????
???????????
?????????????????
????
????
????
????
?????
?????
?????
????
????
????
???? ?
????????
????
???????????
??
??
??
?
?????
?????
?????
?????
?????
????
???? ????
????
?
?
????
?????
?????
????
????
????
????? ?????????????????
? ??
?
???????????????
??????
?
?
?
????? ????? ??????
????
????
????
????
????????????????
? ? ?
?????
?????
?????
???????????
???
??
??
?
???????????????
???????????????? ?
? ?
?????????
????
????
????
???
??
??
?
?????
?????
????????
????????
????
????
?????
?????
?????
?????
?????
?????
?????
?????
????
????
???????
???????
????
????
????
????
????
????
?????
?????
????
????
????????
???????? ???????? ?????????? ?????????? ????? ???????? ?????????????
???????????????
??????????? ??????? ? ?????? ? ?????? ? ?????? ? ?????? ? ?????? ? ??????
???????????????
?????
?????
?????
?????
?????
?????
???????
???????
??????
?????
?????
?????
???????
???????
???????
?????
?????
?????
??????
??????
??????
?????
?????
?????
??????
??????
??????
?????
?????
?????
??????
??????
??????
?????
?????
?????
?????
?????
?????
????
????
????
??????
??????
??????
?????
?????
?????
???????????????
????????????
???? ???
?????????
???? ?????
???????????
??????
?????????
??????
?????????
???? ???
?????????
???????
??????????
??????
??????????
??????????????? ???? ???? ???? ???? ???? ?????? ??????
?????????????? ??????? ??????? ??????? ??????? ??????? ??????? ???????
???????????????? ??????????? ??????????? ??????????? ??????????? ??????????? ??????????? ???????????
??????????? ??????????? ??????????? ????????????? ?????????? ?????????? ??????????? ???????????
???????? ?????????? ??????????? ????????? ??????????? ?????????? ?????????? ??????????
???? ???????????? ??????????? ??????????? ??????????? ??????????? ??????????? ????????????
???????????? ? ?? ?? ?? ?? ? ?
?????????????????? ? ????? ????? ????? ????? ? ?
??????????
?????????????? ?????????? ????????
??????????????? ????? ?????
??????????? ??????????? ???????????
??????????? ???????????
????????????
??????? ???? ????
??? ?? ??
?????????
??????? ????? ?????
??? ??? ???
????? ?? ?
??????????????
??????? ???? ????
??????? ???? ????
??? ???? ????
????? ???? ?
?????????????? ?
???????? ??? ???
???????? ????? ?????
??????????????
???????????????? ????? ?????
??????????????? ????? ?????
????????
?
?
?
RNA base    Atom        Residue     Atom         Distance (Å)   
G      14B  OP2   ...   Lys   862A  NZ     ...   2.59 ***
G    10B  O2'   ...   Lys   381A  N      ...   2.85 ***
U       9B  OP1   ...   Leu   383A  N      ...   2.94 ***
...   Arg   526A  NH2    ...   2.88 ***
U       9B  O4    ...   Lys   870A  NZ     ...   3.13 ***
A       8B  OP1   ...   Arg   526A  NH2    ...   3.06 ***
A       8B  O2'   ...   Ile   378A  N      ...   3.22 ***
A       8B  N7    ...   Lys   381A  O      ...   3.42 *  
A       8B  N6    ...   Lys   381A  O      ...   2.79 ***
C      7B  OP1   ...   Lys  1516A  NZ     ...   2.39 ***
C      7B  O2'   ...   Trp   395A  NE1    ...   3.25 ***
C      7B  N4    ...   Gln   398A  NE2    ...   3.11 ***
C      7B  N3    ...   Arg   531A  NH1    ...   2.86 ***
C      7B  O2    ...   Arg   531A  NH2    ...   3.42 *  
...   Arg   531A  NH1    ...   3.06 ***
C      7B  OP2   ...   Tyr   524A  OH     ...   2.67 ***
A      6B  OP1   ...   Arg   372A  NE     ...   3.07 ***
...   Arg   372A  NH2    ...   3.41 *  
A      6B  OP2   ...   Arg   372A  NH2    ...   2.86 ***
A      6B  O5'   ...   Arg   372A  NH2    ...   3.49 *  
A      6B  O3'   ...   Asn  1308A  ND2    ...   3.11 ***
A      6B  O2'   ...   Asn  1308A  OD1    ...   3.52 *  
...   Asn  1308A  ND2    ...   3.46 *  
A      6B  N3    ...   Ser   520A  OG     ...   3.51 *  
A      6B  N6    ...   Gln   397A  OE1    ...   3.60 *  
C      5B  OP1   ...   His  1515A  NE2    ...   3.35 *  
C      5B  N4    ...   Glu   396A  OE1    ...   3.26 ***
...   Gln   397A  NE2    ...   3.17 ***
C      5B  N3    ...   Gln   397A  NE2    ...   3.58 *  
C      5B  O2    ...   Asn   517A  ND2    ...   2.91 ***
U      4B  O4    ...   Lys   368A  NZ     ...   3.49 *  
A      3B  O2'   ...   Asn   318A  ND2    ...   3.03 ***
A      3B  N7    ...   Lys   323A  NZ     ...   3.03 ***
A      3B  N6    ...   Cys   535A  N      ...   3.29 ***
C      2B  N4    ...   Lys   472A  O      ...   2.83 ***
C      2B  N3    ...   Lys   472A  N      ...   3.41 *  
...   Lys   472A  O      ...   3.42 *  
U      1B  O3'   ...   Pro   314A  N      ...   3.45 *  
...   Asn   538A  ND2    ...   2.71 ***
...   Asn   313A  O      ...   3.18 ***
U      1B  O2'   ...   Asn   318A  OD1    ...   3.53 *  
...   Asn   538A  N      ...   2.99 ***
...   Asn   538A  ND2    ...   2.85 ***
...   Ala   536A  O      ...   2.75 ***
U      1B  N1    ...   Ala   536A  O      ...   3.19 ***
U      1B  N3    ...   Ala   536A  O      ...   3.57 *  
U      1B  O2    ...   Ala   536A  O      ...   3.55 *  
...   His   312A  ND1    ...   3.56 *  
...   Gln   506A  NE2    ...   3.03 ***
U      1B  OP2   ...   Asn   318A  ND2    ...   3.40 * 
RNA base    Atom        Residue     Atom         Distance (Å)
A       1C  OP2   ...   Lys   423A  NZ     ...   3.20 ***
A       1C  O2'   ...   Ala   593A  N      ...   3.09 ***
...   Ala   593A  O      ...   2.63 ***
A       1C  N3    ...   Cys   419A  O      ...   3.51 *  
A       1C  N1    ...   Cys   419A  O      ...   3.21 ***
...   Arg   595A  NE     ...   2.95 ***
G       2C  OP1   ...   Arg   592A  NH1    ...   2.69 ***
G       2C  O2'   ...   Arg   595A  N      ...   2.65 ***
...   Arg   595A  O      ...   2.78 ***
G       2C  O4'   ...   Ala   593A  O      ...   3.14 ***
G       2C  OP2   ...   Lys   302A  NZ     ...   3.34 *  
U       3C  O3'   ...   Arg   600A  NH2    ...   3.02 ***
...   Thr   642A  OG1    ...   3.16 ***
U       3C  O4'   ...   Arg   595A  O      ...   3.48 *  
A       4C  OP1   ...   Arg   600A  NH2    ...   2.82 ***
...   Thr   642A  OG1    ...   3.00 ***
...   Lys   643A  N      ...   2.96 ***
A       4C  OP2   ...   Thr   642A  OG1    ...   3.13 ***
A       4C  O2'   ...   His   761A  ND1    ...   2.68 ***
G       5C  OP1   ...   Lys   643A  NZ     ...   2.86 ***
G       5C  O5'   ...   Tyr   677A  OH     ...   3.14 ***
G       5C  O4'   ...   His   761A  NE2    ...   3.49 *  
G       5C  N7    ...   Tyr   677A  OH     ...   2.94 ***
...   Lys   679A  NZ     ...   2.83 ***
G       5C  N2    ...   Ser   438A  O      ...   3.53 *  
G       5C  OP2   ...   Tyr   677A  OH     ...   2.72 ***
U       6C  O5'   ...   Arg   292A  NH2    ...   3.37 *  
U       6C  O4'   ...   Gln   291A  O      ...   3.23 ***
U       6C  N1    ...   Gln   291A  O      ...   3.60 *  
U       6C  OP2   ...   Arg   292A  NH1    ...   3.49 *  
...   Arg   292A  NH2    ...   3.26 ***
G       7C  N7    ...   Tyr  1120A  OH     ...   3.36 *  
...   Lys   768A  NZ     ...   3.16 ***
G       7C  N3    ...   Gln  1116A  NE2    ...   3.02 ***
G       7C  N2    ...   Gln  1116A  OE1    ...   3.10 ***
...   Gln  1116A  NE2    ...   3.44 *  
...   Asp  1123A  OD2    ...   2.79 ***
G       7C  N1    ...   Asp  1123A  OD2    ...   3.46 *  
...   Asp  1123A  OD1    ...   3.22 ***
G       7C  OP2   ...   Tyr  1120A  OH     ...   2.92 ***
U       8C  OP1   ...   His   761A  NE2    ...   3.07 ***
U       8C  N3    ...   Val  1118A  O      ...   2.55 ***
U       8C  O2    ...   Lys  1117A  N      ...   3.01 ***
...   Val  1118A  N      ...   3.00 ***
...   Val  1118A  O      ...   3.26 ***
U       8C  O4    ...   Val  1118A  O      ...   3.47 *  
...   Tyr  1120A  N      ...   3.21 ***
U       8C  OP2   ...   His   760A  NE2    ...   2.61 ***
G       9C  O4'   ...   His   760A  NE2    ...   3.13 ***
??????? ???????
????????
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3.4.4 L-vRNA crystallization and data collection 
 
Similarly to the L1750 construct the full length L protein was expressed in Hi5 insect cells 
using baculovirus expression system. As described in ‘Methods’ full length L protein was 
purified using the protocol established for L1750, although one significant modification was 
introduced. When the L protein sample was being purified for crystallization experiments the 
vRNA was added to the concentrated sample eluted from the heparin column with the high salt 
buffer (~1M NaCl). Dialysis of such mixture against the final low salt buffer led to L-vRNA 
complex formation and allowed to avoid protein precipitation. After final size exclusion 
chromatography L-vRNA complexes were concentrated up to ~5 mg/ml. Samples were 
supplemented with additional vRNA in order to saturate the protein prior to co-crystallization 
experiments. 
 
 
Figure 3.20 L-vRNA crystals: A – a single plate-like L-vRNA crystal inside the cryo-loop during diffraction 
experiment at the beamline; B – example of the diffraction pattern; C – crystal packing revealing two L-
vRNA molecules in the asymmetric unit and importance of helical C terminus in formation of the crystal 
contact; D – crystallographic statistics 
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As previously for L1750-vRNA crystals, the L-vRNA crystals grew only in case of 16-
nucleotide long, partially double-stranded 3ʹ vRNA. Initial hits – dense, round precipitates – 
were obtained in 100 mM Tris buffer pH 8.0, 100 mM NaCl, and 8% PEG 4000. When manually 
reproduced in hanging drops they yielded a fast-growing, big, and thin hexagonal plates (Fig. 
3.20.A).  
Initial L-vRNA crystals were soft and fragile and if successfully handled and cryo-
protected with 20% glycerol showed weak diffraction of ~8 Å. In order to improve the 
resolution 30% glycerol cryo-protectant was used and crystals were soaked in a stepwise 
manner in cryo-solutions of increasing glycerol concentration. Cryo-protected L-vRNA crystals 
were then subjected to diffraction experiments, using both helical collection strategy and 
maximum transmission of the ID29 beamline. The best crystal diffracted to 4.4 Å (Fig. 3.20.B).     
 
3.4.5 L-vRNA structure solution and structural features 
 
L-vRNA crystallized in the C2 space group (366.7 Å, 144.1 Å, 230.7 Å, 90°, 115.9°, 90°) 
(Fig. 3.20.D). Structure was solved by molecular replacement using the L1750-vRNA as a model. 
There are two molecules of the L-vRNA in the asymmetric unit weakly connected via protein-
protein interactions between the PA-C like domains and the emerging C termini. The same type 
of RNA-protein stacking interactions involving the blunt end of the vRNA, as observed in the 
L1750-vRNA crystals, participates in crystal packing. The C termini of the L proteins interact with 
themselves not only within the asymmetric unit but also with the C termini from the L proteins 
of the neighbouring crystal layer, thus forming major crystal contacts (Fig. 3.20.C). Low 
resolution of the structure does not allow to build in the residues from the C terminus. 
However it is good enough to judge the secondary structure and the connectivity within the 
emerged C terminus, although some of its fragments could not be connected. The portion of 
the C terminus which appears in the L-vRNA C2 structure is solely α-helical. The only exception 
is a small β-strand, forming of which structures the loop 707-718 from the central region of the 
L protein. In the L1750-vRNA structure there is no electron density for this loop, which suggests 
that it gets stabilised upon interaction with the C terminal region.  
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Out of 513 residues, missing in the L1750 construct, the L protein C terminus α-helices 
allow to place around 275 alanines (Fig. 3.21.A-B). Although there is enough space, given the 
very high solvent content and the extensive free areas around the emerged C terminus, yet 
there is no electron density for the remaining ~240 residues (Fig. 3.20.C).  
Given the electron microscopy data obtained by Dr. Hélène Mallet for both the L1750 
(Gerlach et al., 2015) and the full length L protein (not published), and the protein-protein 
interaction experiments with the L1750 and the L7 constructs (see 3.2.4), we know that the C 
terminus does not maintain stable contacts with the body of the protein. It rather hangs 
 
 
Figure 3.21 L-vRNA structure: A – superposition of the L1750-vRNA and L-vRNA structure; RNA strands are 
coloured black and orange in L1750-vRNA and L-vRNA respectively; core unchanged part of the 
polymerase is coloured light grey and light yellow in L1750 and L respectively; endonuclease is coloured 
green and blue in L1750 and L respectively; α-helical C terminus is cloloured red; zoomed-in image 
highlights the difference in endonuclease position between L1750 and L structures. B – overview of the L-
vRNA structure; L protein is coloured as in A. 
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flexibly, and is able to adopt multiple conformations. This flexibility is probably affecting the 
crystal packing, resulting in the lack of density for certain regions, high overall B factors, and 
poor diffraction. To stabilize the C terminus whether by boosting crystal contacts or by blocking 
it in a defined conformation, will be a critical point to improve the diffraction and to obtain the 
structure of this region. 
As far as we can see from the current L-vRNA model, although some structural 
similarities can be noticed between the emerged C terminus and the Influenza virus PB2 mid 
domain, we do not see any structural similarity with the cap-binding domain. Whether 
bunyavirus L protein contains a cap-binding domain remains an open question. However, cap-
binding experiments described below (see 3.5.1) suggest that this activity can be located at the 
very C terminus of the protein, not visible in the L-vRNA C2 structure.  
Superposition of the L-vRNA and the L1750-vRNA unravels another striking feature. The 
position of the endonuclease domain differs significantly between those two structures. In the 
L-vRNA structure it is rotated 170° comparing to the L1750-vRNA structure. The pivotal point is 
located within the flexible linker between the endonuclease domain and the helical linker – 
namely the Gly185 (Fig. 3.21.A). Interestingly in the L-vRNA structure the endonuclease domain 
directly contacts the emerged C terminus, and more specifically its part corresponding to the 
mid domain of Influenza PB2 protein. In this position the endonuclease domain almost 
completely blocks the product exit tunnel. However its active site is oriented in the opposite 
way, so the emerging nascent RNA strand may not reach it. It is worth noticing that in both 
L1750-vRNA and L-vRNA structures the position of the endonuclease domain is not forced by the 
crystal packing. Together with the cryo-EM data, this evidences that the endonuclease domain 
has certain freedom to move, and could be oriented differently at various polymerase 
functional states. 
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3.5 LACV full length L protein and L1750 construct – functional studies 
 
3.5.1 L and L1750 – cap-binding assays 
 
Following unsuccessful trials to identify the cap-binding activity within the C terminus of 
the L protein by means of 7mGTP-sepharose binding, EMSA assays were performed with 
radioactively labelled capped RNA. Following protein samples were tested: the 260 kDa full 
length L, the 200 kDa L1750 (the L9 construct), and the L21 construct (~230 kDa ΔC-terminus). 
Synthetic RNA oligo bearing α-globin mRNA sequence and 5ʹppp modification was radioactively 
labelled by vaccinia capping enzyme (VCE) within the cap structure. The polyU RNA was used in 
all binding assays in order to minimize the unspecific protein-RNA interactions. Experiments 
were performed without Mg2+ to avoid RNA degradation by the N-terminal endonuclease. 
Knowing that L protein specifically binds 3ʹ and 5ʹ vRNA ends their impact on cap-binding 
activity was also tested. The cap-binding complex (CBC) was used as a positive control.  
Results obtained indicate that the 5ʹ vRNA enhances the cap-binding if compared with 
the apo protein. In contrast the 3ʹ vRNA decreases the cap-binding activity. Despite absence of 
the Mg2+ ions in the buffer, degradation of the radiolabelled capped-RNA was observed. This 
might be due to residual amounts of magnesium ions which remained bound to the protein 
during purification procedure. Worth noticing is the significant increase in the capped-RNA 
cleavage in presence of the 3ʹ vRNA (Fig. 3.22.A). Similar experiments using endonuclease 
inhibitor (DPBA) or the H34K mutant of the L protein – that inactivates the endonuclease – 
were performed (not shown). Another experiment comparing putative cap-binding activity of 
the full length L protein, the L21 construct and the L1750 (the L9 construct) strongly suggests that 
the cap-binding region lies within the very C terminus of the polymerase or that at least its 
presence is required to activate the cap-binding. The LACV N protein showed no capped-RNA 
binding activity (Fig. 3.22.B).  
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Figure 3.22 L and L1750 – cap-binding assays. A) EMSA assay with radioactively labelled capped RNA and L 
protein as apo form or in complex with 3ʹ or 5ʹ vRNA; polyU RNA was used to minimize unspecific RNA-
protein interactions; samples in buffer without Mg2+ were incubated ON in RT and resolved on 8-20% 
PAGE (TG). B) similar EMSA experiment but including full length L protein, L1750 (L9), and L21 construct; 
gel was stained with Coomasie (bottom right panel) in order to check whther all the proteins entered 
the gel. In both experiments (Fig. A and B) CBC was used as the positive control. 
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 It has to be emphasized that cap-binding EMSA assays were performed many times and 
proved to vary depending on the batch of protein or incubation times used. Additional 
experiments are envisaged for the future in order to increase the binding signal and to reach 
more reproducibility. This will hopefully allow to confirm our conclusions about the putative 
cap-binding activity of the L protein. 
 
3.5.2 Polymerase activity assays – transcription  
 
In order to check whether recombinant LACV polymerase can perform RNA transcription 
in vitro a set of reactions have been designed (Fig. 3.23.A). Radioactively labelled capped α-
globin mRNA, was used as a substrate for cap-snatching. The 25 nucleotide-long 3ʹ vRNA was 
used as the template for transcription in all the reactions. The polyU RNA was included in all the 
reactions in order to minimize unspecific protein-RNA interactions. The following negative 
controls reactions were performed – with EDTA, with DPBA (the endonuclease inhibitor), and 
with the L protein H34K endonuclease mutant. Additionally some reactions were implemented 
with the 25 nucleotide-long 5ʹ vRNA either added separately, or pre-mixed together with the 3ʹ 
vRNA. The influence of N protein on transcription was checked. It has been also tested whether 
the L1750 (L9) maintains transcriptase activity.  
The results obtained do not show strong evidences for the L protein transcription 
activity in vitro. Instead, two main activities observed are the endonuclease-mediated capped 
RNA degradation and the nucleotide extension of the capped RNA, the latter being template-
independent and not random in terms of nucleotide addition. As observed in the control lines, 
the endonuclease activity can be inhibited in presence of EDTA or DPBA. Moreover, the L 
protein with H34K inactivated endonuclease does not degrade capped mRNA either. As 
observed previously during cap-binding EMSA assays, binding of the 3ʹ vRNA increases slightly 
the endonuclease activity. However, in contrast the cap-binding EMSA assays, the L1750 (L9) 
does not exhibit any endonuclease activity. Presence of nucleoprotein had no significant effect 
on L protein activities. 
Results 
 
157 
 
 
Figure 3.23 Polymerase activity assays – transcription and replication. A) Transcritption assay using 
radiolabelled α-globin RNA; 5 μM L protein/L1750/N protein; 10 μM vRNA, buffer contains 8 mM Mg2+; 
two first lines – ladders generated from the input mRNA by alkaline hydrolysis and T1 RNAse digestion. 
B) Replication assay using 32P-UTP; 3ʹ20WT or 3ʹ9WT11MUT were used as templates; 0.5 μM L1750/vRNA, 
buffer contains 5 mM Mg2+. 
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The transcription product of the expected size range – corresponding to the properly 
cap-snatched primer (~15 nucleotides) extended in a template-dependent manner (+25 
nucleotide) into a final length of ~40 nucleotides – could only be weakly observed in reactions 
containing both 3ʹ and 5ʹ vRNA. This would suggest that 5ʹ vRNA apart of enhancing cap-binding 
is also required during transcription. However, this result does not reflect robust enzymatic 
activity of the L protein if compared with influenza virus polymerase (Reich et al., 2014).  
The main product of L protein activity remains enigmatic. It appears to be a template-
independent, non-random capped-RNA extension. Its synthesis is not modulated by addition of 
the vRNA. It affects capped-RNA but not 3ʹ vRNA (not shown). What is even more confusing is 
that it can be completely shut down by the single H34K mutation inactivating cap-snatching 
endonuclease. Transcription reactions with one out of four nucleotides omitted showed that 
the sequence being built is not random and it most likely starts with a CTP followed by an ATP 
(Fig. 3.23.A).  
 
3.5.3 Polymerase activity assays – replication 
 
Replication assays were performed with either L protein or L1750 using 20 nucleotide-
long 3ʹ vRNA as a template. Reactions were performed with radioactive 32P-UTP and other non-
radioactive nucleotides which, in presence of polymerase activity, should lead to the 
radioactive labelling of the nascent RNA strand. The efficiency of the reactions was always low 
making it difficult to reproduce the results and evidencing the need of forward optimization of 
the experiments.  The resulting products did not correspond to the expected 20 nucleotide-long 
RNAs. In contrast, the controls reactions where only the 32P-UTP was used revealed signal 
corresponding to the 20 nucleotide-long RNA. This suggests that in conditions tested, like in 
case of transcription assays, L protein reveals nucleotide extension rather than template-
dependent polymerase activity. 
Some of the replication experiments were testing the impact of the 5ʹ vRNA on the L 
protein replicase activity. The L protein H34K endonuclease mutant was used to exclude the 
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RNA degradation. Reactions were designed based on previous observations suggesting that the 
5ʹ vRNA might be important for various activities of the L protein (e.g. cap-binding, 
transcription). Moreover, as seen in the L1750-vRNA structure, 5ʹ vRNA proved to have an 
allosteric effect on the catalytic site of the L protein. A set of 5ʹ vRNA oligos of different lengths 
was used, ranging from 10 to 17 and including the 5ʹ cRNA. The RNA oligos representing the 3ʹ 
vRNA template and the 5ʹ vRNA were added sequentially to the L protein. To ensure that the 3ʹ 
and 5ʹ vRNA ends will not anneal, modified 3ʹ vRNA template was also used, having initial 9 
nucleotides WT and following 11 nucleotides mutated (Fig. 3.23.B).  
The results highlight the role of the 5ʹ vRNA, especially when it is incubated with the L 
protein prior to addition of the 3ʹ vRNA template. An RNA product, approximately 27 
nucleotide-long, can be observed when the 12 nucleotide-long 5ʹ vRNA is used (but not others). 
The output of the reaction is different when the 5ʹ vRNA is added after the template 3ʹ vRNA, or 
comparing to reactions when only the template 3ʹ vRNA was used. Other RNA products, the 
nature of which is uneasy to explain, can also be observed. For instance in the reaction with the 
12 nucleotide-long 5ʹ vRNA but omitting the template 3ʹ vRNA a ladder of 14, 17, and 20 
nucleotide-long RNAs appears.  
 
3.5.4 Ribonucleoprotein assembly 
 
Attempts were made to assemble the L1750 or L protein with vRNA and N proteins, in 
order to obtain samples for both replication and transcription activity assays, and co-
crystallization experiments. Given the tendency of N proteins to form tetramers on RNA 
molecules, and knowing that one N protein sequesters 11 nucleotides (Reguera et al., 2013), 
various 3ʹ and 5ʹ vRNA were designed, in order to allow simultaneous binding of a single L1750/L 
protein and four N proteins. vRNA were either synthetic or T7 in vitro transcribed. Following 
initial 1-2 hours incubation of the L1750 protein with the 3ʹ or 5ʹ vRNA, the N proteins were 
added and the mixture was let for longer incubation over few days at 4°C. The final assembly 
mixtures contained 1:1:4 ratio of L1750, vRNA, and N protein at low μM concentrations. 
Structure and function of the La Crosse orthobunyavirus polymerase 
160 
 
Following assembly samples were analysed by the size exclusion chromatography and collected 
fractions resolved on gradient SDS-PAGE. 
Control samples revealed that in absence of vRNA, L1750 and N protieins do not form 
complexes and elute separately as monomeric proteins. N proteins in presence of the vRNA 
form indeed tetramers and elute between elution volumes of monomeric L1750 and N protein. In 
all four assembly samples – 3ʹ53, 3ʹ56, 5ʹ56, and 5ʹ59 – a new gel filtration peak appears 
strongly suggesting that an RNP was formed (Fig. 3.24). Analysis of elution fractions on gradient 
SDS-PAGE confirms that in presence of vRNA a subset of N proteins co-elutes with L1750. It is 
mostly visible in case of both 3ʹ53 and 3ʹ56 vRNA. In all four cases however a significant portion 
of the tetrameric N proteins remains unbound to the L1750. In this type of experiment it is 
impossible to judge whether such behaviour of the tetrameric N proteins is due to the weak 
interaction of the L1750 with the rest of the RNP, which would lead to dynamic assembly and 
disassembly resulting in certain equilibrium. Another, more pragmatic, explanation would be 
that prior to the size exclusion all N protein tetramers are bound to the L1750, but during gel 
filtration samples become greatly diluted which leads to the dis-assembly. Whatever the 
explanation, it is evident that the RNP assembly is mediated by the vRNA, since the L1750 and N 
proteins do not form the complex in its absence. 
Assembled RNPs – samples before gel filtration – were subjected to the co-
crystallization experiments. No crystals were obtained until now. 
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Figure 3.24 RNP assembly of the L1750, N proteins and various 3ʹ or 5ʹ vRNA whose length should 
accommodate single L1750 and a tetramer of N proteins. RNP assembly was tested by gel filtration 
followed by SDS-PAGE. Two upper panels represent controls with either monomeric L1750 and N 
protein, or the N protein tetramer assembled on the RNA. All four RNP assembly experiments (bottom 
panels) reveal a distinct peaks representing the RNPs.   
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Figure 3.25 Interaction with translation factors analysed by gel filtration followed by SDS-PAGE. A) No 
interactions were observed between L protein or N protein and the eIF4GΔ – an eIF4G construct lacking 
both N and C-terminal ends. B) No interactions were observed between L protein or N protein and the 
eIF4A helicase. 
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3.5.5 L protein interactions with host translation factors 
 
In light of the studies showing that bunyavirus transcription requires ongoing translation 
(Barr, 2007; Bellocq and Kolakofsky, 1987), and proving that LACV infection affects the pool of 
some translation factors (Hodges and Connor, 2013), it was decided to study a potential direct 
interactions between the L protein or N protein and some of the subunits belonging to the 
eIF4F translation initiation complex.   
The full length eIF4A helicase and the eIF4GΔ fragment – covering residues 736-1115, 
and lacking both N and C-terminal ends – were kindly provided by Dr. Boris Eliseev from Dr. 
Christiane Schaffitzel team. The eIF4G protein is a platform which binds various translation 
factors, including the eIf4A and the eIF4E, thus contributing to the eIF4F complex formation. 
The proteins were mixed in pair wise combinations and analyzed by gel filtration followed by 
SDS-PAGE (Fig. 3.25.AB). No interactions have been observed. However, it has to be 
emphasized that the eIF4GΔ fragment used in these assays does not comprise regions 
responsible for the interaction with the Influenza PB2 subunit (Yángüez et al., 2012). 
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4. DISCUSSION 
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Bunyavirus L protein is a multifunctional, 260 kDa single chain, RNA-dependent RNA 
polymerase able to both replicate and transcribe the negative-sense viral RNA genome. It 
initiates both processes bound to the pseudo-circularized, nucleoprotein-coated genomic 
segments via their conserved 3ʹ and 5ʹ extremities – the promoter. Lack of structural 
information of the bunyavirus polymerase, especially in complex with vRNA, makes the 
understanding of bunyaviral replication and transcription mechanics elusive and incomplete. 
The aim of this PhD thesis project was to provide structural and functional insight into 
the mechanisms that drive sNSV polymerases. We hoped that studying the La Crosse virus L 
protein we will gain knowledge that could be extrapolated to other sNSV, comprising 
Arenaviridae, Bunyaviridae, and Orthomyxoviridae. The project was designed based on the 
initial assumption that Bunyaviridae LACV and Orthomyxoviridae Influenza virus polymerases 
share similar domain organization. In spite of the fact that, unlike the bunyavirus L protein, the 
Influenza virus polymerase is a heterotrimer composed of PA, PB1, and PB2 subunit, many 
features – the position of the endonuclease domains (Dias et al., 2009; Reguera et al., 2010), 
the position of the highly conserved RdRp motifs, the size of both polymerases, and the head-
to-tail interactions between the Influenza polymerase subunits – were in favour for such 
hypothesis.  
 
Focus of the 1st year of the thesis project was to confirm and characterize both 
structurally and functionally a putative cap-binding domain isolated from the LACV L protein. 
Based on the homologous Influenza virus cap-binding domain positioned in the polymerase PB2 
subunit (Guilligay et al., 2008), we assumed that the LACV cap-binding domain is located within 
the C terminus of the L protein. Constructs were designed following the ESPRIT soluble domain 
screening within that region (Yumerefendi et al., 2010), followed by limited proteolysis and in 
silico prediction of the domain boundaries. Inspite of many protein constructs tested neither 
crystallization trials nor functional cap-binding assays were successful.   
During the 2nd year the project has been broaden to use the LACV full length L protein 
and a more stable C-terminus truncated construct named the L1750 and comprising 3/4 of the 
protein. Both constructs were subjected to numerous trials of crystallization and co-
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crystallization with vRNA, initially without any success. In parallel enzymatic activities and 
vRNA-binding studies were carried out in vitro. Replicase and transcriptase assays provided an 
unclear outcome suggesting that either the polymerase cannot synthesize RNA properly in 
experimental conditions tested, or it requires some additional factors. Cap-binding studies 
strongly suggested that the cap-binding activity may indeed be located within the C terminus of 
the protein, although without providing unambiguous evidence. Binding affinities of the 
genomic 3ʹ and 5ʹ vRNA ends to the L protein – analysed by various approaches including EMSA, 
ITC, and MST – revealed that the bunyavirus polymerase interacts strongly with both genomic 
ends as separate ssRNA and residually when they form dsRNA. Limited proteolysis of the 3ʹ or 5ʹ 
vRNA-protein complexes performed with trypsin revealed different patterns of cleavage, 
suggesting conformational rearrangement upon vRNA binding and/or direct masking of the 
trypsination sites by the vRNA molecules. The MS analysis and Edman degradation of the 
proteolytic fragments allowed to narrow down the region interacting with vRNA to the N-
terminal part of the L protein (residues 368-430) and, surprisingly, to exclude interactions with 
the core RdRp domain. 
During 3rd year of the project LACV L protein-vRNA binding studies were continued. 
They greatly helped to rationalize co-crystallization attempts, which finally resulted in the first 
bunyavirus polymerase crystals. The vRNA which made crystallization of the L1750 possible is a 
partially double-stranded molecule with single-stranded part comprising 3ʹ genomic end. 
Optimized L1750-vRNA crystals diffracted initially to 3.1 Å. Structure was solved with 
experimental phases from tantalum, platinum and selenomethionine derivative crystals. 
Resolution was further improved up to 2.6 Å.  
Details of the L1750-vRNA structure and conclusions that were made based on it are 
described in the publication attached to the ‘Results’ chapter of this thesis (Gerlach et al., 
2015). Below major observations are recapitulated and some additional features – not included 
in the publication – are discussed in light of other results obtained during the PhD project.  
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To our knowledge the LACV L1750-vRNA crystal structure is the first structure of a 
Bunyaviridae polymerase. It reveals for the first time detailed domain architecture of that 
multifunctional protein providing insight into many common RdRp elements and revealing new, 
specific structural features.  Our structure covers ~3/4 of the full length L protein and 
represents the pre-initiation state of the polymerase. The solvent-exposed N-terminal 
endonuclease is followed by an elongated helical linker leading to a compact domain which 
forms one side of the molecule, and contributes to the vRNA binding. The central, right-handed 
RdRp domain contains both classical features – fingers, fingertips, palm, and thumb – as well as 
specific modules. The C-terminal domains close the circular architecture of the polymerase.  
Apart from the structure of the LACV L1750-vRNA complex the Cusack group obtained as 
well protein structures of the bat Influenza A and human Influenza B polymerase in complex 
with their viral promoters (Pflug et al., 2014; Reich et al., 2014). This provides unique chance to 
analyse and compare in detail the architecture of hitherto mysterious sNSV RNA dependent 
RNA polymerases. The major and straightforward conclusion is that bunyavirus monomeric and 
influenza virus heterotrimeric polymerases exhibit extremely high fold similarity. This fact 
greatly exceeds the initial hypothesis concerning domain organization similarity. In spite of 
almost none – except for some catalytically important motifs – sequence identity, the majority 
of secondary structures position is highly similar in both polymerases. This allows structural 
comparison of the LACV L protein N terminus, its core RdRp region, and the C-terminal region 
with the Influenza polymerase PA, PB1 and PB2 subunits. It also raises the question about the 
evolution of sNSV polymerases and suggests that Bunyaviridae (and possibly Arenaviridae) 
polymerases are evolutionary older and had to be split into 3 subunits in order to form the 
Orthomyxoviridae heterotrimeric polymerase. 
Another major observation that can be made based on the L1750-vRNA complex structure 
is the presence of two separate binding sites, specifically recognizing both 3’ and 5’ RNA 
genomic ends. Our in vitro L1750-vRNA binding studies confirm that the L protein recognizes 
both genomic ends as single-stranded molecules via their highly conserved initial nucleotides. 
Trypsin cleavage sites within the L protein are protected upon incubation with vRNA which 
further confirms that indeed in solution both 3ʹ and 5ʹ RNA genomic ends bind to their specific 
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sites observed in the crystal structure. The 3ʹ vRNA end is recognized by the L1750 as a non-
structured stretch of 8 nucleotides. Distant parts of the L1750 protein are contributing to the 3ʹ 
vRNA binding groove formation, although the majority of interactions is mediated by the vRBL 
from the PA-C like domain. Noteworthy structural element is the clamp specifically interacting 
with nucleotides A6-C7-A8. The 5ʹ vRNA end forms a stem-loop containing 10-11 initial 
nucleotides. It is bound in the pocket formed by the fingernode emerging from the fingers 
domain and the vRBL with its elongated loop called the arch. Binding of the 5ʹ vRNA 
allosterically stabilizes the motif F – one of the conserved catalytic RdRp motifs. 
Until now, given the extensive complementarity between bunyavirus RNA genomic ends 
– it was generally assumed that they interact with the L protein as dsRNA panhandle (Barr and 
Wertz, 2004; Kohl et al., 2004; Patterson et al., 1983; Raju and Kolakofsky, 1989). Our structure 
provides completely new image of bunyavirus polymerase-vRNA interactions and creates the 
need for revision of previously reported studies on bunyaviral promoters and polymerase 
activity. We propose that the terminal, conserved 11 nucleotides do not anneal during entire 
viral cycle. The only exception from that rule is when the L protein falls from the RNP creating 
the chance for the 3ʹ and 5ʹ ends to form a dsRNA which would be then recognized by the host-
cell innate immune system receptors like RIG-I (Weber et al., 2013). The dsRNA formation 
observed in LACV vRNP and cRNP upon psoralen cross-linking (Raju and Kolakofsky, 1989) can 
be explained by the distal duplex formation, which was proven to be essential for the efficient 
RNA synthesis (Barr and Wertz, 2004). As discussed in more detail in the attached publication 
(Gerlach et al., 2015) it is possible that the 3ʹ end, while entering the polymerase active site 
through the template entry tunnel, forms such distal duplex with the 5ʹ end which terminal 
bases are bound by the L protein in the form of a stem loop. If this would be true, the terminal 
3ʹ-UCA repeat would overshoot the active site, and the replication would initiate at the second 
UCA repeat. This is consistent with the prime-and-realign mechanism, and would imply that the 
distal duplex formation stabilizes the initiation state of the polymerase. Interestingly, it was 
reported that the assembly of a functional Arenaviridae Machupo virus polymerase complex 
also requires single-stranded genomic RNA ends (Kranzusch et al., 2010).   
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Another intriguing feature of the bunyavirus polymerase is its capacity to switch 
between transcription and replication modes. It was reported that the G:U wobble pair at 
position 9 in the Orthobunnyavirus genomic RNA is critical in mediating this switch. 
Mutagenesis studies performed on the BUNV genomes revealed that while the 3ʹ vRNA 9-U 
promotes transcription, the 3ʹ cRNA 9-C promotes replication (Barr and Wertz, 2005). Our L1750-
vRNA structures with either 5ʹ vRNA or 5ʹ cRNA show no significant difference in the 5ʹ RNA 
binding and the way it allosterically regulates the active site. It remains to be structurally 
verified whether the 3ʹ vRNA and 3ʹ cRNA templates affect differently the polymerase residues 
within the template entry tunnel or the polymerase active site.  
Analysis of the L1750-vRNA structure revealed four tunnels leading into and from the 
inner polymerase cavity which likely serve the purposes of NTP entry, template entry, template 
exit, and product exit. Given the significant structural similarity among viral RdRp domains and 
the availability of the RdRp structures in complex with RNA, we were able to assign all four 
tunnels. Superposing the L1750-vRNA structure with structures of the HCV or the Poliovirus 
polymerase in complex with the template-product RNA duplex (Gong and Peersen, 2010; 
Mosley et al., 2012) we noticed that the LACV polymerase product exit tunnel is too narrow to 
accommodate such RNA duplex. Poliovirus polymerase-RNA structure was particularly helpful 
since having long RNA duplex in the active site cavity – covering approximately a single 
complete double helix turn – it suggests that in LACV polymerase case such duplex undergoes 
separation, forced by the C-terminal region of the L protein, mostly the lid domain. Upon 
separation of both RNA strands the product exits, like in the Poliovirus polymerase case, 
through the product exit tunnel, and the template is directed towards another, distinct tunnel, 
which is located very close to the template entry tunnel. (Fig. 4.1.A). Comparing the distribution 
of the four tunnels from the LACV L protein with the four tunnels from the Qβ replicase-RNA 
structure (Takeshita and Tomita, 2012) ensured us that the fourth LACV L protein tunnel is for 
the template strand to exit the active site cavity (Fig. 4.1.B). 
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Figure 4.1 Distribution of the four tunnels leading into and out from the internal cavity active site of the 
L1750. A) Tunnels and internal cavity are represented as green mesh; LACV 3ʹ and 5ʹ vRNA are coloured in 
cyan and yellow respectively; Poliovirus polymerase was superposed onto the L1750-vRNA structure (PDB: 
3OLB)(Gong and Peersen, 2010); Poliovirus template and product RNA strands are coloured in blue and 
red respectively; Left panel proposes the RNA duplex separation inside the L1750 and highlights RNA 
product and template separate exit tunnels. B) Comparison of the four tunnel distribution between the 
L1750-vRNA structure and the Qβ replicase structure (PDB: 3AVY)(Takeshita and Tomita, 2012).  
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 Not surprisingly all four tunnels are built by highly conserved and positively charged 
residues, able to accommodate the nucleic acids. Distribution of the tunnels, and especially 
both template and entry and exit tunnels, allowed us to propose the replication model, details 
of which are described in (Gerlach et al., 2015). In brief, the model proposes that, in the context 
of the RNP, the close proximity of the template tunnels allows immediate re-coating of the 
genomic RNA by nucleoproteins once it has passed through the polymerase active site and was 
used as a template. During a single replication cycle, when the L protein travels along the vRNP 
or cRNP templates, not a single nucleoprotein is lost or any additional needed. This is supported 
by the several findings from the crystal structures: (a) each nucleoprotein sequesters 11 
nucleotides, (b) the L protein itself, accommodating both 3ʹ and 5ʹ genomic ends during the pre-
initiation state, sequesters approximately 20 nucleotides, (c) modelling of the Poliovirus 
template RNA inside the template tunnels and the active site of the LACV L protein shows that 
the entire template RNA pathway can accommodate around 20 nucleotides. During RNA 
synthesis the template RNA would unwind from the nucleoprotein and would enter through the 
template entry tunnel. At the same time the template emerging from the template exit tunnel 
would bind to the very same RNA-free nucleoprotein. This is possible because the distance 
between the entry and the exit tunnels is not greater than the length of a single nucleoprotein. 
The L protein processing in such manner along the RNP would generate a shift of the 
nucleoprotein neckless in regards to the genomic RNA after each replication round. Proposed 
model explains how the RNP can preserve its structural integrity during transcription and 
replication, avoiding the N protein disassembly and minimally disrupting the RNP. This is 
consistent with previous observations in Orthomixovirus RNP studies that show consistently 
assembled RNPs during its replication (Arranz et al., 2012).    
The replication model which we propose explains as well how the emerging nascent 
strand RNA is directly packaged into the cRNP or vRNP. It assumes that the second L protein 
binds to the processing L protein at the rear, product exit site. The first synthesized 5ʹ vRNA or 
cRNA is immediately bound as a hook structure in its binding pocket. The rest of the emerging 
nascent strand is coated by the N proteins while inactive L protein remains attached to the 
active one during entire replication cycle. At the replication termination the last synthesized 3ʹ 
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end is immediately bound in the 3ʹ binding groove of the inactive L protein. Although 
dimerization between Bunyaviridae L protein has not been reported, there are studies 
suggesting that dimerization of the Influenza polymerase is required for replication (Arranz et 
al., 2012; York et al., 2013).   
Initial hypothesis saying that all sNSV polymerases share the same domain architecture, 
confirmed strongly by comparison of the L1750-vRNA structure with Influenza A and B 
polymerase structures (Pflug et al., 2014; Reich et al., 2014), justifies the assumption that the 
bunyavirus cap-binding domain is located within the C terminus of the L protein. The L protein-
vRNA structure reveals low resolution electron density which allows to position approximately 
250 out of 500 residues missing in the L1750-vRNA structure, however with not enough 
resolution to see any side chains. There are no features that would resemble the Influenza cap-
binding domain, or at least a β-strand like the one present in the cap-binding domain (Guilligay 
et al., 2008). The cap-binding EMSA assays performed with the radioactively labelled capped 
RNA and the full length L protein, the L1750 construct, or the L21 230 kDa construct missing the 
very C terminus showed that the cap-binding activity may be indeed be located within the very 
C terminus of the L protein. However, it has to be emphasized that the EMSA cap-binding 
assays could not be robustly reproduced and many times showed inconsistent results. This can 
be explained by either a non-specific binding of the capped RNA, which occurred more via the 
backbone of the nucleic acid and not the via the cap moiety itself. However, it cannot be 
excluded that the cap-binding activity emerges only at certain conformation of the L protein, or 
requires an unknown host factor that would stabilize the active conformation of the cap-
binding domain. Features revealed by the L protein-vRNA structure are in favour of such 
scenario. We observed that a region of the stabilized C terminus – which can be assigned as the 
homolog of the Influenza PB2 mid domain – interacts directly with the N-terminal endonuclease 
domain. Similarly, different part of the C terminus could either interact with other region of the 
L protein, the N protein, or with an unknown host factor. Although by gel filtration we did not 
observe such interactions between the isolated LACV L protein C terminus (the L7 construct) 
and the L1750 or the N protein, it cannot be excluded that they would occur in the full length L 
protein context.  
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Orthobunyavirus L protein requires an ongoing translation to avoid premature  
transcription termination (Barr, 2007; Bellocq and Kolakofsky, 1987). As revealed by (Vialat and 
Bouloy, 1992) the smaller 40S ribosome subunit scanning along the viral mRNA is sufficient to 
ensure non-interrupted viral transcription. During host-cell translation the 40S subunit is 
recruited onto the mRNA by the eIF4F complex composed of the initiation factors – the 
scaffolding eIF4G, the eIF4A helicase, and the eIF4E cap-binding protein (Gross et al., 2003; 
Myasnikov et al., 2009). The ambiguities concerning bunyavirus L protein cap-binding domain, 
cytoplasmic location of the transcribing L proteins, and the requirement of the ongoing 
translation, open the possibility for a direct interaction between the L protein and the host 
translation initiation factors – like those forming the eIF4F complex. Interestingly, analysis of 
the host-cell proteins upon LACV infection demonstrate the effect on eIF2α phosphorylation 
and eIF4E dephosphorylation, resulting in global shut down of the host translation (Hodges and 
Connor, 2013). Studies on the Orthomyxoviridae Influenza virus translation revealed its 
independence from the cellular cap-binding factor eIF4E, proving in the same time direct 
interaction between the eIF4G and the influenza PB2 subunit, which suggests that this viral 
protein is able to replace cellular eIF4E factor (Yángüez et al., 2012). Similarly, it was reported 
that the Arenaviridae Junin virus translation is also independent from the cellular cap-binding 
factor eIF4E, and instead the N protein associates with the eIF4A and the eIF4G cellular factors 
(Linero et al., 2013). In light of these studies we decided to examine the possibility of the direct 
interaction between the LACV L protein and subunits of the cellular eIF4F complex. So far only 
the eIF4A and the middle region of the eIF4G were tested by gel filtration and showed no 
interaction. Following studies, including the eIF4E translation factor, are being performed.  
Another solution to the cap-binding requirement comes from the studies on the 
Hantavirus HANV. It was proposed that the cap-binding activity resides within the HANV N 
protein which is thought to replace the entire eIF4F complex and actively participate in 
transcription both interacting with the L protein and providing the cap-snatched RNA oligos 
acquired from the pool of the host mRNA directed for decapping in P-bodies (Mir and 
Panganiban, 2008; Mir et al., 2008, 2010). In general it cannot be excluded that the N proteins 
from various sNSV viruses possess additional functions other than RNA-binding and genome 
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encapsidation. A good example is the Arenaviridae Lassa virus N protein which has an 
exonuclease activity (Hastie et al., 2011; Qi et al., 2010). However, in case of the 50 kDa HANV 
N protein the lack of crystal structure makes it difficult to judge its functions with no ambiguity. 
In light of the LACV N protein crystal structure (Reguera et al., 2013) and our negative results 
from the EMSA capped-RNA binding studies it can be stated that the Orthobunyavirus N protein 
does not have the cap-binding activity. We also did not observe any N protein impact on 
transcription in our L protein activity assays. It remains to be tested whether RNP complexes 
assembled in vitro with the L protein, the N proteins, and approximately 55-nucleotide long 3ʹ 
or 5ʹ genomic RNA ends will exhibit replication or transcription activity.      
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